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ABSTRACT 
Apoptosis is a programmed cell death mechanism that is evolutionary conserved 
from worms to humans. Apoptosis is mediated by initiator and effector caspases.  The 
initiator caspases carry long pro-domains for their interaction with scaffolding proteins to 
form a cell-death platform, which is essential for their activation. Activated initiator 
caspases then cleave effector caspases that execute cell death through cleaving 
downstream targets. In addition to their apoptotic function, caspases also participate in 
events where caspase activity is not required for cell killing, but for regulating other 
functions, so-called non-apoptotic functions of caspases. The Drosophila initiator caspase 
Dronc, the ortholog of mammalian caspase-2 and caspase-9 has a CARD domain that is 
essential for its interaction with the scaffolding protein Dark to form the apoptosome. 
Apoptosome formation is crucial for activation of Dronc. Activity of both initiator and 
effector caspases are further kept in control by the ubiquitin system to avoid 
inappropriate caspase activity. However, mechanistic details of how the ubiquitin system 
regulates activation of Dronc are not clear. Therefore, I investigated the ubiquitylation 
status of Dronc and its function in Drosophila. I found that Dronc is mono-ubiquitylated 
at Lys78 (K78) in its CARD domain, which blocks its interaction with Dark and 
formation of the apoptosome. Furthermore, I demonstrated that K78 mono-ubiquitylation 
plays an inhibitory role in Dronc’s non-apoptotic functions, which may not require its 
catalytic activity but may be important for the survival of the fly. This thesis study 
unveils the link between the ubiquitin system and caspases through a regulatory 
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mechanism where a single mono-ubiquitylation event could inhibit both apoptotic and 
non-apoptotic functions of a caspase. 
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CHAPTER I 
 
Introduction 
 
Part I. Apoptosis 
Cell death was first mentioned in the nineteenth century by anatomists who 
worked on metamorphosis of organisms such as tad poles and insects [1]. They used 
histological techniques to examine various tissues that undergo cell death [1]. However, 
the features of cell death were characterized in the twentieth century (early 1970s) by 
electron microscopy [2]. Australian pathologists John Kerr and his colleagues observed 
nuclear and cytoplasmic condensation of dying mammalian cells [2]. These changes 
cause cell shrinkage, DNA fragmentation and blebbing of the plasma membrane, which 
appears in a specific pattern [2]. Eventually, whole cells break up into ‘apoptotic bodies” 
that are being taken up by phagocytic cells to be ingested. They termed this type of cell 
death as “apoptosis” that originates from ancient Greek and means “falling off” [2].  
Cell death is as important as cell survival is when it comes to homeostasis of 
organisms. During development of organisms, apoptosis occurs to shed extra or damaged 
cells and to drive morphogenesis for cellular rearrangements [3, 4]. In the presence of 
stress stimulus, however, apoptosis can aid dying cells to communicate with neighboring 
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cells by releasing mitogenic signals. This type of communication can induce tissue 
regeneration or tumor development [3, 4]. 
Apoptosis is a well-conserved cell death mechanism from worms to humans 
(Figure 1.3). Redundancy between apoptotic players increases in proportion to 
complexity of eukaryotes so as dissecting the mechanism of apoptosis becomes more 
challenging. Higher eukaryotes such as mammals have multiple pro- and anti-apoptotic 
regulators whereas lower eukaryotes such as Drosophila melanogaster have fewer 
players. The following sections will elaborate on mechanistic details of Caenorhabditis 
elegans, Drosophila and mammalian apoptotic machinery. 
A. Apoptotic Machinery in C. elegans 
First insights in to the mechanism of apoptosis came from studies in the nematode 
Caenorhabditis elegans [5]. Examination of cell lineages of C. elegans by J. E. Sulston 
and his colleagues led to the discovery that 131 out of 1090 cells generated during C. 
elegans development undergo programmed cell death (apoptosis) [5, 6]. The first attempt 
to identify genes that are responsible for apoptosis was a genetic screen in C. elegans. 
This screen discovered cell-death abnormal (ced)-1 and ced-2 genes that are important 
for phagocytosis of apoptotic cells [7]. Further screens carried out by Robert Horvitz and 
his colleagues identified core proteins of the apoptotic pathway in C. elegans: egg-laying 
defective (egl)-1, ced-9, ced-3, ced-4 [8-10] (Figure 1.3). Dying cells require EGL-1 (a 
pro-apoptotic protein with a BH3 motif), CED-3 (a caspase homolog) and CED-4 
(homolog of Apaf1 and Dark) (Figure 1.3) [11]. In healthy cells, ced-9 encodes a pro-
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survival bcl-2 homolog, which protect cells from apoptosis by inhibiting ced-4 (Figure 
1.3) [11]. In dying cells, EGL-1 blocks CED-9’s function to inhibit CED-4, which results 
in C. elegans apoptosome assembly and activation of CED-3 [11]. Induction of egl-1 
expression by developmental cues or external signals determines which cells undergo cell 
death [11]. Strong loss of function mutations in egl-1, ced-3 or ced-4 blocks most 
apoptotic cell death; however, do not affect viability of C. elegans. Cells that lack the 
apoptotic machinery can differentiate into neural cells [11]. On the other hand, strong 
loss of function mutations in ced-9 cause embryonic lethality [11]. Studies to identify 
apoptotic players in C. elegans have helped the apoptosis field to advance with the 
discovery of the apoptotic pathways in Drosophila melanogaster and mammals, which 
are described in the next two sections.  
B. Apoptotic Machinery in Drosophila  
Drosophila melanogaster, also known as the fruit fly, has been used as a model 
organism more than one hundred years for genetic analyses. Drosophila has a short life 
cycle, taking 10 days from embryogenesis to eclosion at 25°C. The life cycle of 
Drosophila consists of 4 developmental stages; embryonic, larval, pupal and adult. 
(Figure 1.1) Development of an embryo into an adult requires apoptosis to remove 
unwanted cells and tissues to sculpt the final form of the organism. During 
embryogenesis, developmental apoptosis can be observed 7 hours after egg deposition 
(Stage 11) [12]. Apoptosis contributes to embryonic pattern formation (stages 12-14) that 
allows for segmentation of the embryo along the anterior-posterior axes by segment 
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polarity and homeotic genes [5]. In addition to segmentation, apoptosis is essential for 
Central Nervous System (CNS) maturation during embryogenesis. For example, midline 
glial cells die during stage 12-15 and reduce their numbers from 8-10 cells to 3 cells. One 
of the survival signaling pathways, Epidermal Growth Factor Receptor (EGFR) pathway 
is found to inhibit apoptosis to determine the final number of surviving cells in midline 
glia [5]. In addition, embryonic neuroblasts undergo apoptosis [13]. Completion of 
embryogenesis is followed by the larval phase, when epithelial imaginal discs proliferate 
in preparation to give rise to the final adult structures (Figure 1.1). The mature larva 
enters into metamorphosis, marking the start of pupal development where the pre-
patterned tissues are then differentiated, reorganized, and sculpted leading to the final 
adult stage (Figure 1.1). 
Cell death plays various roles in larva and pupa to remove larval structures that 
are not needed for the fully formed adult fly.  Ecdysone receptor (EcR) signaling 
regulates apoptosis and metamorphosis during both larval and pupal stages [14, 15]. 
During mid-3
rd
 instar, a low-dosage ecdysone pulse induces apoptosis through 
upregulation of pro-apoptotic genes [16]. A higher-dosage ecdysone pulse at the end of 
3
rd
 instar triggers metamorphosis through remodeling of tissues such as abdominal 
muscles via apoptosis [14]. A second ecdysone pulse at 12 hours after puparium 
formation initiates larval salivary gland degradation and larval fat body remodeling, 
which also requires apoptosis [14]. In addition, EcR signaling induces apoptosis for 
removal of a subset of neurons in the ventral nervous system, remodeling of the optic 
lobe and neuronal pruning throughout pupal development [14]. Independently of EcR  
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Figure 1.1. The Life Cycle of Drosophila melanogaster 
The Drosophila life cycle consists of embryonic, larval, pupal and adult stages. At 25°C, 
Drosophila can develop from embryo to adulthood in 10 days. Embryos hatch 1 day after 
egg lay. Larval phase includes 1
st
, 2
nd
 and 3
rd
 instar stages which take about 4 days. Larva 
molts into pupa. Metamorphosis takes 4-5 days, which is followed by eclosion. 
 
 
 
 
 
6 
 
 
 
signaling, apoptosis is also observed to remodel pupal retinal cells where surplus 
interommatidial cells between each ommatidium of the Drosophila eye are eliminated 
through apoptosis [17-20]. Upstream regulation of apoptosis involves various signaling 
pathways that are controlled by developmental cues as exampled above. The remaining 
of this section will focus on the apoptotic cascade and its players in detail. 
Drosophila entered the apoptosis field in the mid-90’s after a deficiency screen in 
embryos for identification of apoptotic genes uncovered the H99 locus (75C1,2) [21]. 
H99 mutant embryos were embryonic lethal and did not show any features of apoptosis in 
developing embryos. However, a high level of X-ray exposure of H99 mutant embryos 
displayed a few apoptotic cells [21]. This suggested that genes that are in the H99 locus 
are upstream regulators of apoptosis because effectors of apoptosis can still function in 
X-ray induced H99 mutant embryos. Reaper (rpr) was the first gene being cloned from 
the H99 locus [21]. After rpr, head involution defective (hid) was isolated from the H99 
locus and shown to work in parallel to rpr for induction of apoptosis [22]. Interestingly, 
allelic combinations of hid mutant have adult male genitalia rotation defects and 
abnormal wing phenotypes [23]. These phenotypes were attributed to defects in cell death 
because both male genitalia rotation and wing development require caspase activation 
[24]. The last gene isolated from the H99 locus was grim which was shown to play a role 
in apoptosis in parallel to rpr and hid [25]. All three genes found in the H99 locus were 
able to induce apoptosis independently in both wild-type and H99 mutant embryos. 
Induction of apoptosis through activation of hid, rpr or grim can be suppressed by 
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baculovirus P35 (an effector caspase inhibitor) protein expression, suggesting that P35 
and caspases act downstream of hid, rpr and grim [22] [25-27].  
In an attempt to screen for cell death inhibitors through mutations that enhance 
rpr-induced cell death in the Drosophila eye, thread was identified as the Drosophila 
Inhibitor of Apoptosis 1 (DIAP1) (Figure 1.2) [28]. IAPs were first discovered in 
baculoviruses and can block apoptosis during viral infection [29]. Their characteristic 
features include at least one Baculovirus IAP Repeat (BIR) motif that is located in the N-
terminus or central portion of IAPs and some have a C-terminally located RING domain 
[30]. A database search after identification of DIAP1 uncovered DIAP2 as the second 
IAP in Drosophila [28]. DIAP1 has two BIR domains; whereas DIAP2 has three BIR 
domains and both IAPs share a C-terminal RING domain [28]. They can suppress rpr and 
hid-induced or developmentally occurring cell death in the Drosophila eye [28]. In 
another screen, the Drosophila homolog of mammalian Bruce (dBruce) was 
characterized as the third IAP in flies. dBruce suppressed rpr- and grim-induced but not 
hid-induced cell death in the Drosophila eye [31, 32]. dBruce encodes an E2 conjugation 
enzyme with one BIR domain but does not function through ubiquitylation of RPR and 
GRIM [31, 32]. A fourth IAP in flies was identified with one BIR domain only and no 
RING domain, which was called Deterin [33] and is most similar to mammalian 
Survivin. Deterin was shown to suppress rpr-induced cell death in Drosophila S2 cells 
[33]. Interestingly, BIR-only or C-terminal-only Deterin could not inhibit ectopically 
induced apoptosis in cells [33]. In fact, C-terminal-only Deterin acted as a dominant 
negative construct by competing with wild-type Deterin [33]. 
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The link between Drosophila IAPs, RPR, HID and GRIM came after two studies 
from the same group showed that DIAP1 and DIAP2 can interact with RPR, HID and 
GRIM physically through their BIR domains and this interaction could yield a depletion 
of RPR, HID and GRIM in SF-21 cells (Figure 1.2) [34, 35]. RPR, HID and GRIM share 
a conserved sequence of 14 amino acids (RHG motif) at their N-terminus [58, 15, 17]. In 
particular, first 37 amino acids of HID and GRIM were required and sufficient to induce 
apoptosis and bind to DIAP1 [58].  
In a screen carried out to find modifiers of rpr- and hid-induced cell death in the 
Drosophila eye, both loss- and gain-of-function mutations in thread were recovered [36, 
37]. To determine the importance of DIAP1 for cell viability, another study characterized 
embryonic thread
5
 homozygote mutants. thread
5
 mutant exhibited embryonic lethality 
associated with increased apoptosis [38]. Genetic and biochemical analyses of loss- and 
gain-of-function mutants showed that the BIR1 domain of DIAP1 binds to RPR and 
GRIM; whereas BIR2 interacts with HID (Figure 1.2) [36, 37]. Controversially, a 
structural study showed that the first 7 aa of HID, RPR and GRIM was sufficient for their 
interaction with DIAP1 BIR2, which was similar to the interaction between their 
mammalian counterparts, BIR3 of XIAP1 and Smac [39]. Two different groups 
characterized sickle (skl) as the new member of IAP antagonists [40, 41]. skl resides just 
outside of the H99 locus and carries homology to N-terminal 4 residues in RPR, HID and 
GRIM. Alanine in the first position and proline on third position were highly conserved 
among RPR, HID, GRIM, Skl and their mammalian counterparts Smac/DIABLO and 
HtrA2/OMI [40-42]. Skl (1-15) appeared to interact with BIR2 of DIAP1; whereas, full 
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length Skl interacted with BIR1 of DIAP1 [40, 41]. Skl expression in Drosophila cells 
resulted in apoptosis that can be suppressed by P35 [40, 41].  
The first link between RHG proteins and mitochondria came from a study 
identifying that the C-terminus of HID (393-409) carries a Mitochondrial Targeting 
Sequence (MTS) and is necessary for mitochondrial localization in mammalian and SF9 
cells [43]. Deletion of the MTS (HID (393-409)) resulted in abrogation of mitochondrial 
localization in mammalian cells; however, it did not affect its function [43]. In contrast, 
hid
A206
 and hid
A329
 truncation alleles were characterized as loss-of-function mutants in 
Drosophila [43]. Among the sequences of GRIM to form an alpha-helix structure Grim 
Helix 3 (GH3) with 15 aa was identified. The GH3 had homology to same regions in 
RPR and Skl [44].  Both the N-terminus of GRIM and its GH3 region were necessary for 
apoptosis-inducing ability of GRIM in Drosophila independent from each other [44]. 
Interestingly, GH3 was essential for GRIM to associate with mitochondria and also co-
localize with cytochrome c [44]. In addition to GRIM, the GH3 region of RPR was 
characterized to be necessary and sufficient to localize to the mitochondria in S2 cells 
[45]. Further examination discovered that the GH3 region interacts with the outer 
membrane of mitochondria and this interaction enhances rpr-induced apoptosis [46]. The 
GH3 region mutant rpr (rpr
∆GH3
) could retain its interaction with DIAP1 and its ability to 
suppress DIAP1-mediated caspase inhibition in yeast cells [45]. However, rpr
∆GH3
 mutant 
cannot induce DIAP1 degradation in S2 cells, which can be restored by targeting rpr
∆GH3
 
mutant to the mitochondria [45]. A study to examine the relationship between RHG 
proteins and their ability to interact with each other and the mitochondria discovered that  
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Figure 1.2. IAP Antagonists bind to BIR1 and BIR2 domains of DIAP1 to inhibit its 
interaction with caspases.  
Upon apoptotic stimuli, RPR, GRIM and HID oligomerize and attach to the mitochondria 
for a better cell killing activity. RPR and GRIM bind to both BIR1 and BIR2 domains of 
DIAP1; whereas, HID binds to BIR2 of DIAP1, which causes DIAP1 auto-degradation. 
These interactions block binding of Drice and Dcp-1 to BIR1 of DIAP1 and Dronc to 
BIR2 of DIAP1. On the other hand, in living cells, DIAP1 could ubiquitylate caspases 
and IAP antagonists for their inhibition. 
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RPR associates with itself and GRIM and HID but not Skl through its GH3 region [47]. 
The MTS of HID was required for recruitment of RPR and DIAP1 to the mitochondria, 
where RPR induces DIAP1 degradation [47]. This study suggested that forming a 
multimeric RHG complex at the mitochondrial membrane provides stability for these 
proteins and enhance degradation of DIAP1 to induce cell death cooperatively and 
efficiently (Figure 1.2) [47]. 
In addition to Skl, another IAP antagonist in Drosophila was identified in the 
same year through tandem affinity purification followed by mass-spectrometry; a 
thioredoxin peroxidase Jafrac2 [48]. Jafrac2 interacts with the BIR2 domain of DIAP1 
and carries the same conserved sequences with other IAP antagonists at its N-terminus 
[48]. Interestingly, Jafrac2 was found to localize and release from the Endoplasmic 
Reticulum (ER) to the cytosol upon apoptosis induction [48]. Interestingly, another study 
showed that DIAP1 when targeted to the ER, away from the mitochondria can be 
degraded by RPR
wt
 and RPR
∆GH3
 mutant, suggesting that intracellular membranes could 
act as scaffolds for DIAP1 degradation [46]. Jafrac2 also can induce apoptosis in S2 cells 
and in the Drosophila eye by competing with Dronc for binding to the BIR2 of DIAP1 
[48]. Further examination of interactions between IAP antagonists and DIAP1 in S2 cells 
identified that RPR and GRIM bind to BIR1 and BIR2 of DIAP1 with equally efficiency; 
whereas HID, Skl and Jafrac2 preferentially bind to BIR2 of DIAP1 (Figure 1.2) [49].  
The apoptotic pathway requires the assembly of a large protein complex critical 
for responding to the developmental or stress-induced cues that trigger activation of 
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caspases (Cysteine-Aspartic proteases) (Figure 1.3) [50]. All caspases are initially 
produced as inactive enzymes, called zymogens. These zymogens contain a large and a 
small subunit [50]. The region required for catalytic activity is located within the large 
subunit [50]. There are two types of caspases; initiator and effector caspases (Figures 1.3 
and 1.4). The difference between initiator and effector caspases is that initiator caspases 
have a long pro-domain for interacting with scaffolding proteins [50]. This interaction 
induces their dimerization that is followed by auto-cleavage between their large and small 
subunits [50]. Activated and mature initiator caspases cleave effector caspases for their 
activation to initiate apoptosis (Figures 1.3 and 1.4). Once activated, effector caspases 
cleave downstream targets to dismantle the cells. 
Because rpr, hid and grim-induced cell death can be suppressed by P35, efforts to 
identify Drosophila caspases through degenerate PCR-based methods revealed two 
Drosophila effector caspases: Drosophila Interleukin-1β-Converting Enzyme (drICE) 
and Drosophila Caspase-1 (DCP-1) [51-54]. These caspases share 57% amino acid 
identity with each other and are homologs of mammalian caspase-3 and caspase-7 [52-
54]. In addition, they both have a catalytic cysteine with conserved QACQG sequence 
and a short pro-domain [52-54]. After discovery of Drosophila caspases, the next 
question was whether or not they could be inhibited by IAPs. In this direction, studies in 
SF-21 cells showed that DIAP1 but not DIAP2 can block apoptosis induced by drICE 
[55]. Further analysis suggested that drICE can be processed by HID activation and the 
processed version but not the pro-enzyme can physically interact with DIAP1 [55].  
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Figure 1.3. The C. elegans, Drosophila and Mammalian (Intrinsic) Apoptotic 
Pathways.  
Apoptosis is an evolutionary conserved mechanism from worms to mammals. Apoptotic 
stimuli induce pro-apoptotic proteins to inhibit IAPs. This inhibition promotes activation 
of the initiator caspases through formation of the apoptosome. Activated initiator 
caspases further activate effector caspases through cleavage to execute apoptosis.  
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Another study that was carried out in yeast with DIAP1 and DCP-1 showed that 
DIAP1 can block activity of DCP-1 [56]. 
The third caspase identified in Drosophila was dredd [57]. Besides carrying 
features of the caspase family, dredd has a long pro-domain which was distinct from 
drICE and dcp-1 and similar to mammalian caspase-8 [57]. Another difference between 
dredd and other Drosophila caspases was the position of the catalytic cysteine, which is 
encompassed by QACQE sequence where Glycine is replaced by Glutamine. 
Heterozygosity at dredd can suppress rpr- and grim-induced apoptosis in the eye [57]. 
Expression of rpr, hid or grim can induce DREDD processing in Drosophila cells and 
this processing was insensitive to P35 expression [57]. This was the first clue of existence 
of Drosophila initiator caspases. The second initiator and fourth caspase characterized in 
Drosophila was Dronc through a database search [58]. Dronc is the only Drosophila 
caspase identified to carry a Caspase Recruitment Domain (CARD) and has a 46% 
similarity to the mammalian caspase-2 [58]. Dronc has a catalytic cysteine, encompassed 
with PFCRG which is distinct from sequences found in other caspases [58]. The same 
study also reported that dronc expression in NIH 3T3 cells induced apoptosis that could 
be suppressed by P35 [58]. In vitro experiments showed that Dronc can undergo 
processing followed by activation [58]. In addition, dronc was the first caspase in 
Drosophila that is found to be regulated by ecdysone signaling [58].  
First null mutants of Dronc (dronc
d5
 and dronc
51
) were generated by P-element 
insertions.  These mutants were pupal lethal [59, 60]. dronc nulls showed suppression of 
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rpr-, hid-, grim-induced apoptosis in the Drosophila eye and did not exhibit 
developmental cell death in the Drosophila embryo, retina and salivary glands [59, 60]. 
dronc null mutants exhibited hid mutant-like phenotypes such as defects in head 
involution in embryos, extra scutellar bristles and darkening of the wings [59, 60]. In 
addition, these studies indicated that maternal contribution of dronc mRNA is essential 
for dronc mutants to survive until late pupal stages [59, 60]. Dronc was also shown to be 
required for radiation and stress-induced apoptosis [59, 60]. Further null mutants of dronc 
(dronc
I24
 and dronc
I29
) recovered from an EMS screen also suppressed rpr- and hid-
induced cell death in the Drosophila eye [61]. Developmental apoptosis in the 
Drosophila embryos, wings and retina could not function because of dronc null mutants 
[61]. This study also clarified the opaque wing phenotype that was observed previously 
[61]. A few escapers of dronc null mutants displayed less transparent, blemished and 
down-curved wings due to lack of apoptosis [61]. dronc germ line clones were embryonic 
lethal, also suggesting the importance of maternal contribution of dronc transcript [61]. 
The fifth Drosophila caspase to be characterized was Drosophila Executioner 
Caspase related to Apopain/Yama (DECAY) [62]. DECAY was found to be similar to 
mammalian caspase-3 and caspase-7 in homology and in substrate specificity [62]. The 
sequence encompassing its catalytic cysteine is QACRG which is shared by caspase-3 
and 7 [62]. Expression of decay in 293T and NIH 3T3 cells leads to apoptotic 
morphology, confirming its ability to induce apoptosis [62]. 
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Another database search for caspases yielded identification of the sixth and the 
seventh Drosophila caspases; Ser/Thr Rich Caspase (STRICA) and Death-Associated 
Molecule related to Mch-2 (DAMM) [63, 64]. DAMM has a high similarity to 
mammalian caspase-6 and 3; whereas, STRICA is more similar to caspase-8 with a long 
pro-domain lacking any CARD or Death Effector Domain (DED) domain [63, 64]. 
STRICA could interact with DIAP1 and DIAP2 in vitro; whereas DAMM could not 
interact with either of the IAPs [63, 64]. Additionally, both caspases did not form a 
complex with P35 [63, 64]. STRICA could induce apoptosis when expressed in 
Drosophila cells [64]. Similarly, expression of DAMM induced apoptosis in NIH 3T3 
cells. In addition, expression of DAMM in the Drosophila eye caused a rough eye 
phenotype [63]. rpr-induced cell death could be suppressed by catalytically inactive 
DAMM in the Drosophila eye [63].  
The idea of inducing cell death through RPR, HID and GRIM by disrupting 
interactions between caspases and DIAP1 came from a study conducted in yeast [38]. 
This study showed that co-expression of DCP-1 and DIAP1 in yeast cells did not result in 
death; however, co-expression of either RPR, HID or GRIM along with DCP-1 and 
DIAP1 killed yeast cells, suggesting that RPR inhibits DIAP1’s ability to block DCP-1 
[38]. Co-expression of DIAP1, DCP-1 and the N-terminal 37 residues of HID (HID(1-
37)) was also sufficient to kill yeast cells [38]. Another study also discovered that the 
BIR1 domain of DIAP1 interacts with processed drICE and DCP-1 [49]. Interestingly, 
both pro-Dronc and either activated drICE or DCP-1 can bind to BIR2 and BIR1 of 
DIAP1 simultaneously (Figure 1.2) [49].  
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A strong hypomorph of drice, drice
17
 and a null allele of dcp-1, dcp
∆1 
were 
characterized [65, 66]. Homozygous drice
17
 and dcp-1
∆1 
flies exhibited opaque wing 
phenotype, in agreement with hid and dronc mutants [65, 66]. drice
17
 and drice
∆1 
suppressed developmental apoptosis and partially protected against radiation-induced cell 
death [65, 66]. Homozygous drice
17 
and drice
∆1 
cannot completely abolish cell death in 
Drosophila embryos [65, 66]. However, apoptosis was reduced in double homozygous 
dcp-1
Prev1
 (a null allele) [67] and drice
17
 mutant embryos [65]. Heterozygosity at dcp-1 
caused drice
∆1
 flies to die in late larval or early pupal stages [66]. This suggests that 
DCP-1 and drICE can be functionally redundant in Drosophila [65, 66]. Further 
examination of roles of drICE and DCP-1 in apoptosis uncovered that both caspases were 
activated upon irradiation-induced apoptosis in Drosophila larval wing [68]. 
Interestingly, DCP-1 cannot trigger radiation-induced apoptosis in the absence of drICE; 
whereas drICE can exert apoptosis in the absence of DCP-1 in the Drosophila wing [68]. 
The reason for this observation was that drICE can cleave some of caspase substrates 
more efficiently than DCP-1 in vivo; however, DCP-1 can cleave drICE and make it a 
more potent apoptotic inducer [68]. This suggest that intrinsic abilities of these caspases 
and their levels in cells are determinants of the cell death [68]. 
More mechanistic details of caspase activation came from a yeast two-hybrid 
assay [69]. This study revealed that pro-drICE can dimerize without its short pro-domain 
region even in its inactive form [69]. In addition, Dronc can interact with and cleave 
drICE [69]. This study also indicated that BIR2 domain of DIAP1 binds to pro-Dronc 
[69]. Lastly, reducing gene dosage of dronc can suppress the rpr- or hid-induced 
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Drosophila eye phenotype [69]. Each caspase showed different substrate cleavage 
specificity towards lamin, confirming the difference in sequences of their active sites 
[69]. Another study about Dronc’s cleavage specificity showed that Dronc can cleave 
itself after glutamate at TQTE
352
; however, it cleaves drICE after aspartate at TQTD
230 
[70]
 
. Interestingly, DCP-1 can also cleave drICE at the same position [70]. This report 
also suggested that DCP-1 and drICE can cleave Dronc at its pro-domain and drICE can 
also remove its own pro-domain after cleaved by Dronc [70]. Both studies demonstrated 
that catalytically inactive Dronc suppressed rpr-, hid-, grim-induced cell death in the 
Drosophila eye, suggesting a dominant negative role for the catalytically inactive Dronc 
[69, 70]. Interestingly, Dronc could not cleave the caspase inhibitor P35 unlike drICE and 
DCP-1 [70].  
Another main player of Drosophila apoptosis, Drosophila homolog of Apaf-1 
was identified by three different groups under three different names: Dark, Dapaf-1 and 
HAC-1 (Figure 1.4) [71-73]. Drosophila Apaf-1-related killer (Dark) was identified by 
database searches and found to have an N-terminal CARD domain for interaction with 
caspases [71]. In the same study Dark was suggested to interact with Dredd and 
cytochrome c [71]. The authors also reported that a hypomorphic allele of dark (dark
CD4
) 
has developmental abnormalities, but can develop to adulthood [71]. In addition, this 
mutant had less apoptosis in embryos and suppressed RPR, HID and GRIM induced cell 
death in the eye [71]. Drosophila Apaf-1 (Dapaf-1) was identified by degenerate PCR 
and found to have two isoforms; a short one (dapaf-1S with 531 aa) and a long one 
(dapaf-1L with 1440 aa - the major form in Drosophila) [72]. Both isoforms can activate 
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caspases in Drosophila S2 cells [72]. Immunoprecipitation experiments in S2 cells also 
indicated that drICE can bind to Dapaf-1S and Dronc can interact with Dapaf-1L, 
suggesting different specificities for these isoforms and first evidence of a Dark-Dronc 
complex (Figure 1.4) [72]. Loss-of-function mutant of dapaf-1 (dpf
K1
) exhibited reduced 
apoptosis in embryos and suppressed RPR-induced cell death in the eye, in parallel to the 
previous study [72]. This mutant was 25% semilethal during pupal stage [72]. Further 
examination of dpf
K1
 displayed extra cells that did not undergo apoptosis in neural cells 
during development [72]. Homolog of Apaf-1 and CED-4 (HAC-1) was also identified 
through a database search [73]. The findings of the other two groups were also confirmed 
in this study [73]. In addition, the authors made a hac-1 null mutant (hac-1
k11502
) which 
was embryonic lethal [73]. Recovery of additional null dark mutants from hid-induced 
cell death in the Drosophila eye indicated that Dark is essential for Drosophila 
development because homozygous null dark mutants were pupal lethal [74]. Just like 
dronc, maternal contribution of dark mRNA also lasts until late larval stages, allowing 
flies to develop to pupal stages [74]. Homozygosity at dark can inhibit most, but not all 
cell death in Drosophila embryo [74]. Dark was also shown to be required for irradiation-
induced apoptosis [75]. Another study in Drosophila S2 cells suggested that 
downregulation of DIAP1 can be suppressed by downregulation of Dronc and/or Dark, 
indicating that in addition to Dronc, Dark is epistatic to DIAP1 [76]. This study also 
displayed that expression of catalytically inactive Dronc could enhance cell death 
induced by DIAP1 downregulation, suggesting an effector caspase independent pathway 
[76]. In confirmation with the previous study, DIAP1 was also shown to increase hid and 
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grim-induced apoptosis in the Drosophila eye that could be suppressed by dark
CD4
 
mutant [77].  
Because DIAP1 bears a RING domain, its importance in cell viability and 
regulation of caspases was investigated. diap1
∆RING 
mutant flies failed to suppress rpr-
induced cell death, alleviated hid-induced cell death and enhanced dronc-induced cell 
death in the Drosophila eye, suggesting a requirement of RING domain for DIAP1’s 
function [78]. Moreover, diap1
∆RING 
mutant can still preserve its interaction with RPR, 
HID and Dronc [78]. The same study also exhibited the first evidence for E3 ligase 
activity of DIAP1 towards itself and Dronc [78]. This study also made the point that both 
interaction between DIAP1 and caspases and E3 ligase activity of DIAP1 are necessary 
and sufficient for inhibition of caspases [78]. Because DIAP1 can ubiquitylate Dronc in 
vitro, the next question was what does this ubiquitylation do to Dronc protein. Upon 
downregulation of DIAP1 or UV treatment, proteolytically processed large and small 
subunits of Dronc accumulated in S2 cells [79]. Treatment of S2 cells with proteasome 
inhibitor MG132 also caused accumulation of large processed version of Dronc [79]. 
However, downregulation of Dark resulted in accumulation of full-length Dronc [79]. 
Overall, this study suggested that Dronc is continuously processed in S2 cells, which is 
dependent on Dark and Dronc could be degraded by DIAP1 [79]. Another study about 
Dronc’s fate upon RPR, HID, GRIM-mediated apoptosis induction indicated that Dronc 
has a 12 residue IAP Binding Motif (IBM) between its CARD domain and large subunit 
that interacts with BIR2 of DIAP1 [80]. This motif is similar to the RHG domain [80]. 
Mutation in this domain of Dronc generated a more potent apoptotic inducer in the 
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Drosophila eye, which cannot be suppressed by DIAP1 [80]. Interestingly, Dronc and 
RHG proteins bind to the same surface groove in DIAP1, suggesting a competition 
between IAP antagonists and caspases [80]. In fact, in vitro ubiquitylation assay showed 
that addition of a10-residue peptides from the N-termini of Hid, RPR, GRIM or Sickle 
eliminated DIAP1-mediated Dronc ubiquitylation [80]. The authors also suggested that 
two caspase cleavage sites preceding the IBM of Dronc could regulate its function upon 
apoptosis induction by removing the IBM and eliminating its binding to DIAP1 [80]. One 
of these caspase cleavage sites at D135 of Dronc was later found to be mediated by Drice 
and had no effect on Dronc’s activity [81]. However, auto-cleavage of Dronc at D352 
between large and small subunits was shown to be essential for Dronc’s activity [81]. 
This cleavage was dependent on Dark [81]. Another study confirmed the competition 
between RHG proteins and caspases to DIAP1. In this study, the authors showed that 
RPR and GRIM and surprisingly Jafrac2 but not HID abrogated binding of drICE or 
DCP-1 to BIR1 and BIR2 of DIAP1 [49].  
As DIAP1 could mediate auto-ubiquitylation, a study asked the question whether 
or not this ubiquitylation depends on RHG proteins. This study conducted in vivo found 
that induction of RPR led to reduction of DIAP1 protein level which was dependent on 
the RING domain of DIAP1. In search for mediators of RPR-induced DIAP1 
degradation, the authors identified UBCD1, E2-ubiquiting conjugating enzyme [82]. Loss 
of one functional copy of ubcD1 was able to suppress rpr-, hid- and diap1
RING
-induced 
cell death in the Drosophila eye [82]. This genetic analysis was supported by biochemical 
assays that showed interaction between RPR or GRIM, UBCD1 and DIAP1 [82, 83]. 
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This interaction promoted auto-ubiquitylation of DIAP1 [82].  Further investigation of 
DIAP1 degradation upon induction of apoptosis through expression of rpr, hid or grim 
identified that all three apoptotic inducers could reduce DIAP1 protein level in 
Drosophila embryos [84]. In particular, HID could induce DIAP1 auto-degradation; 
whereas RPR and GRIM could exhibit inhibition of general protein translation [84, 85]. 
This report also suggested that DIAP1 is a short-lived protein with 40 min half-life and 
one of its targets, Dronc, has a longer half-life about 3 hours in S2 cells [84]. As a 
secondary layer of DIAP1 regulation, DIAP1 was characterized as the first protein to 
undergo degradation through N-end rule pathway in Drosophila [86]. DIAP1 has a 
caspase cleavage site DQVD
20
NN at its N-terminus, which is a target of DCP-1/drICE 
[86]. Cleaved DIAP1 could be stabilized by inhibition of the proteasome and 
downregulation of the N-end rule pathway in S2 cells [86]. Degradation of DIAP1 
through N-end rule pathways is not dependent on its RING domain but its Asparagine-
bearing N-degron [86]. Interestingly, this cleavage was necessary for DIAP1 to suppress 
rpr-induced cell death [86]. Repression of the N-end rule pathway in the Drosophila eye 
presumably stabilized DIAP1 and enhanced rpr-induced cell death and alleviated hid-
induced cell death in the eye, similar to observations with diap
∆RING
 mutant [78, 86]. 
Other than ubiquitylating itself and Dronc, DIAP1 was also shown to ubiquitylate 
RPR, HID and GRIM in cells [87]. Further examination of this phenomenon uncovered 
that RPR is degraded by DIAP1, which is dependent on RHG domain of RPR (RPR (1-
15)) and RING domain of DIAP1 [87]. Inhibition of the proteasome or mutating lysine 
residues of RPR to arginine to block ubiquitylation resulted in a stable RPR protein that 
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could induce apoptosis more potently [87]. In addition, another study reported that RPR, 
HID and GRIM could not induce apoptosis in S2 cells if their IBM domains are mutated 
[49]. 
The first detailed mechanism of effector caspase ubiquitylation by DIAP1 came 
from a study showed that DIAP1 poly-ubiquitylates and inhibits drICE and DCP-1 in a 
non-degradative manner [88]. In particular, cleavage of 20 aa of DIAP1 (due to the N-end 
rule pathway) provided a better interaction with drICE and DCP-1 and recruited UBR1 to 
promote ubiquitylation of effector caspases together with RING domain of DIAP1 [88]. 
Interestingly, DIAP1-mediated drICE ubiquitylation does not lead to proteasomal 
degradation but hinders the substrate interaction of drICE allosterically [88]. Non-
ubiquitable drICE could bind to DIAP1 but was still active [88]. In a model the authors 
suggested that DIAP1 resides in a ‘closed’ form and activation of effector caspases leads 
to cleavage of DIAP1 to generate an ‘open’ form which could in turn inhibit effector 
caspases [88]. In this model, the half-life of DIAP1 is rate-limiting for negative 
regulation of caspases [88]. In addition to effector caspases, Dronc was shown not to 
undergo proteasomal degradation upon increasing or decreasing the protein level of 
DIAP1 in Drosophila larval eye discs [89]. Extracts from DIAP1 RING mutant embryos 
also indicated that Dronc protein levels do not change compared to wild type embryonic 
extracts [89]. Furthermore, Dronc is processed in the presence of diap1
∆RING
 mutant, 
suggesting that DIAP1 controls Dronc’s activity through a non-degradative manner in 
vivo [89]. 
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Figure 1.4. The activation mechanism of Dronc 
Upon apoptosis induction, Dronc is recruited to the Dark apoptosome through homotypic 
CARD interactions. Apoptosome is formed in 1:1 protein stoichiometry. Dronc is auto-
cleaved in the apoptosome, which forms a homodimer consisting of its large and small 
subunits. The caspase domain is released from the apoptosome and cleaves effector 
caspases for their activation. 
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Involvement of mitochondria in Drosophila apoptosis has been debated over the 
years. Although early studies suggested that cytochrome c binds to Dark and induces cell 
death, other studies showed the controversial results such as cytochrome c is not released 
upon UV induction and loss of cytochrome c cannot suppress UV-induced and rpr or 
grim-induced apoptosis [90, 91]. Cytochrome c from mitochondria was not released and 
remained attached to mitochondria when Dronc and drICE were activated and led to 
death of Drosophila BG2 cells [92]. Interestingly, Dronc and active drICE partially 
located to mitochondria in serum-deprived BG2 cells. The same study also provided the 
first evidence of Drosophila apoptosome formation through gel filtration assays of BG2 
cell extracts. In contrast, cytochrome c addition accelerated the formation of the 
apoptosome [92].  
Structural insights of the Drosophila apoptosome came from two studies (Figure 
1.4) [93, 94]. First study uncovered that Dark apoptosome consists of two rings that 
contain 8 Dark molecules [103]. Interestingly, cytochrome c did not interact with Dark in 
the apoptosome [103]. Further insights into the structure of the Drosophila apoptosome 
revealed that the CARD domains of Dronc and Dark form a crown-like structure at the 
central hub of the Drosophila apoptosome (Figure 1.4). The single-ring apoptosome was 
found to be sufficient to activate Dronc and represented the physiological state of the 
apoptosome. However, a more recent study recovered the two-ring apoptosome structure 
with 16 Dark and 16 Dronc molecules at a higher resolution [95]. Interestingly, formation 
of the apoptosome was triggered by addition of Dronc with or without dATP. The CARD 
domain of Dronc was essential for recruitment into the apoptosome. Once the 
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apoptosome was formed, Dronc was activated and caspase domain of Dronc that bears 
large and small subunits is released from the apoptosome (Figure 1.4). Atomic 
interactions between the CARD domains of Dronc and Dark showed that each CARD of 
Dronc interacts with neighboring CARD of Dronc through van der Waals contacts and 
with two different CARDs of Dark through Hydrogen bonds.  
Supportive of above-mentioned studies, mutants affecting the WD40 domains of 
Dark exhibited a loss-of-function phenotype, suggesting that WD40 domain of Dark may 
function in a pro-apoptotic manner [74]. Interestingly, in the recent structural report the 
WD1 repeat of Dark was shown to interact with the CARD of Dronc, which is essential 
for formation of the multimeric apoptosome complex [95]. This finding could link the 
two studies together, where a pro-apoptotic WD40 repeat functions by interacting with 
the CARD of Dronc in the apoptosome possibly further stabilizing it. The second study 
showed that auto-cleaved Dronc undergoes homo-dimerization after cleavage at D352 to 
enhance its activity; whereas Dronc zymogen exists as a monomer [104]. Dronc also 
undergoes another cleavage to release its CARD domain at D135, which suggests that 
activated Dronc does not remain in the apoptosome unlike mammalian caspase-9 [104]. 
Two studies on activation mechanism of Dronc highlighted that auto-cleavage of Dronc 
at D352 was not essential for its activation and for inducing cell death in Drosophila BG2 
or SL2 cells [96, 97]. Dronc could cleave both after aspartate (drICE) and glutamate 
(itself); however, prefers Asp on its substrates [96, 97]. Interestingly, these studies also 
suggested that auto-cleavage of Dronc could be a stabilizing factor for Dronc 
dimerization, which is essential for its activity after recruitment into the Dark 
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apoptosome [96, 97]. This phenomenon is similar to mammalian caspase-2 and caspase-9 
activation, as they also do not undergo an initial auto-cleavage for their activation [96, 
97]. Interestingly, Dronc is activated in the apoptosome only after addition of cytosolic 
fractions, suggesting a requirement of a cytosolic factor other than cytochrome c in 
Dronc’s activation [96]. 
Dronc’s activity was shown to be regulated by metabolic input in Drosophila S2 
cells [98]. This interesting study uncovered an inhibitory phosphorylation site for Dronc 
at S130, which is responsive to increased NADPH levels and mediated by CamKII kinase 
[98]. S130 phosphorylation of Dronc can inhibit its interaction with Dark; however, it 
does not affect its catalytic activity [98]. Suppression of Dronc activity through S130 
phosphorylation was also observed in specific neural tissues of Drosophila [98].  
Regulation of the Drosophila apoptosome activity was shown to be regulated by 
‘feedback inhibition’ mechanism, in which excess levels of Dronc or Dark are degraded 
through a mechanism requiring catalytic activity of Dronc, the C-terminal of Dark and 
DIAP1 [99]. Dark carries a Dronc cleavage site at 1292 [100]. A non-cleavable Dark 
mutant could not be degraded through feedback inhibition mechanism [99]. This 
mechanism could ensure cell viability in times of accidental amplification of apoptosome 
activity [99].  
There are two isoforms of cytochrome c in Drosophila, dc3/cyt c-p (the major 
form) and dc4/cyt c-d [101]. Examination of mutants of these isoforms revealed that 
neither of them are required for caspase activation in S2 cells or in flies, suggesting 
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further that cytochrome c is not required for Dark-mediated Dronc activation [102]. 
Interestingly, the dc4/cyt c-d isoform was found to be required for caspase activation 
during spermatid individualization [103] (discussed in detail in Chapter I, Part ID2 and 
Part IIIB). Further examination of DC3/Cyt c-p revealed that this isoform is required for 
mitochondrial respiration [104]. In addition to its role in spermatid individualization, 
DC4/Cyt c-d was also shown to be required for extra interommatidial cell death in 
developing Drosophila eye [105].  
Homologs of Bcl-2 family proteins were identified in Drosophila. For example, 
Debcl was reported to be a pro-apoptotic Bcl-2 family member and has a correlating 
expression level with developmental cell death [106]. debcl is epistatic to apoptosome 
activation [106]. debcl-induced apoptosis cannot be suppressed by H99 deficiency, but 
can be rescued by losing one functional copy of DIAP1 [106]. buffy, another Bcl-2 family 
member was conversely shown to be anti-apoptotic by blocking developmental and 
radiation-induced cell death [107]. buffy interacted with debcl both genetically and 
physically to block its function [107]. On the other hand, rpr-, hid- or grim-induced cell 
death could be suppressed by buffy expression in the Drosophila eye [107]. Cell death-
induced by thread heterozygosity was also suppressed with buffy expression in the 
Drosophila embryo [107]. Debcl localized to mitochondria but did not result in 
cytochrome c release [92]; whereas, Buffy resided in ER [108]. However, both proteins 
are shown to act conversely in a context dependent manner [109]. Because, homozygous 
debcl or buffy null mutant flies develop normally, these two Bcl-2 homologs are not 
essential for viability and developmental apoptosis but may be required in specific tissues 
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and in stress-induced conditions [110]. In addition to Bcl2 family homologs, a 
Drosophila homolog of Omi/HtrA2 (dOmi) was characterized [111]. dOmi can bind to 
BIR2 of DIAP1 through two IBM domains that are exposed after dOMI is recruited to the 
mitochondria and undergoes proteolytic cleavage [111]. This interaction can displace 
Dronc and degrade it proteolytically [111]. dOmi was also shown to induce apoptosis 
when expressed in the Drosophila eye, which can be suppressed by DIAP1 expression 
[111, 112]. dOmi was also a target of DIAP1 ubiquitylation [112].  
In another study, mitochondrial dynamics were examined upon rpr- or hid- 
expression in S2 cells [113]. HID and RPR could localize to mitochondria to induce 
mitochondrial permeabilization and changes in mitochondrial ultrastructure, independent 
of their function on DIAP1 [113]. Inhibition of mitochondrial disruption blocked 
apoptosis [113]. The role of mitochondria in Drosophila apoptosis seems to be important; 
however, it is not similar to mammalian apoptosis. Often times, mitochondrial elements 
contribute to Drosophila apoptosis in a context- and tissue-dependent manner.  
Conservation of the apoptotic pathway between Drosophila and the mammals, the 
lack of redundancy among the apoptotic factors and the short life cycle have made 
Drosophila an excellent model system to dissect apoptotic machinery over the years as 
discussed in detail above. Mammalian apoptosis also has distinct features and has been 
studied extensively to understand its mechanism due to its relevance to human diseases. 
The following section will examine mammalian apoptotic cascade in detail. 
B. Apoptotic Machinery in Mammals 
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There are two apoptotic pathways in vertebrates: extrinsic and intrinsic apoptosis 
[114]. While the extrinsic pathway relies on receptor-mediated signaling through a subset 
of Tumor Necrosis Factor Receptors (TNFR) in response to inflammation or infection, 
the intrinsic pathway is regulated by a mitochondria response to cytotoxic stimuli such as 
DNA damage or ER stress [114, 115]. Both of these pathways utilize the same effector 
caspases to execute apoptosis. 
A subset of TNFRs that play a role in extrinsic apoptosis are called Death 
Receptors (DR) [116]. DR have an extracellular Cysteine-rich domain and an 
intracellular death domain of ~80 amino acids. DR transmit apoptotic signals through 
death ligands [115, 117]. Examples of well-characterized death receptor/ligand pairs are 
TNFR1/TNFα, FasR/FasL and TRAIL/TRAIL-R [118]. To transmit death signals, 
ligands bind to and trimerize their cognate receptors [114]. In the case of FasR/FasL and 
TRAIL/TRAIL-R, this induces recruitment of adaptor protein Fas-Associated protein 
with Death Domain (FADD) and initiator caspase-8 through interactions between their 
death domains to form the Death-Inducing Signaling Complex (DISC) [114, 117]. In this 
complex, caspase-8 dimerizes for its activation and then undergoes auto-cleavage 
between its large and small subunits for stabilization. Another cleavage occurs between 
the pro-domain and the large subunit, which releases caspase-8 from DISC. Activated 
caspase-8 can cleave and activate caspase-3 to execute apoptosis. In the case of 
TNFR1/TNFα, this ligand/receptor complex induces recruitment of TNFR1-Associated 
via Death Domain (TRADD), Receptor Interaction Protein 1 (RIP1) kinase, ubiquitin 
ligases TNFR-Associated Factor 2 (TRAF2) and cellular Inhibitor of Apoptosis 1 and 2 
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(c-IAP1 and c-IAP2) to form a regulatory complex that has implications in either cell 
death or inflammatory responses such as involvement of NF-κB signaling [114, 117].  
The intrinsic apoptotic pathway is activated in a cell-autonomous manner upon 
cellular stress signals via the mitochondria (Figure 1.3). Developmental or stress-induced 
signals initiate Mitochondrial Outer Membrane Permeabilization (MOMP) to release 
factors in the mitochondrial intermembrane space such as cytochrome c, Smac/Diablo or 
Omi/HtrA2 into the cytosol [119-125]. MOMP is believed to display a point of no return 
in apoptosis and it is a tightly regulated process by a family of B-cell Lymphoma 2 (Bcl-
2) proteins [126-129]. Bcl2 family proteins are defined by having at least one Bcl-2 
Homology (BH) motif that determines pro- or anti-apoptotic function of the protein 
[130]. There are three classes of Bcl-2 family proteins. The first class is pro-apoptotic 
effector proteins such as BAX, BAK and BOK that regulate MOMP directly [131]. The 
second class involves pro-survival proteins such as Bcl-2 and Bcl-xL [130, 132]. The 
third class consists of pro-apoptotic proteins such as Bid, Bim, Noxa and PUMA that are 
called BH3-only proteins and can activate effector proteins (BAX/BAK/BOK) or inhibit 
anti-apoptotic proteins (Bcl-2 etc.) [131]. 
In dying cells, BAX and BAK function redundantly and are activated through 
multiple steps including conformational changes, insertion into the Outer Mitochondrial 
Membrane (OMM), homo-dimerization and higher-order oligomerization, which results 
in MOMP [131]. BOK is not redundant with BAX/BAK and can mediate MOMP by 
itself [131]. However, its structural mechanism of activation is less clear. BH3 only 
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proteins such as Bid and Bim can interact with BAK and BAX, respectively, to initiate 
their activation [131, 133]. For MOMP to proceed, pro-survival Bcl2 proteins such as 
Bcl2 and Bcl-xL are inhibited by BH3-only proteins such as Noxa and PUMA [130]. As 
regulators of both first and second class Bcl2 proteins, BH3-only proteins are tightly 
controlled at both transcriptional and post-translational levels such as cleavage or 
modification upon apoptosis induction. 
Release of cytochrome c after MOMP is critical for activation of the Apaf1 
apoptosome, which is a ring-like cell death platform and analogous to the Dark 
apoptosome in Drosophila [114]. Cytochrome c binds to auto-inhibited, monomeric and 
ADP-bound Apoptotic protease-activating factor 1 (Apaf1) [134]. This interaction 
triggers nucleotide exchange (replacement of ADP to (d)ATP), which results in 
conformational changes and formation of an active, heptameric apoptosome complex 
[134]. Apaf1 is a large protein consisting of N-terminal Caspase Recruitment Domain 
(CARD) that recruits caspase-9 through homotypic interactions between their CARD 
domains. In addition, Apaf-1 consists of a number of regulatory domains such as 
Nucleotide Binding Domain (NBD), 2 Helical Domains (HD1, HD2), Winged Helix 
Domain (WHD) and 15 WD40 repeats. These regions play roles in Apaf1 auto-inhibition, 
nucleotide exchange and oligomerization [134].  
Recent structural studies suggest that the CARD domain of Apaf1 is surface-
exposed, dynamic and sits at the spoke of a central hub that consists of regulatory 
regions, which gives Apaf1 apoptosome a ring/wheel like structural look [135, 136]. The 
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recruitment of caspase-9 into the Apaf1 apoptosome occurs in 1:1 protein stoichiometry 
[135]. This recruitment is essential for caspase-9 activation. In the apoptosome, caspase-9 
is dimerized and auto-cleaved between its large and small subunits. Auto-cleaved 
caspase-9 can be released into the cytoplasm to cleave effector caspases caspase-3 and 
caspase-7 for execution of apoptosis. The released caspase-9 can be replaced with 
inactive zymogen in the apoptosome to continue efficient processing and activation of 
caspase-9 [137].  
In addition to caspase-8 and caspase-9, mammals have another initiator caspase 
named caspase-2. Caspase-2 is highly conserved and has a CARD domain at its N-
terminus. Similar to other initiator caspases, caspase-2 is induced by dimerization 
followed by auto-cleavage and recruited into a cell death platform called PIDDosome 
[138, 139]. This protein complex consists of caspase-2, adaptor protein RAIDD and 
PIDD. Upon stressed-induced conditions, caspase-2 forms a homotypic interaction with 
the CARD domain of RAIDD and PIDD binds to RAIDD through their DDs after 
undergoing sequential cleavage [138, 139]. A recent study suggests that RAIDD forms in 
a closed state and can only interact with caspase-2 after RAIDD interacts with PIDD, 
suggesting that PIDD mediates and stabilizes the PIDDosome. [140]. Once assembled, 
PIDDosome have 7 caspase-2, 7 RAIDD and 5 PIDD proteins [138, 139]. In contrast to 
other initiator caspases, caspase-2 does not cleave effector caspases but cleaves other 
substrates that have roles in cell cycle progression, in response to ER-stress, DNA-
damage, etc. One reported caspase-2 target is Bid, an interaction that results in MOMP 
and cytochrome c release [141]. Although caspase-8 and caspase-9 knockout mice are 
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embryonic lethal, caspase-2 knockout mice develop normally, suggesting that caspase-2 
may not be essential for embryonic development [138].  
Caspases play essential roles in initiating and executing mammalian apoptosis, 
similar to flies. Activity of caspases is tightly controlled by a group of Inhibitor of 
Apoptosis (IAP) proteins. Examples of well-characterized mammalian IAPs are X-
chromosome linked IAP (XIAP), cellular IAP1 and IAP2 (c-IAP1, c-IAP2). XIAP has 
three BIR domains, each having different affinities for caspases/pro-apoptotic proteins 
(IAP antagonists). While BIR2 of XIAP binds to processed caspase-3 and caspase-7, 
BIR3 of XIAP binds to processed caspase-9 through their IAP Binding Motif (IBM). IAP 
antagonists such as Smac/DIABLO and Omi/HtrA2 are released after MOMP and can 
also bind to both BIR2 and BIR3 domains of XIAP through their IBM. The interaction of 
XIAP with caspases leads to ubiquitylation and inhibition of caspases, whereas 
interaction between XIAP and IAP antagonists causes auto-inhibition of XIAP through 
degradation. Xiap knockout mice surprisingly showed no embryonic lethality and 
developmental defects [142-145]. RING domain deletion of XIAP in mice stabilized 
XIAP protein and also did not show any embryonic lethality and developmental 
abnormalities. However, Xiap
∆Ring
 MEFs and mouse embryonic stem cells showed 
increased caspase-3 activity and impaired ubiquitination of caspase-3 [146]. Xiap
∆Ring
 
MEFs were also sensitized to TNF-induced apoptosis. Furthermore, Xiap deficient MEFs 
displayed elevated protein levels of cIAP1 and cIAP2 [142].This may suggest that other 
IAP proteins may compensate for the loss of XIAP, resulting in lack of observed 
phenotypes in development of Xiap knockout mice. 
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As an example of crosstalk between extrinsic and intrinsic apoptotic pathways, 
after activation in the DISC, caspase-8 can cleave BH3-only protein Bid. Cleaved Bid 
can locate to the mitochondria to activate BAX and BAK, which promotes MOMP and 
release of IAP antagonists [114]. This is a defense mechanism against XIAP inhibition of 
effector caspases.  
C. Apoptosis and Cancer 
There is a delicate balance between cell survival and cell death. Even a subtle 
change could lead to an imbalance of either side. Down-or up-regulation of apoptosis 
could result in cancer and neurodegenerative diseases. After an extensive introduction to 
the apoptotic pathway in Part IA and IB, this section will examine various apoptotic 
players in terms of their contribution to cancer 
Cancer is currently one of leading causes of death in the United States. 
Downregulation of apoptosis is a hallmark for cancer. Suppression of apoptosis 
contributes to tumor initiation, progression, metastasis and resistance to therapeutic 
approaches. Bcl2 family proteins, the upstream regulators of MOMP, play an important 
role in cancer development.  For example, pro-survival Bcl2 gene was found be 
translocated (t(14;18)) in non-Hodgkin’s Lymphomas, even before its involvement in 
apoptosis was discovered [147]. This chromosomal translocation results in elevated Bcl2 
gene expression. Moreover, downregulation of micro RNAs that repress Bcl2 gene and 
hypomethylation of Bcl2 were shown to increase Bcl2 gene expression in chronic 
lymphocytic leukemia [148]. Furthermore, pro-apoptotic Bcl2 family proteins such as 
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BAX and BAK are misregulated in colon and gastric cancer development [147]. In 
addition to BAX, BH3-only pro-apoptotic proteins such as Bid, Noxa and Puma are 
shown to be regulated by P53 through both transcriptional and post-translational levels in 
cancer cells [148].  
Pro-survival Bcl2 and pro-apoptotic BH3-only proteins are important 
determinants of cancer therapy. Bcl2 proteins are found to protect cells in response to 
cytotoxic anti-cancer drugs [149]. On the other hand, upstream of Bcl2 proteins, BH3-
only proteins are shown to induce apoptosis in response anti-cancer drugs [149]. Recent 
studies are focused on identifying BH3-only protein mimetics to inhibit pro-survival 
factors and induce apoptosis of cancer cells. 
Death receptors of the extrinsic apoptotic pathway are shown to have implications 
in various cancer types such as colon, ovarian, cervical and pancreatic cancers [150]. For 
example, increased expression of antagonistic TRAIL receptors can inhibit TRAIL 
signaling, contributing to cancer progression. In addition to death receptors, the extrinsic 
apoptotic pathway can be impaired by low level expression of caspase-8 due to 
epigenetic regulation [150]. Recent studies suggested that this kind of impairment could 
be targeted by demethylation agents or HDAC inhibitors for therapeutic reasons. 
Moreover, caspase-8 activation is regulated through post-translational modifications such 
as phosphorylation in cancer cells [150].  
High level expression of IAPs such as XIAP, cIAP-1, cIAP-2 has been indicated 
in breast, colorectal, non-small cell lung cancer, cervical cancer and others [151]. 
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Elevated expression of IAPs contributes to cancer through inhibiting apoptosis and 
ensuring survival of cancer cells. For example, to restrain XIAP activity, Smac mimetics 
are widely used for therapeutic reasons. Smac mimetics are designed to bind BIR2 and 
BIR3 domains of XIAP for better activation of caspases [151]. 
Apoptosome components could be deregulated in cancer. Due to epigenetic 
regulation, Apaf1 expression level was shown to be downregulated in melanomas, 
leukemias, glioblastomas and cervical carcinomas [152]. To overcome this dysregulation, 
pan-histone deacetylase inhibitors could be used to induce expression of Apaf1. In 
addition, defects in cytochrome c-induced caspase activation were observed in acute 
myeloid leukemia. As a resistance mechanism to apoptosis, Apaf1 was also shown to be 
sequestered from the cytosol to plasma membrane in B-cell lymphoma cells. Recent 
studies are focused on developing cytochrome c mimetics or agents that induce release of 
cytochrome c from mitochondria for therapeutic reasons. The other component of the 
apoptosome complex is caspase-9. Caspase-9 is not frequently mutated in human cancers; 
however it can contribute to tumor progression in sensitized backgrounds [153]. In 
addition, short isoforms of caspase-9 zymogen were shown to act as dominant negative in 
tumor cells [154]. In a recent study, germline genetic variations of caspase-9 at both gene 
and SNP level were observed in non-Hodgkin’s Lymphoma [155]. Therefore, a better 
understanding of the structural mechanism of apoptosome assembly will help designing 
drugs to induce apoptosome formation in cancer cells. Although being downstream 
effectors of the apoptotic pathway, caspase-3 and caspase-7 also play a role in cancer 
development. For example, caspase-3 transcript and protein levels were downregulated in 
38 
 
 
 
primary breast tumor cells [153]. Moreover, mutations in caspase-7 were observed in 
colon, esophageal and head/neck carcinomas [153].  
As examples above show, pro- or anti-apoptotic factors can be misregulated at 
transcriptional and/or translational level in cancer cells. Misregulation of apoptotic 
players could contribute to tumor initiation and/or progression. Understanding the 
apoptotic pathway in more detail will shed light into better therapeutic approaches to 
overcome cancer. 
D. Non-Apoptotic Functions of Caspases 
Aside from their jobs to execute cell death and dismantle cells, caspases function 
in non-apoptotic ways without causing cell death but helping cell differentiation, 
proliferation, regeneration, etc. This section highlights examples of non-apoptotic 
functions of caspases in mammalian and Drosophila development. 
D1. Non-Apoptotic Functions of Mammalian Caspases 
The importance of non-apoptotic functions of mammalian caspases was unveiled 
through caspase knock out studies. For example, caspase-8 null MEFs showed a 
deficiency in cell motility due to impairment of activation of calpains, Rac and 
lamellipodial assembly [156].  Interestingly, loss of caspase-8 was observed in metastatic 
neuroblastoma [157]. Reconstitution of caspase-8 in neuroblastoma resulted in 
suppression of their metastasis, suggesting a pro-survival role for caspase-8 in tumor 
invasion [157]. Caspase-8 was also indicated to be a regulator in NF-κB signaling during 
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macrophage differentiation [158]. Patients with homozygous deficiency at caspase-8 
displayed immunodeficiency dependent on lack of activation of their T-lymphocytes, B-
lymphocytes and natural killer cells [159]. In addition, deletion of caspase-8 in T-cells 
resulted in immunodeficiency, indicating importance of caspase-8 for T-cell homeostasis 
and T-cell mediated immunity [160].  
An interesting study suggested caspase-8 and caspase-3 are required for mediating 
programming of induced Pluripotent Stem Cells (iPSC) from fibroblast [161]. Both 
caspases were activated by Oct-4 transcription factor and caspase-3 could cleave 
Retinoblastoma susceptibility (Rb), a cell cycle regulator, to facilitate iPSC induction 
[161]. Activity of caspase-3 was also required in Embryonic Stem Cells through cleavage 
of Nanog and Hematopoetic Stem Cell differentiation due to alterations on cytokine-
mediated signaling pathways [162, 163]. Caspase-3 has been implicated in cell 
proliferation by targeting cell cycle regulators. For example, caspase-3 can promote 
proliferation of B-lymphoid cells through cleaving Cyclin Dependent Kinase (CDK) 
inhibitor p27 [164]. An anti-proliferative role of caspase-3 in B-cell homeostasis was 
described through cleavage of PCDNA interaction domain CDK inhibitor 21 and thus 
release of PCDNA and impairment of proliferation. Caspase-3 knock-out mice showed 
defects in muscle cell differentiation. Sterile twenty-like kinase (MST1) cleavage by 
caspase-3 is required for skeletal muscle differentiation [165]. Activation of caspase-3 
was also indicated in keratinocyte differentiation and osteogenic differentiation of bone 
marrow stromal stem cells [166, 167]. Caspase-3 was also shown to be crucial for 
neuronal development. For example, active caspase-3 was required for differentiation of 
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neurospheres, Bergmann glia and PC12 cells. Interestingly, caspase-3, 7, 6 or 8 could 
cleave Tau, which contributes to Alzheimer’s Disease due to enhanced assembly of 
cleaved Tau (discussed in Part IC2) [168]. In addition, a recent study uncovered that 
caspase-2 could cleave Tau, which does not trigger its fibrillation but regulate missorting 
of full-length Tau [169]. This cleavage product was elevated in Alzehiemer’s Disease 
cases and decreasing levels of caspase-2 could protect against neurodegeneration [169]. 
In addition to caspase-3, the initiator caspase-9 was implicated in neuronal 
development. Activity of caspase-9 was found to be necessary for maturation of olfactory 
neurons during late embryogenesis [170]. In particular, caspase-9 cleaved 
Semaphorin7A, a member of membrane-anchored Semaphorin family proteins for axonal 
guidance [170]. Caspase-9 and caspase3/7 were also shown to be involved in Long Term 
Depression (LTD) and AMPA receptor internalization in hippocampal neurons through 
cleavage and inactivation of Akt1 which was shown to regulate synaptic modifications 
via LTD [171]. Caspase-9 and caspase-3 were also indicated to play a role in axonal 
degeneration and pruning [172]. Specifically, Neural Growth Factor (NGF)-deprived 
neurons exhibited high activity of these caspases [172].  
Caspases can also function in response to inflammation. Human caspases-1, -4, -5 
and -12 that carry CARD domains were found to be mediating inflammatory responses 
[173, 174]. In particular, caspase-1 can be recruited to distinct protein complexes called 
inflammasomes upon external or internal insults such as infections, toxins, metabolites 
and irritants [173, 174]. Caspase-1 can be activated by the inflammasome formation, 
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which leads to cleavage and maturation of Interleukin (IL) cytokine family members IL-
1β and IL-18 that are important for inflammatory responses [173, 174]. A distinct form of 
cell death, pyroptosis can also be initiated by caspase-1 activation through the 
inflammasome in macrophages and dendritic cells upon infection by intracellular 
pathogens [175]. Pyroptosis has different morphological features compared to apoptosis 
and downstream effectors of caspase-1 in pyroptotic cell death are still not well-known 
[175].  
D2. Non-Apoptotic Functions of Drosophila Caspases 
While apoptotic stimuli cause cell death autonomously, it can also signal non-
autonomously to proliferate and compensate for the loss of dying cells. This is called 
‘Apoptosis induced Proliferation’ (AiP). This phenomenon was first described forty years 
ago in a study involving Drosophila imaginal discs and their regenerative capacity upon 
bisecting or grafting operations [176]. Drosophila imaginal discs that are composed of 
epithelial monolayer are great tools to study regeneration due to their remarkable 
regenerative capacity. One popular model for regeneration is overgrowth associated by 
the co-expression of hid or rpr and p35 in the Drosophila eye or wing imaginal discs. 
Expression of hid or rpr in the Drosophila eye induces apoptosis; however, simultaneous 
expression of p35 blocks the execution of apoptosis, which results in overgrowth of the 
head capsule, multiplication of bristles and ocelli. This model system is used to identify 
components of AiP. Earlier studies showed that Dronc activity is necessary and sufficient 
for AiP [177, 178]. Wingless (Wg) and Decapentaplegic (Dpp) signaling were activated 
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in another setting of AiP when cell death is induced through X-ray or heat shock and 
blocked with P35 expression [179]. The importance of mitogenic signaling and activation 
of Jun N-terminal Kinase (JNK) was depicted in another report, which placed wg 
epistatic to JNK signaling [180]. EGFR signaling was also shown to be activated 
downstream of JNK signaling in AiP [181]. The link between Dronc and JNK signaling 
in AiP came from a recent study in which our lab showed that Drosophila macrophages 
are activated by extracellular Reactive Oxygen Species (ROS) and induce JNK signaling 
through release of Drosophila TNF, Eiger and its receptor Grindelwald [182]. Signaling 
roles for Dronc were uncovered in another study that showed that Dronc could induce 
Drosophila p53 (dp53) for cell-cycle arrest and AiP [183]. Further examination of the 
role of dp53 uncovered that N-terminally truncated form of dp53 activates Wg signaling 
to promote AiP [184]. Another type of AiP is indicated in differentiating tissue as 
opposed to proliferating tissue where most of the studies are done. This particular study 
showed that effector caspases turn on Hedgehog signaling in photoreceptor neurons 
expressing hid, which triggers proliferation of undifferentiated yet post-mitotic cells 
[185].  
A few non-apoptotic functions of caspases could be detected in cell differentiation 
such as patterning of arista and bristles. Drosophila antenna has a feather-like structure at 
its tip, called arista. Arista development in Drosophila was abnormal when hid, diap1, 
dronc, drice or dcp-1 were not functional [66, 186, 187]. Interestingly, the abnormal 
arista phenotype was not observed when P35 was overexpressed [66, 186, 187]. Null 
alleles of a myosin family factor crinkled (an interactor of Dronc) also exhibited 
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abnormal arista development [188]. However, it is not clear how caspases could regulate 
this process in a non-apoptotic way. Mechanosensory bristles in adult Drosophila thorax 
originates from Sensory Organ Precursors (SOP) in the larval wing discs through a series 
of cell divisions. Loss-of-function mutants of dark, dronc, ubcd1 or expression of a 
dominant negative dronc mutant showed extra bristles on the notum, suggesting 
activation of Dronc is essential in this process, dependent on Dark [71, 72, 82]. Further 
examination of this phenotype revealed Shaggy46, an isoform of Drosophila GSK-
3/Shaggy, as a caspase substrate [189]. Shaggy is cleaved by caspases to get activated 
and antagonize Wg signaling in SOP development [189]. A recent study suggested that 
CRINKLED could recruit Shaggy46 to Dronc to mediate cleavage of Shaggy46 [188]. In 
the absence of caspase activity, an additional SOP cell differentiates and gives rise to an 
extra bristle. Interestingly, Drosophila IKKε could phosphorylate DIAP1, leading to its 
degradation in proneural cells in wing discs, which controls caspase activation in SOP 
cell development [190]. In line with these findings, loss of one functional copy of diap1 
suppressed the extra bristle phenotype [191].  
Caspases are also found to play a role in neural pruning. To sculpt neural circuits, 
larval axons such as Class IV dendritic arborization (C4da) neurons undergo pruning 
during metamorphosis. Caspase activity was localized in C4da neuron dendrites and 
observed at late stages of pruning [192]. Ubcd1 and Valocin-containing protein (VCP), a 
ubiquitin-selective AAA chaperone, contributed to degradation of DIAP1 to control 
activation of Dronc in C4da dendrites [193, 194]. Additionally, mutations in dronc 
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strongly suppressed pruning, while mutations in drice suppressed pruning mildly and 
mutations in dcp-1 had a weak suppression [195]. 
Caspases are implicated in immune responses. In Drosophila, the caspase-8 
homolog Dredd was shown to regulate NF-κB signaling. Upon immune stimulation 
Dredd could cleave IMD, which exposes an N-terminal IBM for DIAP2 interaction, and 
NF-κB factor Relish for its activation (discussed in Chapter I, Part IIIB) [196-199].  
An interesting study in Drosophila neuroblasts suggested a role for Dronc that is 
independent of its catalytic activity. Drosophila neural stem cell (neuroblast) homeostasis 
is controlled by Numb which limits proliferative potential of neuroblasts. 
Phosphorylation of Numb negatively regulates its activity because phospho-mimetic 
Numb induced excess neuroblast production. Dronc was identified to interact with wild 
type or phospho-mutant Numb better than with phospho-mimetic Numb [200]. In 
addition, overexpression of wild type or catalytically inactive Dronc could rescue 
proliferative phenotype of neuroblasts associated with phospho-mimetic Numb 
expression, suggesting a non-apoptotic role for Dronc in regulating neuroblast 
homeostasis through acting on Numb [200]. It will be interesting to show how interaction 
of Dronc with Numb could exert this regulation and whether a non-catalytic function of 
Dronc is also required for homeostasis of other types of stem cells. 
An example for regulation of cell migration through non-apoptotic function of 
caspases is depicted with border cell migration in the Drosophila ovary. A group of 
follicle cells migrate to the center of the egg chamber during Drosophila oogenesis [201]. 
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This phenomenon is controlled by various molecular players such as Rac GTPase [202]. 
Expression of a dominant negative form of Rac (RacN17) in border cells blocks the 
migration, which could be suppressed by expression of DIAP1 independently of its anti-
apoptotic function [203]. This suppression required both BIR domains but not the RING 
domain [202]. In fact, DIAP1 could physically interact with Rac in vitro [203]. 
Interestingly, loss-of-function of dark or dominant negative form of dronc could also 
suppress this blockage of border cell migration, suggesting that Dronc may play a 
negative role in border cell migration [203]. Supportive of this result, another study 
showed that the kinase IKKε that could lead to degradation of DIAP1 could also inhibit 
border cell migration when overexpressed [204]. Interestingly, a recent study indicated 
that a dominant negative form of crinkled could also suppress RacN17-induced 
phenotype [188]. 
Spermatid individualization occurs late in spermatogenesis. 64-interconnected 
spermatids go along in a cyst while they get rid of their cytoplasm and organelles and 
mature to become individual spermatids that are enclosed with plasma membrane. Both 
initiator and effector caspase activity and Dark are required for elimination of these extra 
structures during spermatid individualization [103, 205]. In addition, male germline 
specific cyto-c-d is essential for this process because it is required for activation of 
caspases [103, 105, 205]. Caspase activity is regulated by a Cullin3 ubiquitin ligase 
complex which targets DIAP1 and dBruce [103, 206-208]. The activity of Cullin3 
complex is controlled by its antagonist Soti which competes with substrates or its 
activator A-Sβ (a Krebs cycle component), which interacts with Cullin3 complex at the 
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surface of mitochondria [103, 206-208]. This regulation is dependent on spatial and 
temporal expression of these components during the individualization process [103, 206-
208]. Another study identified that Tango7 genetically and physically interacts with the 
apoptosome to transform its apoptotic activity into a cell remodeling one during 
spermatid individualization [209].  
As seen in examples of non-apoptotic functions of caspases above, there are 
possible mechanisms how caspase activity could be used in cellular events other than cell 
death. One of these mechanisms could be localizing caspases in specific subcellular 
compartments such as in spermatid indivualization or neural pruning. Another 
mechanism could be fine-tuning the levels of caspases through signaling events upstream 
of caspases such as in SOP cell development. Although it has been more than ten years 
since the first observations of non-apoptotic functions of caspases, it will be intriguing to 
discover new regulatory roles for caspases and understand the mechanisms underlying 
these functions. 
 
Part II. The Ubiquitin System 
Organisms require a proper communication system to translate cues into action. 
One such mechanism is the ubiquitin system that ensures homeostasis of the organism 
through controlling cellular events such as division, differentiation and survival. The fate 
of a protein and thus regulation of such cellular events can be determined by the ubiquitin 
system. Conjugation of a 76 amino acid molecule called ubiquitin (Ub) to a substrate 
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(ubiquitylation) can result in either its proteasomal degradation or change in its 
localization, activity, conformation or interaction with its binding partners (Figure 1.5) 
[210].  
Ubiquitylation is a post-translational modification. The mechanism of 
ubiquitylation requires an Ub, an E1 Ub-activating enzyme, an E2 Ub-conjugating 
enzyme and an E3 Ub-ligase (Figure 1.4). In an ubiquitylation reaction, Ub is first 
activated in an ATP-dependent manner by joining the carboxyl group of Gly76 of Ub to 
the catalytic Cys of the E1 enzyme through a thioester bond [211, 212]. Activated Ub is 
then transferred to catalytic cysteine of the E2 enzyme and forms an E2-Ub thioester 
[211, 212]. The E3 enzyme binds to both E2-Ub and the substrate by regulating E2 and 
substrate specificity [211, 212]. The E3 enzyme, depending on its structure either 
transfers Ub from the E2 to the substrate (RING E3s) or transfers Ub to its catalytic Cys 
first and then to the substrate (HECT E3s) [211, 212]. In the end, the carboxyl group of 
Ub (Gly76) forms an isopeptide bond with the ε-amino group in the side chain of a Lys in 
the substrate. This is called mono-ubiquitylation of a substrate. Proteins can also be 
modified at multiple Lys residues (multi-mono-ubiquitylation). Mono-ubiquitylation of a 
substrate is often linked to non-degradative means of regulation (See below for detail).  
Ubiquitin is a stable protein that is conserved from yeast to human. It has seven 
Lys residues: K6, K11, K27, K29, K33, K48 and K63. After a substrate is mono-
ubiquitylated, any of these Lys residues or the first Methionine (Met1) can be used for 
addition of another ubiquitin molecule to form poly-ubiquitin chains. This chain 
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formation can occur between the same type of linkage (homotypic) or different type of 
linkages (such as mixed or branched chains). Poly-ubiquitylation of a substrate could lead 
to either its proteasomal degradation or its non-degradative regulation (See below for 
details). Poly-ubiquitin chain specificity is determined by E2 enzymes, whereas substrate 
specificity is controlled by E3 ligases.  
Regulation of ubiquitylated proteins often requires interaction with other proteins 
to fulfill their fate. For example, a substrate to undergo degradation is poly-ubiquitylated 
and recruited to the proteasome in multiple steps. One of these steps includes the 
interaction between ubiquitin and a Ubiquitin Binding Domain (UBD) containing protein 
or between ubiquitin and the proteasome. For this reason, ubiquitin has hydrophobic 
surfaces such as the Ile44 Patch with Leu8, Val70 and His68 and the Ile36 Patch with 
Leu8, Leu71 and Leu73 [210]. The Ile44 Patch can mediate interactions with the 
proteasome and UBDs, while the Ile36 Patch can be bound by UBDs and 
Deubiquitylating enzymes (DUB) [210].  
Ubiquitylation is a reversible process. Deubiquitinases (DUBs) hydrolyze the 
isopeptide bond between ubiquitin and the substrate or between ubiquitin molecules 
[213]. DUBs are important for recycling and maintaining free ubiquitin in the cells by 
removing ubiquitin from proteins that will undergo degradation [213]. They also break 
bonds between un-anchored linear ubiquitin chains to generate mono-ubiquitin that will 
be used for ubiquitylation of a substrate [213].  
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Figure 1.5. The Ubiquitin System 
The ubiquitin system utilizes an Ubiquitin, ATP, an E1 activation enzyme, an E2 
conjugating enzyme and an E3 ligase. Ubiquitin is conjugated to a Lysine residue of a 
substrate, which is called mono-ubiquitylation. Addition of ubiquitin to Lysine residues 
of the ubiquitin on the substrate results in poly-ubiquitylation. Ubiquitylation could 
regulate substrates in cellular events through non-degradative or degradative manners and 
can be reversed by deubiquitinases.  
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In addition, they function in regulating ubiquitylated proteins through chain editing and 
by acting as antagonists for ubiquitylation [213].  
Ubiquitylation is a reversible process. Deubiquitinases (DUBs) hydrolyze the 
isopeptide bond between ubiquitin and the substrate or between ubiquitin molecules 
[213]. DUBs are important for recycling and maintaining free ubiquitin in the cells by 
removing ubiquitin from proteins that will undergo degradation [213]. They also break 
bonds between un-anchored linear ubiquitin chains to generate mono-ubiquitin that will 
be used for ubiquitylation of a substrate [213]. In addition, they function in regulating 
ubiquitylated proteins through chain editing and by acting as antagonists for 
ubiquitylation [213].  
A. Degradative Ubiquitylation 
The Ubiquitin-Proteasome System (UPS) was first described more than 30 years 
ago by Avram Hershko and his colleagues, which had earned them the Nobel Prize in 
Chemistry in 2004 [214-216]. Cells utilize UPS to selectively get rid of misfolded and 
abnormal proteins [212]. In addition, the UPS controls concentrations of short-lived 
proteins and contributes to regulation of protein activity by destroying inhibitory regions 
[212]. One of the most-studied and abundant types of ubiquitylation is K48 poly-
ubiquitylation. K48 linkage with four or more ubiquitins targets substrates to the 26S 
proteasome for degradation [210]. NMR studies of tetra ubiquitin chains revealed that 
K48 poly-ubiquitin chains adopt a compact conformation by interaction of hydrophobic 
moieties with each other, thus limiting its surface exposure for regulatory reasons [210]. 
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A recent study conducted in yeast showed that upon proteasome inhibition, K11 linkage 
was found be to the most abundant after K48 and followed by K63, K6 and K29 linkages, 
suggesting that non-K48 linkages also contribute to UPS [217]. Studies focusing on K11 
linkage identified its role in the cell cycle. Induction of Anaphase Promoting Complex 
(APC/C), which mediates degradation of cell cycle proteins, led to accumulation of K11 
signal and inhibition of K11linkage resulted in stabilization of APC/C targets [218, 219]. 
Branched poly-ubiquitin chains were also shown to be involved in UPS. For example, 
branching of K11 ubiquitin chain with K48 and K63 can be synthesized by APC/C to 
function in and improve proteasomal degradation [220]. As being one of most well-
known regulatory poly-ubiquitylation signal, K63 linkage was also reported to contribute 
to UPS in yeast [221]. Interestingly, a recent study indicated that upon inhibition of 
formation of poly-ubiquitin chains, mono-ubiquitylated proteins can undergo proteasomal 
degradation in yeast and mammalian cells [222]. 
Linkage specificity is not a random process. E2 conjugating enzymes determine 
length and topology of a ubiquitin chain [223]. By controlling chain initiation and 
elongation, one E2 enzyme can bind to multiple E3 ligases to regulate their substrates’ 
fate [223]. For example, APC/C conjugates K11 poly-ubiquitin chain with the help of 
Ube2S [224]. Linkage specificity for different DUBs has also been shown before. For 
example, OTUB1 and Cezanne, two members of the Ovarian Tumor (OTU) family of 
DUBs, specifically remove K48 linkages and K11 linkages, respectively [225-227].  
B. Non-Degradative Ubiquitylation 
52 
 
 
 
In addition to degradation, ubiquitylation of a substrate can also regulate its 
activity, interactions and localization. Non-degradative ubiquitylation can occur through 
mono-ubiquitylation or poly-ubiquitylation of substrates [210]. Regulation of protein 
interactions through mono-ubiquitylation has been implicated in DNA damage response 
[210, 228]. For example, upon DNA damage, PCNA (a processivity factor for DNA 
polymerases) is mono-ubiquitylated [210, 228]. This recruits Y family DNA polymerases 
that substitute for replicative polymerases from PCNA and restore replication process 
[210, 228]. In addition, FANCD2 and FANCI are found to be mono-ubiquitylated, which 
leads to their assembly in nuclear foci together with other related proteins for DNA repair 
[229]. Both of these mono-ubiquitylation events can be reversed by Usp1 deubiquitinase 
[228]. Another substrate of mono-ubiquitylation that affects protein interaction is Smad4, 
central transducer of TGFβ signaling. Mono-ubiquitylation of Smad4 blocks its 
interaction with Smad2/3 and thus hinders formation of an active complex and represses 
its transcriptional targets [230]. In the case of P53 regulation, mono-ubiquitylation 
induces its transportation from nucleus to cytoplasm, resulting in inhibition of its target 
genes [231].  
K63 poly-ubiquitylation is the most commonly observed non-degradative poly-
ubiquitylation. NMR analysis and crystal structure of K63 poly-ubiquitin chain displayed 
an open conformation, which could support chain flexibility and distance for diverse 
regulation [210]. K63 poly-ubiquitylation and Met1- linked linear ubiquitin chains have 
regulatory implications in NF-κB signaling (see Part III for details) [210, 232].  
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The ubiquitin system has implications in both degradative and non-degradative 
means of regulation of proteins in cellular events as mentioned above. It is important to 
understand the relationship between the ubiquitin system and apoptosis as both pathways 
regulate cell homeostasis. The following section will discuss examples of how the 
ubiquitin system controls apoptosis and what are the consequences of ubiquitylation of 
anti- and pro-apoptotic proteins in detail. 
 
Part III. Regulation of Apoptosis through the Ubiquitin System 
A. The Ubiquitin System and Mammalian Apoptosis 
Inhibitor of apoptosis proteins (IAPs) are important for the cells’ defense against 
caspase activity. The physiological inhibitor of caspases in mammals is XIAP, which is 
shown to target caspase-3, 7 and 9 for ubiquitylation and thus inhibition (discussed in 
Part IB). IAP antagonist such as SMAC/DIABLO, HtrA2/Omi and ARTS were shown to 
be ubiquitylated and degraded by XIAP [233].  
The mature form of caspase-9 could interact with BIR3 of XIAP through its IBM 
(residues 316-319) [234]. A structural study revealed that both mature and procaspase-9 
are monomers in solution; however, interaction of mature caspase-9 with XIAP prevents 
caspase-9 to homodimerize [235]. This interaction also masks the activation interface of 
caspase-9 so that caspase-9 function is fully inhibited [235]. In the case of effector 
caspases, the linker region between BIR1 and BIR2 of XIAP binds to caspase-3 or 7 
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active homodimers and hinders the substrate entry for cleavage [236-238]. Studies 
conducted in mammalian cells suggested that XIAP could ubiquitylate caspase-3 for 
degradation [239]. Mature caspase-9 was also shown to be poly-ubiquitylated by XIAP at 
its large subunit for degradation [240]. However, deletion of the RING domain of XIAP 
in mice did not result in increase in protein levels of caspase-3, 7 or 9 [146]. This could 
suggest that these caspases could be regulated by the ubiquitin system in a non-
degradative way. 
An interesting study in rat brains showed that XIAP could be mono-ubiquitylated 
to regulate its localization and/or activity upon traumatic brain injury [241]. However, 
whether XIAP or another ubiquitin ligase mediates this mono-ubiquitylation is unclear. 
In addition to XIAP, mammalians have c-IAP1 and c-IAP2 E3 ligases that 
function in the extrinsic apoptotic pathway. c-IAP1 and c-IAP2 bear three BIR domains, 
a UBiquitin-Associated (UBA) domain, a CARD and a RING domain [242]. They do not 
inhibit caspase-8 directly, however, they are important signaling proteins in TNF-induced 
cell death. c-Iap1 and c-Iap2 double knockout Mouse Embryonic Fibroblast (MEF) cells 
are resistant to TNF-induced cell death [242]. Upon infection, TNFα signaling could be 
activated as a response in three distinct mechanisms, which could lead to survival, 
apoptosis or necrosis (another type of cell death) [243]. Binding of TNFα to TNFR1 
recruits TRADD which then acts a scaffolding protein to recruit RIP1 and ubiquitin 
ligases TRAF2, c-IAP1 and c-IAP2 and form Complex I [243]. In this protein complex, 
c-IAP1 and c-IAP2 partner with UBCH5/UBE2D1 E2 enzyme to ubiquitylate RIP1, 
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TRAF2 and themselves non-degradatively [243]. The complex formation followed by 
these ubiquitylation events culminate in activation of NF-κB signaling [243]. Linear 
Ubiquitin Assembly Complex (LUBAC) could also ubiquitylate RIP1 linearly to further 
stabilize TNFR signaling [242]. If RIP1 ubiquitylation is inhibited by blockage of c-IAPs 
or removed by deubiquitinases such as cylindromatosis (CYLD), RIP1 and TRADD are 
released from the Complex I [242]. Free TRADD monomer could interact with FADD 
through Death Domain interaction [242]. FADD then binds to Caspase-8 through the 
Death Effector Domains [242]. These interactions form a complex for caspase-8 
dimerization and activation (Complex II), which leads to apoptotic signaling [242]. If 
caspase-8 is inhibited, RIP1 binds to RIP3, which mediates necroptotic cell death [243]. 
Therefore, TNF signaling nicely illustrates the importance of the ubiquitin pathway in 
recruitment and assembly of signaling complexes. 
The function of the CARD domain in an IAP is still a mystery. However, a recent 
study highlighted that the CARD of c-IAP1 could inhibit the E3 ligase activity of c-IAP1 
through preventing RING dimerization which is a critical step for activation of c-IAP1 
and c-IAP2 [244]. This inhibition is important to block caspase-8-mediated apoptosis 
through TNF signaling [244]. 
The UBA domain of c-IAP1 was shown to bind to mono-ubiquitin and K48- and 
K63-linked poly-ubiquitin chains, which serves a scaffolding platform for NF-κB 
signaling [245, 246]. The UBA domain of c-IAP1 and c-IAP2 are required for their anti-
apoptotic function; however, mutations in UBA did not abolish the recruitment of TNF 
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signaling components [245]. Similar to XIAP, IAP antagonists can also bind to BIR3 
domain of c-IAP1 and c-IAP2, which leads to their auto-degradation. Interestingly, the 
UBA domain was necessary for IAP antagonist-induced proteasomal degradation of c-
IAP1 and c-IAP2 [245]. Similar to c-IAP1 and c-IAP2, XIAP also carries a UBA domain 
that was shown to bind mono-ubiquitin, K48-linked and linear di-ubiquitin chains [247], 
which could serve as a scaffold for regulatory reasons. 
c-IAP1 and 2 were shown to be involved in interaction and ubiquitylation of 
caspase-3, 7 and SMAC/DIABLO. Interestingly, caspase-3 and 7 were shown to be 
mono-ubiquitylated by c-IAP2 in vitro [248]. In a recent study, c-IAP1 was shown to 
bind processed caspase-7 and intermediate form of caspase-3 [249]. These interactions 
result in ubiquitylation and degradation of caspase-7 and 3 [249]. Another study 
suggested that c-IAP1 inhibits procaspase-3 but not active and mature caspase-3 in 
mammalian cells through interaction with the apoptosome [250]. However, compared to 
XIAP, c-IAP1 is a poor physiological inhibitor of effector caspases [249]. The reason for 
this observation could be that XIAP, c-IAP1 and c-IAP2 have distinct interaction 
mechanisms with caspases that may affect consequences of IAP-mediated inhibition 
[251]. Regulation among IAPs through ubiquitylation could also be possible. For 
example, c-IAP1 could target XIAP for degradation [233].  
Recently, caspase-8 activation was shown to be regulated by ubiquitylation. In the 
DISC, caspase-8 activation is induced through poly-ubiquitylation (potentially K63-
linked) at its small catalytic subunit by Cullin3 E3 ligase [252]. Activated caspase-8 
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interacts with TRAF2 E3 ligase and undergoes K48-linked poly-ubiquitylation at its large 
subunit, which results in proteasomal degradation of caspase-8 [253]. These 
ubiquitylation events elegantly show how activation of caspases could be regulated by the 
ubiquitin system. 
Another interesting study suggested that Apollon E2 enzyme with a BIR domain 
could poly-ubiquitylate mature or procaspase-9, SMAC/DIABLO and HtrA2/Omi in an 
E3-independent, but UBC-dependent manner [254-256], which results in proteasomal 
degradation of these targets. 
Neuronal Apoptosis Inhibitory Protein (NAIP) is the first identified E3 ligase with 
three BIR domains and a Nuclear Oligomerization Domain (NOD). NAIP was originally 
misindetified as the gene for spinal muscular atrophy [257]. In cell culture studies, the 
BIR2 and BIR3 domains of NAIP, BIR2 with more potency, could inhibit the function of 
caspase-3 and caspase-7 [258]. Further studies revealed that NAIP could not interact with 
SMAC/DIABLO [259, 260]. However, the BIR3 domain of NAIP but not BIR3 of XIAP 
could interact with procaspase-9 in the apoptosome in an ATP-dependent manner but not 
with monomeric procaspase-9 [259, 260]. Another study on this observation showed that 
the NOD of NAIP actually interacts with CARD-NOD of APAF1 [261]. Hence, this 
regulation of the apoptosome by NAIP inhibits processing of procaspase-9 and thus 
procaspase-3 [261]. 
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Involvement of SCF type ubiquitin ligase complexes were also shown in 
mammalian apoptosis. For example, SCF(βTRCP) could ubiquitylate a pro-apoptotic 
BCL-2 family protein BIMEL and procaspase-3 for degradation [262, 263].  
In addition to IAP E3 ligases, DeUbiquitinating Enzymes (DUB) constitute an 
important part of the Ubiquitin System. Multiple DUBs are implicated in regulation of 
apoptosis [264]. For example, USP15 was found to control stability of procaspase-3 
positively and its interaction with SCF complex negatively [265]. Similarly, USP41 was 
shown to be a pro-apoptotic DUB as expression of USP41 activated caspase-3 [266]. 
DUBs are also shown to regulate apoptosis through signaling at upstream of caspases 
[264]. 
B. The Ubiquitin System and Drosophila Apoptosis 
Being an E3 ligase, DIAP1 represents the central link in the hub of apoptosis and 
ubiquitylation network. DIAP1 could target both RHG proteins and caspases (discussed 
in detail in Part IA). However, regulation of apoptosis through ubiquitylation is not 
limited to DIAP1, other players in the ubiquitin pathway have been characterized to 
regulate Drosophila apoptosis via DIAP1 or other players.  
Even before Drosophila caspases were shown to be regulated non-degradatively 
by DIAP1, an interesting study found that DIAP1 could generate K63 poly-ubiquitin 
chain for its auto-ubiquitylation with Ubcd1 or Ubc13/Uev1a as E2 ligases [267]. This 
K63 poly-ubiquitylation of DIAP1 seems to be blocking its E3 ligase activity on its 
targets, most likely through steric hindrance [267]. In confirmation with other studies, 
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this study also showed that DIAP1 is cleaved by caspases at its N-terminus, which makes 
it a substrate for the N-end rule pathway [267]. However, the same study also uncovered 
that full-length DIAP1 could be degraded with or without apoptosis induction by a novel 
E3 ligase, independently of caspases, its E3 ligase activity and N-end rule pathway [267]. 
DIAP2 was shown to bind and induce degradation of DIAP1 [267]. It is possible that 
other ligases are also involved in this new type of DIAP1 regulation.  
A new look at DIAP1-induced RHG protein ubiquitylation identified that 
dimerized GRIM could bind to DIAP1 through BIR1 and BIR2 domains; however only 
BIR2-bound GRIM could be ubiquitylated by DIAP1 at K136 [268]. DIAP1 cooperates 
with Ubcd1 to conjugate K48-linked poly-ubiquitin chains to GRIM for proteasomal 
degradation [268]. Interestingly, this ubiquitylation can be prevented when GRIM is 
cleaved by caspases at Asp132 [268]. A cleavage mutant GRIM was less potent activator 
of cell death than wild type GRIM in Drosophila S2 cells [268]. One explanation for this 
phenotype would be that GRIM is in a feed-forward loop where activated caspases cleave 
GRIM to block its ubiquitylation so that it could continue antagonizing DIAP1 and 
activating caspases. 
A screen to identify E3 ligases in the apoptotic pathway led to characterization of 
UBR3 [269]. It has been previously shown that UBR proteins are involved in apoptosis 
such as in DIAP1 degradation through the N-end rule pathway or interacting with DIAP1 
for its anti-apoptotic function. This study showed that downregulation of UBR3 in the 
Drosophila eye caused an abnormal eye phenotype due to increased apoptosis [269]. 
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UBR3-induced cell death appeared to be upstream of Dronc but downstream of or in 
parallel to DIAP1 [269]. Interestingly, the UBR-box domain but not the RING domain of 
UBR3 was essential for its anti-apoptotic function [269]. UBR1, which was shown to 
interact with DIAP1 for its anti-apoptotic function in Drosophila cells together with 
UBR3, -5, -6, -7, could not suppress UBR3-induced cell death, suggesting that these 
enzymes have different functions in apoptosis [269]. N-terminally cleaved but not wild 
type DIAP1 could interact with UBR3 through the UBR-box domain, enhancing its 
interaction with caspases and thus its ability to ubiquitylate caspases [269]. 
UBA1, the Drosophila E1 enzyme, was found as a suppressor of hid-induced cell 
death in the Drosophila eye; which displays a good example of the impact of 
ubiquitylation to Drosophila apoptosis [270]. Further examination of this phenotype 
identified that weaker Uba1 alleles could suppress both ectopic and developmental cell 
death due to a still functioning ubiquitin system [270]. Because the cells contained 
increased DIAP1 and decreased Dronc levels [270]. In contrast, stronger Uba1 alleles 
which block the ubiquitin system induced apoptosis as DIAP1 could not utilize the 
ubiquitin system for inhibiting Dronc [270]. This study also argued that ubiquitylation of 
DIAP1 versus Dronc occurs at different rates to set the equilibrium of life and death 
[270]. 
A recently characterized E3 ligase, elfless has been indicated to induce apoptosis 
when expressed in the Drosophila eye, which could be suppressed by heterozygosity at 
dronc or enhanced by heterozygosity at ubcd1 [271]. Extracts from elfless expressed 
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Drosophila heads showed increased levels of DIAP1 and no change in UBCD1 level 
[271]. These results may suggest that DIAP1 stability could be regulated by Elfless and 
UBCD1 in the apoptotic pathway through affecting UBCD1 activity rather than its 
protein level or degradation of RHG proteins. Further characterization of the function and 
the nature of elfless will be interesting in terms of finding out its place in the apoptotic 
pathway. 
A screen to identify modifiers of rpr/grim-induced apoptosis in the Drosophila 
eye characterized four enhancers related to ubiquitylation: the E1 activating enzyme 
UBA1, the deubiquitylating enzyme fat facets (faf) and two proteins of an SCF E3 
ubiquitin ligase complex, Skp1 and Morgue [272]. Heterozygosity at the morgue locus 
resulted in suppression of cell death induced by rpr/grim, rpr or hid in the Drosophila 
eye and inhibition of removal of extra interommatidial cells in the Drosophila eye [272, 
273]. Expression of morgue in Sf-9 cells caused apoptosis, which could be suppressed by 
P35 and DIAP1 expression, suggesting that Morgue functions in a caspase-dependent 
pathway, antagonist to DIAP1 [272, 273]. Morgue contains F-box and E2 conjugating 
domains [272, 273]. Because F-box and Skp proteins are known to interact with SCF 
complexes, the authors tested the ability of Morgue and Skp1 to interact [272, 273]. They 
observed an interaction between these two proteins, dependent on the F-box domain of 
Morgue [272, 273]. Because Morgue is also an E2 ligase, its interaction with DIAP1 was 
tested in the same study. DIAP1 and Morgue interacted independent of F-box and E2 
conjugating domain of Morgue and the RING domain of DIAP1 [272, 273]. Expression 
of morgue in S2 cells or 3
rd
 instar larval eye discs led to reduction of DIAP1 level, which 
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was independent of the RING domain of DIAP1 and could be suppressed by inhibition of 
the proteasome [272, 273].  
dBruce can suppress rpr- and grim-induced cell death in the Drosophila eye [31]. 
Further examination of this phenotype showed that the levels of a non-ubiquitable RPR 
are still increased in dBruce mutant background [274]. In fact, RPR is a direct target of 
dBruce. The BIR domain of dBruce could interact with the IBM and GH3 region of RPR 
[274]. Interestingly, this interaction provides ubiquitylation of RPR at non-lysine residues 
[274]. It will be of interest to see if other IAP antagonists are regulated similarly by 
dBruce. 
DeUBiquitylating-Apoptotic-Inhibitor (DUBAI) was characterized to stabilize 
DIAP1 and protect cells from apoptosis [275]. Downregulation of DUBAI led to eye 
ablation which was enhanced by rpr-, hid- and grim-induced cell death and was 
suppressed by DIAP1 in the Drosophila eye [275]. In addition to their genetic interaction, 
DUBAI and DIAP1 physically interacted and this interaction stabilized DIAP1 [275]. 
The recently identified Drosophila USP5 deubiquitinase (dmUSP5/leon) was 
shown to be required for Drosophila development because null allele of dmUsp5/leon are 
late larval lethal accompanied with increased apoptosis in larval brain and imaginal discs 
[276]. Extracts prepared from dmUsp5/leon null larva showed that hid and rpr genes 
were upregulated [276]. Expression of DIAP1 partially rescued the developmental and 
apoptotic phenotypes [276]. Mammalian USP5 is important for disassembling conjugated 
or unconjugated poly-ubiquitin chains to mono-ubiquitin [276]. Null mutants of 
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dmUsp5/leon have decreased or increased free mono-ubiquitin and increased conjugated 
and unconjugated poly-ubiquitin chains that could impair ubiquitin homeostasis [276, 
277]. In particular, dmUSP5/Leon could hydrolyze K48-linked poly-ubiquitin chain 
better than K63 poly- ubiquitin chain [277]. In fact, dmUsp5/leon null mutant exhibited 
proteasomal impairment [277]. However, a more recent study showed that dmUSP5/Leon 
could cleave unanchored K11, K63 and linear poly-ubiquitin chain in addition to K48 
[278]. The same study also provided evidence that knockdown of dmUsp5/leon did not 
result in decrease in mono-ubiquitin levels due to compensation of the function by 
increased transcription of USP14 [278]. The authors suggested that the function of 
dmUSP5/Leon is not to maintain mono-ubiquitin levels as opposed to its mammalian 
counterpart [278]. Apoptosis could be affected through inhibition of proteasomal 
degradation in dmUsp5/Leon mutants; however, the underlying mechanism is still unclear 
and yet to be discovered. 
Another deubiquitinase, emperor’s thumb(et)/scrawny, was identified to have a 
role in the apoptotic pathway [279]. Loss of et function resulted in abnormal eye 
phenotypes in the Drosophila eye, which stemmed from increased apoptosis and reduced 
DIAP1 level [279]. et has 6 isoforms of which a short and a long isoform have been 
characterized. Both isoforms have protease activity; however, the short isoforms lack an 
N-terminal 55 aa sequence [279]. Expression of the long et isoform in the Drosophila eye 
blocked interommatidial cell death and suppressed rpr- and grim- induced cell death 
[279]. Interestingly, expression of the short isoform in the Drosophila eye behaved in the 
opposite way and caused a small eye phenotype due to apoptosis, which could be 
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partially suppressed by expression of the long et isoform or DIAP1 or Dronc 
downregulation [279]. However, this phenotype could not be suppressed by P35 
expression [279]. It is possible that long and short et isoforms have competing functions 
to fine-tune levels of apoptotic factors such as RPR, GRIM, DIAP1 and Dronc.  
Recently, a deubiquitinase called DUBA was characterized to induce apoptosis. In 
vitro studies suggested that DUBA interacted with DIAP1 and Dronc to possibly regulate 
their functions [280]. In case of the mammalian counterpart, phosphorylation of DUBA at 
S183 was required for its catalytic activity [280]. Interestingly, DUBA could remove K11 
and K63 poly-ubiquitin chains more efficiently than others [280]. Further examination of 
Duba null and phospho-mutant versions in vivo identified that Duba is essential for 
spermatogenesis [280]. In the late stages of spermatogenesis, spermatid individualization 
occurs which requires non-apoptotic functions of caspases [280]. Because level of 
ubiquitylated proteins were lower in Duba null mutant testes, it is possible that DUBA 
regulate function of caspases through removing their inhibitory ubiquitylation [280]. 
Another study in spermatid individualization showed that Cullin3 E3 ligase is 
required for caspase activation in this process [206]. Cullin3 forms a complex with 
Roc1b, a small RING domain protein and the Klhl10 BTB domain protein to mediate 
protein ubiquitylation at the onset of spermatid individualization [206].  
In addition to Dronc, drICE and Dcp-1, the caspase-8 homolog DREDD was 
shown to be ubiquitylated. DREDD was shown to regulate innate immunity responses in 
flies [281]. It functions in the Immune Deficiency (IMD) pathway, which is similar to 
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mammalian NF-κB signaling. Upon microbial infection, DIAP2 was shown to bind 
DREDD at its Death Effector Domain 1 (DED1) and mediates its K63 poly-
ubiquitylation [282]. This ubiquitylation leads to processing and activation of DREDD 
[282]. Activated DREDD cleaves IMD protein, which exposes an IBM that is required 
for its interaction with DIAP2 [196, 282]. DIAP2-mediated K63-poly-ubiquitylation of 
IMD protein provides a scaffolding complex with other components of IMD signaling 
[196]. Impaired ubiquitylation of DREDD and IMD proteins hinders IMD signaling 
pathway to respond to microbial infection [196, 282]. These studies elegantly suggest that 
caspases could be ubiquitylated for activation as well as inhibition.  
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CHAPTER II 
 
An inhibitory mono-ubiquitylation of the Drosophila initiator caspase Dronc 
functions in both apoptotic and non-apoptotic pathways 
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Summary 
Apoptosis is an evolutionary conserved cell death mechanism, which requires 
activation of initiator and effector caspases. The Drosophila initiator caspase Dronc, the 
ortholog of mammalian Caspase-2 and Caspase-9, has an N-terminal CARD domain that 
recruits Dronc into the apoptosome for activation. In addition to its role in apoptosis, 
Dronc also has non-apoptotic functions such as compensatory proliferation. One 
mechanism to control the activation of Dronc is ubiquitylation. However, the mechanistic 
details of ubiquitylation of Dronc are less clear. For example, monomeric inactive Dronc 
is subject to non-degradative ubiquitylation in living cells, while ubiquitylation of active 
apoptosome-bound Dronc triggers its proteolytic degradation in apoptotic cells. Here, we 
examined the role of non-degradative ubiquitylation of Dronc in living cells in vivo, i.e. 
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in the context of a multi-cellular organism. Our in vivo data suggest that in living cells 
Dronc is mono-ubiquitylated on Lys78 (K78) in its CARD domain. This ubiquitylation 
prevents activation of Dronc in the apoptosome and protects cells from apoptosis. 
Furthermore, K78 ubiquitylation plays an inhibitory role for non-apoptotic functions of 
Dronc. We provide evidence that not all of the non-apoptotic functions of Dronc require 
its catalytic activity. In conclusion, we demonstrate a mechanism whereby Dronc’s 
apoptotic and non-apoptotic activities can be kept silenced in a non-degradative manner 
through a single ubiquitylation event in living cells. 
Introduction 
In multicellular organisms, cells have a turning point in their lives to commit to 
either living or dying. Cells which are committed to die can employ different forms of 
cell death, the most common one being a conserved form of programmed cell death, 
called apoptosis [2, 283]. Apoptosis plays important roles during development, to 
maintain tissue homeostasis in adult organisms and in response to stress conditions [4, 
284]. Studies aimed at the elucidation of regulatory pathways of apoptosis are of 
outstanding importance because dysregulation of apoptosis can lead to many disorders, 
including neurodegenerative diseases and cancer [147, 285]. The fruit fly Drosophila 
melanogaster provides an excellent model system in which to study the molecular 
mechanisms of apoptosis owing to its genetic conservation with mammals [50], low 
genetic redundancy of the apoptotic factors, and a variety of well-established genetic 
techniques that allow to easily manipulate gene function in specific tissue types and even 
individual cells.  
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Caspases, a highly conserved family of Cysteine (Cys) proteases, play a pivotal 
role in the regulation and execution of apoptosis. Caspases are produced as inactive 
monomeric zymogenes that consist of three domains, an N-terminal pro-domain, a large 
subunit containing the catalytic Cys residue, and a C-terminal small subunit. There are 
two types of apoptotic caspases: initiator caspases such as Caspase-2, Caspase-9 and the 
Drosophila ortholog Dronc; and effector caspases such as the Caspase-3, Caspase-7 and 
the Drosophila orthologs Drice and Dcp-1 [24, 286]. The prodomains of initiator 
caspases carry protein/protein interaction motifs such as the Caspase Recruitment 
Domain (CARD) [287]. The scaffolding protein Apaf-1 and its Drosophila ortholog Dark 
also carry an N-terminal CARD domain [71-73, 288]. In apoptotic cells, through 
CARD/CARD interactions with Dark, Dronc is recruited into and activated by a death-
inducing protein complex, termed apoptosome [95, 289]. Effector caspases which have 
short prodomains without protein/protein interaction motifs, are activated by the 
apoptosome through proteolytic cleavages between their subunits.  
Interestingly, correct stoichiometry between Dronc and Dark molecules is 
important for execution of apoptosis [99]. There is feedback inhibition between Dronc 
and Dark. Overexpression of one protein triggers degradation of the other one [99] 
ensuring that the levels of functional apoptosome units are low under these conditions. 
Only if both proteins are co-expressed can a significant apoptotic phenotype be recorded. 
Inhibitor of Apoptosis Proteins (IAPs) restrict apoptosis by inhibiting caspases 
[290, 291]. IAPs are characterized by the presence of one to three Baculovirus IAP 
Repeats (BIR) and some bear a C-terminal RING domain that provides E3 ligase activity 
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for ubiquitylation [290, 292, 293]. In living cells, Drosophila IAP1 (Diap1) interacts with 
Dronc, Drice and Dcp-1 through the BIR domains [49]. Importantly, binding of Diap1 to 
caspases is not sufficient for their inhibition; ubiquitylation by the RING domain of 
Diap1 is required for full inhibition of these caspases [49, 78, 89]. In dying cells, the pro-
apoptotic proteins Reaper (Rpr), Hid and Grim bind to Diap1 and change the E3 ligase 
activity of the RING domain which promotes auto-ubiquitylation and degradation of 
Diap1 [36-38, 82, 84, 85, 272, 273]. This leads to release of Dronc from Diap1 inhibition 
and free Dronc monomers can be recruited into the Dark apoptosome.  
Ubiquitylation is a post-translational modification, which results from conjugation 
of a protein called Ubiquitin to lysine residues of substrates either as a single moiety 
(mono-ubiquitylation) or by conjugation of ubiquitin chains (poly-ubiquitylation) [210, 
294]. The fate of a poly-ubiquitylated protein depends on the nature of the ubiquitin 
linkage. For example, K48 poly-ubiquitylation triggers proteolytic degradation of target 
proteins, while K63 poly-ubiquitylation regulates non-degradative events such as cell 
signaling [295-298]. In contrast, mono-ubiquitylation of a protein is usually not 
associated with protein degradation. Mono-ubiquitylation of target proteins is involved in 
DNA repair and endocytosis or may regulate translocation and interaction with other 
proteins [296, 297]. 
Both mammalian and Drosophila caspases are subject of regulatory ubiquitylation 
mediated by IAPs [242, 290, 292, 293, 299, 300]. For example, previous studies 
conducted in vitro and by transfection experiments in cell culture demonstrated that in 
Drosophila Dronc is ubiquitylated by Diap1 [78, 80, 89]. The importance of the RING 
70 
 
 
 
domain for control of Dronc activity became clear from genetic analysis. diap1 mutants 
lacking the RING domain are embryonic lethal due to massive apoptosis [38]. 
Consistently, loss of the RING domain of Diap1 triggers processing and activation of 
Dronc [89] suggesting that ubiquitylation negatively regulates Dronc processing and 
activation. Initially, it was proposed that ubiquitylated Dronc is degraded by the 
proteasome [79, 80, 180]. However, we showed recently that the level of Dronc protein 
does not increase in proteasome mutants [301] suggesting that Dronc is not subject of 
proteasome-mediated degradation. In fact, the control of Dronc activity by ubiquitylation 
is much more complex than initially anticipated. In living cells, free monomeric Dronc is 
subject to non-degradative ubiquitylation, while processed and activated Dronc in the 
Dark apoptosome is degraded in a Diap1-dependent manner [89, 99]. That raises the 
question about the nature and function of non-degradative ubiquitylation of free 
monomeric Dronc in living cells.  
Here, we report that in living cells Dronc is mono-ubiquitylated at Lysine 78 
(K78) in its CARD domain. To examine the role of K78 mono-ubiquitylation of Dronc, 
we mutated this residue to non-ubiquitable Arginine (K78R). Dronc
K78R
 and Dronc
wt
 
display similar enzymatic activities in vitro. However, Dronc
K78R
 is easier incorporated 
into the Dark apoptosome, is more efficiently processed and thus has higher enzymatic 
activity there. These data suggest that K78 ubiquitylation inhibits incorporation of Dronc 
into the Dark apoptosome.  Surprisingly, Dronc
K78R
 also suppresses some of the 
phenotypes associated with catalytic inactivity of Dronc such as lethality, loss of 
compensatory proliferation and defects in male genitalia rotation. These observations 
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provide evidence that K78 mono-ubiquitylation also controls non-apoptotic functions of 
Dronc and suggest that not all of the non-apoptotic functions of Dronc require its 
catalytic activity. In summary, this in vivo study provides a mechanistic link of how 
ubiquitylation of an initiator caspase can control its activity in both apoptotic and non-
apoptotic pathways in a non-degradative manner. 
Results 
Dronc is mono-ubiquitylated in living cells 
Because available anti-Dronc antibodies perform poorly in immunoprecipitation 
(IP) experiments, we took advantage of the Gal4/UAS system [302] and expressed Flag-
tagged Dronc (Flag-Dronc) [98] ubiquitously using the daughterless-Gal4 (da-Gal4) 
driver (denoted da>Flag-Dronc). Expression of da>Flag-Dronc in whole animals does 
not cause any significant developmental, apoptotic or lethality phenotypes. To examine 
the functionality of Flag-Dronc, we tested if it can rescue the lethal phenotype of strong 
dronc mutants (dronc
I24
/dronc
I29
) [61]. We indeed observed that da>Flag-Dronc is able 
to rescue the pupal lethality caused by dronc null mutations and can be activated in the 
apoptosome (Figure 2.1A, B).  
To address the status of Dronc ubiquitylation, we immunoprecipitated Flag-Dronc 
from embryonic, larval, pupal and adult fly extracts and blotted with FK1 and FK2 
antibodies that bind to ubiquitin-conjugated proteins, but not free, unconjugated 
ubiquitin. FK2 antibody binds to mono- and poly-ubiquitylated proteins, while FK1 
antibody detects only poly-ubiquitin-conjugated proteins [303]. Blotting the IPs with FK2 
antibody revealed high molecular poly-ubiquitin species; however, these are comparable 
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to the control IPs and may represent unspecific co-immunoprecipitated proteins (Figure 
2.2A). In contrast, in the 60 kDa range, FK2 detected a single band specifically in Dronc 
IPs (Figure 2.2A, arrow). This band is found in all developmental stages tested from 
embryos to adults. The FK1 antibody did not detect this band (Figure 2.2A). Flag-Dronc 
has an estimated molecular weight (MW) of 51 kDa, and adding one ubiquitin moiety of 
~8.5 kDa results in a combined MW of about 60 kDa, suggesting that this band may 
correspond to mono-ubiquitylated Flag-Dronc.  
To further verify mono-ubiquitylation of Dronc in vivo, we co-expressed 
da>Flag-Dronc and 6xHis-tagged ubiquitin (6xHis-ubiquitin) and pulled down all 
ubiquitylated proteins using Ni-NTA agarose beads. Blotting for Flag-Dronc revealed a 
single band of about 60kDa, that was not present in the control IP in which we only 
expressed 6xHis-ubiquitin (Figure 2.2B). This result further confirms that Dronc is 
ubiquitylated in vivo and the differential detection by FK2, but not FK1, suggests that it is 
– surprisingly - mono-ubiquitylated. 
As further evidence that this modification of Flag-Dronc corresponds to 
ubiquitylation, we incubated larval Flag-Dronc immunoprecipitates with a de-
ubiquitylating enzyme, USP2, which removes conjugated ubiquitin from target proteins. 
Consistently, in immunoblots, the FK2 signal is strongly reduced after USP2 incubation 
compared to the control (Figure 2.2C, upper panel, arrow; quantified in 2.2C’). 
Interestingly, although the majority of Flag-Dronc is de-ubiquitylated after USP2 
incubation, this does not result in a significant reduction of the molecular weight (MW)  
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Figure 2.1. Flag-Dronc
wt 
is functional. 
(A) Flag-Dronc can rescue the lethality associated with dronc null mutations.  
(B) Flag-Dronc can be activated in the apoptosome. Expression of either da>Flag-Dronc 
or GMR-Dark does not lead to any caspase (cleaved caspase-3, cc3) activity. However, 
when these transgenes are co-expressed (da>Flag-Dronc+GMR-Dark), caspase activity 
is increased in the posterior domain. 
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Figure 2.2. Dronc is mono-ubiquitylated at K78 in living cells for its inhibition.  
Arrows indicate mono-ubiquitylated Dronc. Asterisks denote unspecific bands. 
(A) Immunoprecipitates with Flag antibody from da>Flag-Dronc extracts of the 
indicated developmental stages were examined for Flag-Dronc ubiquitylation with FK2 
and FK1 antibodies.  
(B) Extracts from da>Flag-Dronc+6xHis-ubiqitin larvae were used to pull down 6xHis-
tagged ubiquitylated proteins. Flag antibody was used to detect Flag-Dronc.  
(C, C’) USP2 de-ubiquitinase can remove the conjugated mono-ubiquitin on Flag-Dronc. 
(C’) is the quantification of the Flag-Dronc bands, n=3. The FK2 signal in (C’) is 
normalized against immunoprecipitated Flag-Dronc. The removal of mono-ubiquitin does 
not cause a significant change in MW of Flag-Dronc. 
(D, D’) Heterozygous diap15 mutants display reduced Flag-Dronc mono-ubiquitylation 
(quantified in D’, n=2). The loss of mono-ubiquitin does not significantly change the 
MW of Flag-Dronc. 
(E) Domain structure of Dronc, showing relative position of K78 in the CARD domain. L 
= large subunit; S = small subunit. 
(F, F’) Flag-DroncK78R mono-ubiquitylation is significantly reduced compared to Flag-
Dronc
wt
. (quantified in F’, n=5). The loss of mono-ubiquitin does not significantly change 
the MW of Flag-Dronc
K78R
. 
For quantifications, the student’s t-test was used. Error bars are SD. * P<0.05; ** P<0.01. 
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of non-ubiquitylated Flag-Dronc (Figure 2.2C, lower panel). Nevertheless, this 
characterization indicates that Flag-Dronc is mono-ubiquitylated under in vivo conditions. 
We were also interested to identify the ubiquitin ligase that mediates mono-
ubiquitylation of Dronc. One good candidate is Diap1 which has been shown to 
ubiquitylate Dronc in vitro [78, 80, 89]. Ideally, to test if Diap1 ubiquitylates Flag-Dronc 
in vivo, one should examine homozygous mutant diap1 animals for loss of ubiquitylation 
of Dronc. However, these animals are early embryonic lethal due to strong apoptosis 
induction by loss of Diap1 [38] which makes this analysis very difficult. Therefore, we 
examined Flag-Dronc immunoprecipitates from larvae that were heterozygous for the 
strong diap1
5
 allele [36, 37]. Immunoprecipitates of Flag-Dronc from heterozygous 
diap1
5
 extracts display a significant reduction of FK2 immunoreactivity (Figure 2.2D, 
upper panel; quantified in 7D’) suggesting that Diap1 is involved in mono-ubiquitylation 
of Flag-Dronc. However, as already noted above in the context of the USP2 experiments, 
the Flag immunoblots do not display a significant size difference between ubiquitylated 
and non-ubiquitylated Flag-Dronc (Figure 2.2D, lower panel). The reason for this unusual 
behavior is not known. 
Flag-Dronc is ubiquitylated at K78 in the CARD domain 
To identify the ubiquitylated Lysine (K) residue, we submitted the 60kDa band 
from immunoprecipitated Flag-Dronc samples from both larval and pupal stages to mass-
spectrometry (LC-MS/MS) analysis. Both analyses showed that Flag-Dronc is 
ubiquitylated at K78 (Figure 2.3A). To also examine for poly-ubiquitylation, we 
submitted higher molecular weight bands of the Flag immunoprecipitates for LC-MS/MS 
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analysis. However, there was no trace of ubiquitylation. In addition to mono-
ubiquitylation of K78, we also observed phosphorylation of Ser130, an inhibitory 
modification of Dronc that has previously been reported [98]. Confirmation of a known 
modification of Dronc validates the LC-MS/MS approach. Importantly, LC-MS/MS 
analysis of apoptotic extracts (induced by hs-hid) revealed that the mono-ubiquitylation 
at K78 is absent (Figure 2.3B). This observation suggests that K78 mono-ubiquitylation 
is a feature of Dronc in living cells and that it may control (inhibit) the apoptotic activity 
of Dronc. 
To determine whether DIAP1 can ubiquitylate Dronc at K78, we performed in 
vitro ubiquitylation assays of Dronc with Diap1 as E3 ubiquitin ligase and analyzed in 
vitro ubiquitylated Dronc by mass spectrometry. As E2 conjugating enzymes we used 
either human UBE2D2 or Drosophila UBCD1. In both cases, Dronc was found to be 
ubiquitylated at K78 by DIAP1 in vitro (Figure 2.3C, D), suggesting that DIAP1 can 
mediate K78 ubiquitylation of Dronc. 
K78 resides in the CARD domain of Dronc (Figure 2.2E) which interacts with the 
CARD domain of Dark for recruitment of Dronc into the apoptosome. To study the role 
of K78 ubiquitylation, we mutated K78 to Arginine (R) and generated transgenic UAS-
Flag-Dronc
K78R
 flies by phiC31-based site-specific integration [304, 305]. In addition, we 
combined the K78R mutation with a mutation that changes the catalytic Cys (C) to Ala 
(A) (C318A), generating transgenic UAS-Flag-Dronc
K78RC318A
 flies. As controls, we 
generated UAS-Flag-Dronc
wt
, a catalytically inactive Dronc (UAS-Flag-Dronc
C318A
) and  
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Figure 2.3. LC-MS/MS analysis shows that Dronc is ubiquitylated at K78.  
(A, B) Of the peptides obtained by Chymotrypsin digests of immunoprecipated Dronc 
from larval and pupal extracts under surviving conditions (A), only the peptide 
K
78
ITQRGPT was found to carry the di-Glycine signature indicative of ubiquitin 
modification. di-Glycine adds 114 Da to this peptide. Correspondingly, all b peaks of this 
peptide obtained under surviving conditions (A) are shifted compared to the b peaks 
under apoptotic conditions (B); see asterisk at peak b1 as example.  
(C, D) Mass-spec analyses of in vitro ubiquitylated Dronc with Diap1 as E3 ligase and 
either human UBE2D2 (C) or Drosophila UBCD1 (D) as E2 conjugating enzymes show 
that K78 can be ubiquitylated by DIAP1. 
Arrows indicate 114 Da mass shift due to ubiquitylation on K78.  
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empty vector transgenic flies. Because all constructs are inserted in the same landing site 
in the genome (VK37 on 2
nd
 chromosome), the expression and protein levels of these 
Dronc constructs are expected to be the same which was confirmed by immunoblotting 
(Figure 2.9H). To test whether da>Flag-Dronc
K78R
 mutant flies lose the mono-
ubiquitylation signal, we immunoprecipitated Dronc from larval samples and probed 
immunoblots with FK2 antibody. da>Flag-Dronc
K78R
 larval samples showed significantly 
reduced levels of mono-ubiquitylation (Figure 2.2F, arrow; quantified in Figure 2.2F’), 
suggesting that Flag-Dronc
K78R
 is less efficiently ubiquitylated compared to Flag-
Dronc
wt
.  However, because K78 is the only Lys residue being detected by LC-MS/MS, 
we expected a complete loss of ubiquitylation in the Flag-Dronc
K78R
 mutant. Although 
significantly reduced, the mono-ubiquitylation signal is not completely lost (Figure 2.2F’) 
suggesting that in the absence of K78 as major ubiquitin acceptor, another Lys residue 
may be used as alternative ubiquitylation site (see Discussion). Nevertheless, the K78R 
mutation revealed that K78 of Dronc is a major ubiquitin acceptor. Interestingly also, as 
already observed in the USP2 and diap1
5
 experiments, the MW of ubiquitylated and non-
ubiquitylated Dronc is not significantly different (Figure 2.2F, lower panel). 
Flag-Dronc
K78R
 shows enhanced genetic interaction with Dark in a Diap1-dependent 
manner 
Formation of the apoptosome is essential for activation of Dronc. Interestingly, a 
recent structural report about the Drosophila apoptosome revealed that K78 forms an 
intramolecular hydrogen bond with a critical residue (Q81) that is required for interaction 
of the CARD domains of Dronc and Dark for apoptosome formation [95] (Figure 2.4).  
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Figure 2.4. Atomic interactions between K78 and Gln81 (Adapted from [95]).  
(A) Under apoptotic conditions, K78 at the CARD of Dronc forms an intramolecular 
hydrogen bond with Gln81 that is an essential residue for interactions between CARDs of 
Dark and Dronc. Intramolecular interactions between K78 and Gln81 were suggested to 
support interactions of Gln81 with CARD of Dark. 
(B) Under surviving conditions, K78 is ubiquitylated, it cannot form a hydrogen bond 
with Gln81, which may lead to a weaker interaction between Gln81 and corresponding 
residue in CARD of Dark. This may hinder apoptosome formation. 
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Therefore, we hypothesized that mono-ubiquitylation of Dronc at K78 inhibits the 
interaction with the CARD of Dark, effectively blocking recruitment of Dronc into the 
apoptosome under surviving conditions (Figure 2.4). To test this hypothesis in vivo, we 
used genetic and biochemical approaches.  
In genetic experiments, we tested whether apoptosis is induced when the K78 
mono-ubiquitylation is lost in animals expressing da>Flag-Dronc
K78R
. However, similar 
to da>Flag-Dronc
wt
, expression of da>Flag-Dronc
K78R
 does not induce a significant 
apoptotic phenotype or even cause lethality. This is most likely due to the feedback 
inhibition mechanism between Dronc and Dark according to which overexpressed Dronc 
destabilizes Dark [99], keeping the number of active apoptosome units low (see 
Discussion).  
Nevertheless, combined expression of Flag-Dronc
wt
 and Dark (tagged with GFP 
(GFP-Dark) [99]) with GMR-GAL4 in the posterior eye imaginal disc induces apoptosis, 
causing eyes of reduced size with pigment loss (Figure 2.5A) and enhanced pupal 
lethality. Therefore, we asked whether loss of K78 mono-ubiquitylation causes increased 
activity of Flag-Dronc
K78R
 in the presence of mis-expressed GFP-Dark [99]. Indeed, we 
found that the adult eyes of GMR>Flag-Dronc
K78R
+GFP-Dark flies are significantly 
smaller than GMR>Flag-Dronc
wt
+GFP-Dark eyes (Figure 2.5A, 2B). In addition, the 
pupal lethality was significantly increased in GMR>Flag-Dronc
K78R
+GFP-Dark 
compared to GMR>Flag-Dronc
wt
+GFP-Dark (Figure 2.5C).  
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Figure 2.5. Loss of K78 ubiquitylation results in increased Dronc activity in the 
apoptosome.  
(A-C) Flag-Dronc
K78R
 and GFP-Dark co-expression under GMR-Gal4 control results in 
significantly smaller eyes and a lower survival rate than GMR>Flag-Dronc
wt
+GFP-Dark. 
Control flies just expressing GMR>Flag-Dronc
wt
, GMR>Flag-Dronc
K78R
 or GMR>GFP-
Dark alone, show wild type eye phenotype. (B) Quantification of the eye sizes in (A). 
n=19 for GMR>Flag-Dronc
wt
+GFP-Dark; n= 20 for GMR>Flag-Dronc
K78R
+GFP-Dark. 
(C) Quantification of the reduced survival of GMR>Flag-Dronc
K78R
+GFP-Dark 
compared to GMR>Flag-Dronc
wt
+GFP-Dark. 
(D,E) Significantly higher TUNEL labeling in the GMR-expression domain (arrows) of 
GMR>Flag-Dronc
K78R
+GFP-Dark compared to GMR>Flag-Dronc
wt
+GFP-Dark eye 
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imaginal discs of 3
rd
 instar larvae. GFP labels Dark. (E) Quantification of TUNEL 
positive cells in (D). n=7 for both genotypes. 
(F) In vitro caspase activity assays of adult fly head extracts show significantly higher 
caspase activity with GMR>Flag-Dronc
K78R
+GFP-Dark towards Ac-DEVD-AMC 
substrate than GMR>Flag-Dronc
wt
+GFP-Dark.  
For quantifications, the student’s t-test was used. Error bars are SD. ** P<0.01; *** 
P<0,001; **** P<0.0001. 
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To understand whether this phenotype is due to increased apoptotic activity of 
Flag-Dronc
K78R
, we examined 3
rd
 instar larval eye discs for apoptosis using TUNEL 
labeling. Parallel to the adult eye phenotypes, we observed significantly more apoptosis  
in the GMR>Flag-Dronc
K78R
+GFP-Dark eye imaginal discs (Figure 2.5D, E). In 
addition, fluorimetric caspase activity assays with extracts from GMR>Flag-
Dronc
K78R
+GFP-Dark heads showed a significantly higher cleavage activity towards the 
synthetic DEVD substrate than GMR>Flag-Dronc
wt
+GFP-Dark (Figure 2.5F). These 
data suggest that loss of K78 mono-ubiquitylation increases the apoptotic activity of 
Dronc
K78R
 in the Dark apoptosome. 
To examine the role of Diap1 for K78 mono-ubiquitylation of Flag-Dronc, we 
compared the eye phenotypes of GMR>Flag-Dronc
wt
+GFP-Dark and GMR>Flag-
Dronc
K78R
+GFP-Dark in a heterozygous diap1
5
 background. diap1 heterozygosity 
strongly enhanced the eye phenotype and lethality of GMR>Flag-Dronc
wt
+GFP-Dark 
animals (Figure 2.6A-C). However, loss of one copy of diap1 only weakly enhances the 
eye phenotype and lethality of GMR>Flag-Dronc
K78R
+GFP-Dark animals (Figure 2.6A-
C). These genetic interaction data suggest that K78 ubiquitylation depends on Diap1. 
Dark has a C-terminal caspase cleavage site that is thought to destabilize Dark, 
thus reducing its apoptosis-promoting activity [99, 100]. Consistently, a cleavage 
resistant version of Dark (Dark
V
) showed a hypermorphic phenotype [100]. Therefore, in 
theory, Dark
V
 should uncouple the anti-apoptotic feedback of Dronc on Dark. However, 
experimentally, that was not observed [99]. Co-expression of GMR>Dronc
wt
+GFP-Dark
V
 
caused a similar small eye phenotype compared to GMR>Dronc
wt
+GFP-Dark
wt
 [99].  
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Figure 2.6. Heterozygous diap1
5
 mutant strongly enhances GMR>FlagDronc
wt 
+GFP-Dark eye phenotype, but only weakly enhances GMR>Flag-Dronc
K78R
+GFP-
Dark. 
(A-C) Loss of one copy of diap1 strongly enhances eye phenotype of GMR>Flag-
Dronc
wt
+GFP-Dark (quantified in B) and causes a significant increase in lethality 
(quantified in C). In contrast, diap1 heterozygosity only weakly enhances GMR>Flag-
DroncK78R+GFP-Dark eye phenotype (quantified in B) and lethality (quantified in C). 
(B) Quantification of eye size phenotypes in (A). n=9 for GMR>Flag-Dronc
wt
+GFP-
Dark , n=11 for GMR>Flag-Dronc
wt
+GFP-Dark+diap1
5/+
, n=8 for GMR>Flag-
Dronc
K78R
+GFP-Dark, n=11 for GMR>Flag-Dronc
K78R
+GFP-Dark+diap1
5/+
 
(C) Quantification of eclosion rates of GMR>Flag-Dronc
wt
+GFP-Dark and GMR>Flag-
Dronc
K78R
+GFP-Dark with or without loss of one copy of diap1. 
For quantifications, the student’s t-test was used. Error bars are SD. * P<0.05; *** 
P<0,001; ns – not significant. 
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Figure 2.7. Cleavage resistant Dark
V
, but not cleaved-mimic Dark
CC
, can form a 
more functional apoptosome with Flag-Dronc
K78R
 than with Flag-Dronc
wt
. 
(A) Expression of GMR>Flag-Dronc
K78R
+GFP-Dark resulted in significantly smaller 
eyes than GMR>Flag-Dronc
wt
 +GFP-Dark. Expression of GMR>GFP-Dark
V
 alone does 
not have any eye phenotype.  
(B) Quantification of eye size phenotypes in (A). n=10 for each genotype  
(C) Eclosion rates of flies expressing GMR>Flag-Dronc
K78R
 +GFP-Dark
V
 are 
significantly smaller than GMR>Flag-Dronc
wt
 +GFP-Dark
V
. 
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 (D, E) Expression of Dark
CC
 and Flag-Dronc
wt
 or Flag-Dronc
K78R
 under GMR-Gal4 
control does not lead to any eye phenotype or lethality. 
For quantifications, the student’s t-test was used. Error bars are SD. ** P<0.01. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
 
 
Thus, although Dark
V
 was suggested to be more active than Dark
wt
, expression of either 
transgene with Dronc
wt
 did not change the equilibrium of the apoptosome activation [99]. 
Therefore, we examined whether co-expression of Flag-Dronc
K78R 
with GFP-Dark
V
 
under GMR control is sufficient to shift the equilibrium of apoptosome formation towards 
higher induction of apoptosis. Indeed, GMR>Flag-Dronc
K78R
+GFP-Dark
V
 executed 
more apoptosis compared to GMR>Flag-Dronc
wt
+GFP-Dark
V 
(Figure 2.7A). Both the 
adult eye phenotype and the pupal lethality are worsened significantly in 
GMR>Dronc
K78R
+GFP-Dark
V
 flies (Figure 2.7A-C).   
On the other hand, a mutant that mimics the cleavage product of Dark (Dark
CC
) is 
unstable and failed to induce apoptosis when co-expressed with Dronc
wt 
[99]. 
Consistently, co-expression of GFP-Dark
CC
 did not display any abnormal phenotype with 
either Flag-Dronc
wt
 or Flag-Dronc
K78R
 (Figure 2.7D, E). These findings are consistent 
with the notion that Flag-Dronc
K78R
 requires functional Dark for increased activity. 
The K78R mutation increases processing of Dronc through enhanced interaction with 
Dark 
To examine if the increased caspase activity of Flag-Dronc
K78R
 is due to increased 
intrinsic catalytic activity, we performed in vitro cleavage assays with bacterially 
expressed 6xHis-Dronc
wt
, 6xHis-Dronc
K78R
, 6xHis-Dronc
C318A
 and 6xHis-Dronc
K78RC318A
. 
Because bacteria lack an ubiquitin system, 6xHis-Dronc
wt
 is not modified by ubiquitin 
enabling us to directly compare the intrinsic activities of the Dronc variants. In these 
experiments, we first tested the ability of the Dronc constructs to auto-process [96, 97]. 
Both 6xHis-Dronc
wt
 and 6xHis-Dronc
K78R
 proteins are able to auto-process to a similar 
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extend (Figure 2.8A). In contrast, the catalytic mutant Dronc
C318A
 and double mutant 
Dronc
K78RC318A
 fail to auto-process (Figure 2.8A), consistent with the expectation.  
Next, we performed in vitro cleavage assays of these Dronc preparations with its 
known cleavage target drICE [96, 97] which is Myc-tagged and carries a mutation in the 
catalytic site (Myc-drICE
C211A
) to block auto-processing of drICE. While the catalytic 
mutants 6xHis-Dronc
C318A
 and 6xHis-Dronc
K78RC318A
 failed to cleave Myc-drICE
C211A
, 
both 6xHis-Dronc
wt
 and 6xHis-Dronc
K78R
 processed Myc-drICE
C211A
 in vitro (Figure 
2.8B). However, the cleavage activities of 6xHis-Dronc
wt
 and 6xHis-Dronc
K78R
 are very 
similar in these assays suggesting that there are no intrinsic differences in the catalytic 
activities of 6xHis-Dronc
wt
 and 6xHis-Dronc
K78R
. Furthermore, these data imply that the 
K78R mutation does not cause any structural defect to Dronc
K78R
. However, in vivo, in 
the presence of Dark, Flag-Dronc
K78R
 has a higher catalytic activity than Flag-Dronc
wt
 
(Figure 2.5) suggesting that Dronc
K78R
 requires Dark for increased catalytic activity. 
Consistent with the increased catalytic activity of Flag-Dronc
K78R
 in the presence 
of Dark, a significantly higher amount of Flag-Dronc
K78R
 is found in the processed form 
compared to Flag-Dronc
wt
 in immunoblots of total extracts from da>Flag-Dronc
wt
 + 
GFP-Dark and da>Flag-Dronc
K78R
 + GFP-Dark larvae (Figure 2.8C, C’). To understand 
the mechanism of increased processing and catalytic activity of Flag-Dronc
K78R
 in the 
Dark apoptosome, we examined the interaction between Dronc
K78R
 and Dark. Because 
specific antibodies to Dark do not exist, we used the GFP-Dark transgenes [99] to 
immunoprecipitate GFP-Dark and associated Flag-Dronc. To avoid embryonic lethality 
of da>Flag-Dronc
K78R
+GFP-Dark, Gal80
ts
 was used to control the expression of UAS-
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GFP-Dark and UAS-Flag-Dronc transgenes. Using Gal80
ts
, da>Flag-Dronc
wt
+GFP-
Dark, da>Flag-Dronc
K78R
+GFP-Dark and EV (empty vector)+GFP-Dark as control 
were induced for 24 h at 29°C and larval extracts were analyzed for Flag-Dronc and 
GFP-Dark. Longer induction periods (e.g. ≥48 h) also caused lethality. Consistent with a 
previous report [99], compared to the EV control, expression of da>Flag-Dronc
wt
+GFP-
Dark and da>Flag-Dronc
K78R
+GFP-Dark reduces Dark’s protein stability, as shown for 
GFP-Dark in Figure 2.8D (top panel). In co-IP experiments, we detect an increased 
interaction between Flag-Dronc
K78R
 and GFP-Dark compared to Flag-Dronc
wt
 and GFP-
Dark (Figure 2.8D, bottom panel). In addition, the ratio between processed versus 
unprocessed Dronc is significantly increased for Flag-Dronc
K78R
 in complex with GFP-
Dark compared to Flag-Dronc
wt
 (Figure 2.8D, bottom panel; quantified in 2.7D’), 
consistent with the increased apoptosis in imaginal discs and head extracts (Figure 2.5). 
These results suggest that compared to Flag-Dronc
wt
, Flag-Dronc
K78R
 interacts stronger 
with Dark and is more efficiently processed for apoptosis induction. 
Taken together, these data suggest that living cells are protected from apoptosis 
by keeping Dronc at least partially inactive through K78 mono-ubiquitylation which 
appears to block recruitment into the Dark apoptosome. However, when cells are 
undergoing apoptosis, K78 mono-ubiquitylation is no longer present, allowing Dronc to 
interact with Dark in the apoptosome and induce cell death. 
K78R is an intragenic suppressor of the lethality associated with loss of catalytic 
activity of Dronc 
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Figure 2.8. Biochemical characterization of Flag-Dronc
K78R
. 
(A) Bacterially expressed 6xHis-Dronc
wt
 and 6xHis-Dronc
K78R
 constructs display similar 
auto-processing activities. 6xHis-Dronc
C318A
 and 6xHis-Dronc
K78RC318A
 do not show any 
auto-processing.  
(B) In vitro caspase cleavage assays show that 6xHis-Dronc
wt
 and 6xHis-Dronc
K78R
 
cleave Myc-Drice
C211A
 with similar activities. 6xHis-Dronc
C318A
 and 6xHis-
Dronc
K78RC318A
 cannot cleave Myc-Drice
C211A
 . 
(C, C’) 3rd instar lysates of da>GFP-Dark+Flag-Droncwt and da>GFP-Dark+Flag-
Dronc
K78R 
 show that in the presence of Dark, Flag-Dronc
K78R
 is processed significantly 
more than Flag-Dronc
wt. In (C’), the average of 4 immunoblots is plotted.  
(D) GFP-Dark interacts with Flag-Dronc
wt
 and Flag-Dronc
K78R
. GFP-immunoprecipitates 
of 3
rd
 instar larval extracts from da>GFP-Dark+Flag-Dronc
wt
, da>GFP-Dark+Flag-
Dronc
K78R 
and da>GFP-Dark+EV (Flag-Empty Vector) animals, probed with anti-GFP 
antibody (upper panel) and anti-Flag antibody (lower panel). There is a stronger 
interaction between GFP-Dark and Flag-Dronc
K78R
, resulting in significantly more 
efficient procession of Flag-Dronc
K78R
 compared to Flag-Dronc
wt
.  
(D’) Relative ratio of processed and unprocessed Flag-Dronc proteins in the Dark 
apoptosome. Flag-Dronc
K78R
 is more efficiently processed than Flag-Dronc
wt
. The 
average of 3 immunoblots is plotted. 
For quantifications, the student’s t-test was used. Error bars are SD. * P<0.05 
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Next, we examined the physiological role of K78 mono-ubiquitylation of Dronc. 
For this, we expressed wild-type and mutant Flag-Dronc transgenes using da-Gal4 in a 
dronc null background and scored for rescue. The null mutants used, dronc
I24
 and 
dronc
I29
, have early stop codons at positions 28 and 53, respectively [61] and do not 
produce any Dronc protein. dronc
I24
/dronc
I29
 null mutants display a strong semi-lethal 
phenotype. Less than 10% of the expected dronc homozygous mutant animals survive 
development (Figure 2.9A) and hatch as adults with wing abnormalities (Figure 2.9) [61]. 
Expression of da>Flag-Dronc
wt
 rescues the lethality of dronc null mutant flies, but it is 
only a partial rescue. There is still about a 35% lethality (Figure 2.9A), suggesting that 
da>Flag-Dronc
wt
 does not reach sufficient Dronc activity for full rescue. Interestingly, 
however, da>Flag-Dronc
K78R
 rescued the lethality of dronc null mutant significantly 
better than da>Flag-Dronc
wt
. More than 80% of the expected progeny emerges as adults 
in the presence of Flag-Dronc
K78R
 (Figure 2.9A). Because these transgenes were obtained 
by phiC31 integration in the same landing site, the expression levels of all Flag-Dronc 
constructs are comparable (Figure 2.9H) and are not responsible for the observed 
differences. Therefore, this result further supports the notion that Flag-Dronc
K78R
 has 
more activity than Flag-Dronc
wt
 and thus can better substitute for the loss of endogenous 
dronc. 
As expected, expression of catalytically inactive da>Flag-Dronc
C318A
 failed to 
rescue the lethality of dronc null mutants (Figure 2.9A). Surprisingly, however, 
expression of da>Flag-Dronc
K78RC318A
 which lacks the K78 mono-ubiquitylation site and 
is catalytically inactive (Figure 2.9A, B), did rescue the lethality of dronc null mutants to  
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Figure 2.9. Examination of K78 mono-ubiquitylation with respect to Dronc’s 
catalytic activity.  
(A) da>Flag-Dronc
wt
, da>Flag-Dronc
K78R
 and da>Flag-Dronc
K78RC318A
 can rescue the 
lethality of dronc
I29 
null mutants, whereas da>Flag-Dronc
C318A
 cannot.  
(B) Quantification of the number of additional interommatidial cells (IOC) shown in (C-
G). Genotypes are indicated. MARCM was used to express transgenic Flag-Dronc 
constructs in dronc
I29
 mutant cell clones. n= 10 for dronc
I29
 MARCM clones, n=11 for 
Flag-Dronc
wt
 in dronc
I29
 clones, n=7 for Flag-Dronc
K78R
 in dronc
I29
 clones, n=11 for 
Flag-Dronc
K78RC318A
 in dronc
I29
 clones, n=8 for Flag-Dronc
C318A
 in dronc
I29
 clones. Each 
n corresponds to an average of extra IOC of 3 clones. ns – not significant. 
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(C-G) Pupal retinae 48h after puparium formation expressing the indicated Flag-Dronc 
constructs in dronc
I29
 MARCM clones. Clones are marked by GFP and are enclosed by 
white dashes in the right panels. Examples of extra IOC are marked with yellow arrows. 
Flag-Dronc
wt
 and Flag-Dronc
K78R
 rescue the IOC phenotype of dronc null mutants. 
However, Flag-Dronc
K78RC318A
 and Flag-Dronc
C318A
 fail to rescue this phenotype. 
Quantified in (B). 
(H) Immunoblotting of lysates of each Flag-Dronc construct in the dronc
I24
/dronc
I29
 
background shows similar expression levels. 
For quantifications, the student’s t-test was used. Error bars are SD. * P<0.05; ** P<0.01; 
*** P<0,001; **** P<0.0001. ns – not significant. 
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Figure 2.10. Both Flag-Dronc
K78RC318A
 and Flag-Dronc
C318A
 cannot rescue the wing 
phenotype of dronc null mutants.  
Compared to control flies (A, w
1118
), wings from dronc null mutants are held-out, often 
irregularly shaped and less transparent (B). Often one wing is missing (see (F)). da>Flag-
Dronc
K78RC318A
 (E) and da>Flag-Dronc
C318A
 (F) do not rescue this phenotype. In contrast, 
Flag-Dronc
wt 
and Flag-Dronc
K78R 
rescue the wing phenotype of dronc null mutants (C,D). 
However, these wings do not appear normal because of ectopic apoptosis (for details see 
reference [98]). 
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a significant degree! About 60% of dronc mutant flies survived when expressing 
da>Flag-Dronc
K78RC318A
 compared to only 10% of dronc mutant flies expressing 
da>Flag-Dronc
C318A
 (Figure 2.9A). Thus, the K78R mutation behaves as an intragenic 
suppressor of the lethality associated with loss of catalytic activity of Dronc. This result 
suggests that loss of K78 ubiquitylation can be advantageous for the survival of dronc 
mutant flies and can even –at least partially- overcome loss of the catalytic activity of 
Dronc.  
Flag-Dronc
K78RC318A
 does not rescue the apoptotic phenotype of dronc null mutants 
Because of the intragenic suppression of the lethality of the catalytic dronc
C318A
 
mutant by the K78R mutation, we considered – although did not expect - that the K78R 
mutation would rescue the catalytic activity of Dronc
C318A
 and thus the apoptotic 
phenotype of dronc mutants. To test this possibility, we employed the developing 
Drosophila retina which consists of individual units called ommatidia. In developing 
Drosophila retinae, cells produced in excess between ommatidia (interommatidial cells, 
IOCs) are eliminated by apoptosis around 28-30h after puparium formation (APF) [17-
20]. The retinal lattice is fully differentiated at 42-45h APF. Previous studies showed that 
dronc
I24
 and dronc 
I29
 mutants fail to remove excess IOCs during development; about six 
additional IOCs remain per ommatidium in dronc mutants (Figure 2.9B, C) [61, 105]. To 
understand the relationship between K78 mono-ubiquitylation and catalytic inactivity 
during developmental apoptosis, we generated dronc
I29
 mutant clones expressing Flag-
Dronc
wt
, Flag-Dronc
K78R
, Flag-Dronc
C318A
 and Flag-Dronc
K78RC318A
 by MARCM and 
examined the ability of these constructs to restore IOC apoptosis in the pupal retina of 
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dronc mosaics. As expected, while expression of Flag-Dronc
wt
 and Flag-Dronc
K78R
 
rescues IOC apoptosis in dronc
I29
 mutant clones, Flag-Dronc
C318A
 does not (Figure 2.9D, 
E, G; quantified in Figure 2.9B). Importantly, although expression of Flag-
Dronc
K78RC318A
 rescued the lethality of dronc mutant flies (Figure 2.9A), it does not 
restore IOC apoptosis in dronc mutant clones (Figure 2.9B, F). Consistently, da>Flag-
Dronc
K78RC318A
 expression in dronc null background does not rescue the wing phenotype 
of dronc mutants (Figure 2.10E). In addition, Flag-Dronc
K78RC318A
 does not have catalytic 
activity in vitro (Figure 2.8A, B).  
Therefore, as expected, these findings suggest that the K78R mutation does not 
restore the catalytic activity of Flag-Dronc
K78RC318A
. They further suggest that the 
suppression of the pupal lethality of dronc mutants by expression of Flag-Dronc
K78RC318A
 
occurs independently of the catalytic activity of Dronc which is therefore not absolutely 
essential for the survival of the flies.  These data further imply that K78 mono-
ubiquitylation controls additional, non-catalytic (apoptosis- and effector-caspase-
independent) functions of Dronc whose failure in dronc mutants contribute to lethality. 
K78 ubiquitylation of Dronc is involved in control of apoptosis-induced proliferation 
Next, we examined whether K78 mono-ubiquitylation is involved in a non-
apoptotic function of Dronc. We and others have shown that Dronc can trigger apoptosis-
induced proliferation (AiP) of neighboring surviving cells independently of downstream 
effector caspases and thus apoptosis [178, 180, 181, 183]. Expression of the effector 
caspase inhibitor P35 is used to uncouple AiP from apoptosis. This treatment blocks 
apoptosis, but triggers chronic Dronc activity which causes tissue overgrowth due to 
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permanent AiP [177, 178, 180, 183, 306, 307]. It was previously shown that co-
expression of p35 with dronc or pro-apoptotic hid using ey-Gal4 (ey>dronc+p35 or 
ey>hid+p35) in eye imaginal discs causes head overgrowth with pattern duplications, 
while expression of catalytically inactive ey>dronc
C318S
+p35 did not [177, 178, 183]. 
Consistently, expression of Flag-Dronc
wt
 and Flag-Dronc
K78R
 in ey>p35 or ey>hid+p35 
background induced or enhanced head overgrowth, respectively, while catalytically 
inactive Flag-Dronc
C318A
 displayed wild-type head phenotypes in these assays (Figure 
2.11A, B; Figure 2.12A). Surprisingly, however, expression of Flag-Dronc
K78RC318A
 in 
ey>hid+p35 and ey>p35 assays also showed a similar overgrowth phenotype compared to 
Flag-Dronc
wt 
or Flag-Dronc
K78R
 (Figure 2.11A, B; Figure 2.12A). Thus, similar to the 
results obtained in the rescue crosses of dronc induced lethality, loss of K78 
ubiquitylation can suppress loss of catalytic activity in AiP. As controls, we expressed 
Flag-Dronc constructs with ey-GAL4 in the absence of p35. However, simple 
overexpression of the Flag-Dronc construct did not trigger any overgrowth phenotype in 
these crosses (Figure 2.12B). 
Because we showed in Figures 2.5 and 2.7 and, that Flag-Dronc
K78R
 interacts 
better with GFP-Dark than Flag-Dronc
wt
, we wondered if the rescue of AiP by Flag-
Dronc
K78RC318A
 is dependent on the interaction with Dark. Indeed, in the absence of Dark 
(by RNAi), Flag-Dronc
K78RC318A
 is no longer able to restore AiP in ey>hid+p35 
background (Figure 2.11A, B). 
K78 ubiquitylation of Dronc is involved in control of male genitalia rotation  
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Figure 2.11. K78 ubiquitylation plays inhibitory roles for additional functions of 
Dronc.  
(A) Quantification of the enhanced head overgrowth phenotype of ey>hid+p35 animals 
expressing the indicated Flag-Dronc transgenes. Overgrowth is characterized by 
expanded head cuticle with pattern duplications such as bristles and ocelli (see examples 
in (D)). Flag-Dronc
C318A
 acts in a dominant negative manner in ey>hid+p35 background. 
Flag-Dronc
K78RC318A
 phenotype in ey>hid+p35 background is dependent on Dark as 
observed by 94% suppression of the overgrowth phenotype when dark RNAi is 
expressed. 
(B) Representative head phenotypes of ey>hid+p35 animals expressing the indicated 
Flag-Dronc transgenes. 
(C) Male genitalia rotation defect of dronc null mutants is fully suppressed by da>Flag-
Dronc
wt
 and da>Flag-Dronc
K78R
 (100% of males display 360° rotation) (quantified in B) 
and partially suppressed by da>Flag-Dronc
K78RC318A
 (62% of males display 360° 
rotation). da>Flag-Dronc
C318A
 failed to suppress this phenotype. The i surrounded by a 
circle indicates the relative orientation of the male genitalia in the depicted animals (i = 
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wild-type). The suppression by da>Flag-Dronc
K78RC318A 
is partially reverted (38% of full 
rotation) when Dark RNAi is expressed (quantified in B). 
(D) Quantification of male genitalia rotation defect phenotype in dronc null mutants, 
expressing the indicated Flag-Dronc transgenes. 
For quantifications, the student’s t-test was used. Error bars are SD. * P<0.05; ** P<0.01; 
ns – not significant. 
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Figure 2.12. Flag-Dronc
K78R
 and Flag-Dronc
K78RC318A
 can induce a head capsule 
overgrowth phenotype.  
(A) Expression of Flag-Dronc
wt
, Flag-Dronc
K78R
 and Flag-Dronc
K78RC318A
 in ey>p35 
background can induce overgrowth phenotypes. Overgrowth is characterized by 
expanded head cuticle with pattern duplications such as bristles and ocelli. In contrast, 
Flag-Dronc
C318A
 cannot induce this phenotype. 
(B) Expression of indicated Flag-Dronc constructs with ey-GAL4 does not lead to any 
eye phenotype. 
For quantifications, the student’s t-test was used. Error bars are SD. * P<0.05; ** P<0.01; 
ns – not significant. 
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During development, Drosophila male genitalia make a full 360° clockwise 
rotation [308]. When components of the apoptotic machinery (hid, dronc, drICE) are 
impaired, the rotation fails or is incomplete [309-312] suggesting that it is an apoptosis-
driven event. We examined whether expression of da>Flag-Dronc constructs could 
rescue the genitalia rotation defect in dronc
I24
/dronc
I29
 males. da>Flag-Dronc
wt
 and 
da>Flag-Dronc
K78R
 fully rescued the male genitalia rotation phenotype of dronc mutant 
males (100% of males display 360° rotation) (Figure 2.11C; quantified in Figure 2.11D). 
In addition, these males were fertile. In contrast, da>Flag-Dronc
C318A
 was unable to 
rescue the dronc
I24
/dronc
I29
 rotation defect and had incomplete rotations ranging from 
180° to 270° (Figure 2.11C, D). These males were also sterile. Interestingly, da>Flag-
Dronc
K78RC318A
 partially rescued the rotation defect associated with dronc null mutations 
(62% of males display 360° rotation) (Figure 2.11C, D). However, sterility caused by 
dronc null mutations was not suppressed suggesting that other non-apoptotic processes 
such as sperm maturation are not rescued [206]. The partial rescue of the rotation 
phenotype by Flag-Dronc
K78RC318A
 is potentially interesting because it may suggest that 
Dronc has two functions for male genitalia rotation: in addition to the previously reported 
effector caspase-dependent function [311, 312], it may also have an effector caspase-
independent function. Because effector caspases require catalytic activity of Dronc for 
activation, only the effector caspase-independent function can be rescued by Flag-
Dronc
K78RC318A
, giving rise to the observed partial rescue (Figure 2.11C, D). The rescue of 
the rotation phenotype by Flag-Dronc
K78RC318A
 is also dependent on Dark – at least 
partially – as dark RNAi reduces the rescue to 38% full rotation (Figure 2.11D). These 
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data further suggest that K78R mutation is an intrinsic suppressor of loss of Dronc’s 
catalytic activity. 
DISCUSSION 
Implications of K78 mono-ubiquitylation for apoptotic functions of Dronc 
Our in vivo data uncovered an elegant mechanism of how Dronc activation is 
regulated through mono-ubiquitylation and how this modification affects both catalytic 
and non-catalytic functions of Dronc. Our MS/LC-MS data from larval and pupal 
samples demonstrate that in living cells, Dronc is mono-ubiquitylated at K78. Because 
mono-ubiquitylation is not a mark for proteasome-mediated degradation, this finding 
explains why monomeric Dronc is not degraded in living cells [89]. Mono-ubiquitylation 
of Dronc is not an unprecedented observation in the caspase field. It was previously 
reported that cIAP2 promotes mono-ubiquitylation of the effector caspases Caspase-3 and 
Caspase-7 in vitro [248]. However, the significance of this mono-ubiquitylation is not 
known. Furthermore, the paracaspase MALT1 is subject to mono-ubiquitylation [313, 
314]. Interestingly, this modification leads to MALT1 activation. Here, we add the 
initiator caspase Dronc in Drosophila to the list of caspases being mono-ubiquitylated.  
Mono-ubiquitylation of K78 of Dronc does not regulate the intrinsic catalytic 
activity of Dronc. Purified recombinant Flag-Dronc
wt
 and Flag-Dronc
K78R
 have 
comparable catalytic activities in vitro. However, the location of K78 in the CARD 
domain suggests a regulatory modification for the interaction with Dark. Consistently, 
K78 was recently reported to be a critical residue for the interaction between the CARD 
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domains of Dronc and Dark [95]. Indeed, our genetic analysis suggests that Flag-
Dronc
K78R
 increases the physical association with Dark, resulting in increased processing 
of Dronc and thus higher apoptotic activity. Thus, we propose that in living cells, K78 
mono-ubiquitylation of Dronc prevents the interaction with Dark.  
Because of the increased processing and activation of Flag-Dronc
K78R
, we 
expected a very strong apoptotic phenotype when expressing Flag-Dronc
K78R
 in flies. 
However, although we observed increased apoptosis by expression of Flag-Dronc
K78R
 
compared to Flag-Dronc
wt
, it was not as severe as expected and depended on the 
presence of mis-expressed Dark. There are a few possibilities to explain this result. 
Although K78 was identified as the only ubiquitin acceptor site by LC-MS/MS analyses, 
we did not see a complete loss of mono-ubiquitylation in Flag-Dronc
K78R 
flies. It is 
possible that when this major ubiquitin acceptor site is mutated, another Lys residue is 
selected for ubiquitylation. Nevertheless, the partial loss of ubiquitylation in Dronc
K78R
 
(Figure 2.2E) is sufficient to shift Dronc activity to a higher level. This increased activity 
depends on the presence of Dark.  
Another possibility to explain the absence of a significant apoptotic phenotype of 
da>Flag-Dronc
K78R
 is that correct stoichiometry between Dronc and Dark molecules is 
important for execution of apoptosis [99]. These proteins mutually control their stability. 
Overexpression of one protein triggers degradation of the other one [99]. This balance 
ensures that the levels of functional apoptosome units are low and this is most likely the 
reason why expression of each protein by itself in a tissue or even in the whole animal 
does not cause a significant apoptotic phenotype or complete lethality [99]. Only if both 
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proteins are co-expressed can a significant apoptotic phenotype be recorded and under 
those conditions can Flag-Dronc
K78R
 trigger a stronger apoptotic phenotype compared to 
Flag-Dronc
wt
, as observed in Figure 2.5. 
Implications of K78 mono-ubiquitylation for non-catalytic functions of Dronc 
We also examined the role of K78 ubiquitylation in a catalytically inactive 
(C318A) Dronc background. da>Flag-Dronc
C318A
 fails to rescue any of the dronc null 
mutant phenotypes examined such as lethality, apoptosis and male genitalia rotation, and 
also fails to induce AiP. However, surprisingly, the ubiquitylation-defective and 
catalytically inactive double mutant of Dronc (da>Flag-Dronc
K78RC318A
) does rescue the 
lethality and male genitalia rotation phenotypes of dronc null mutants and promotes AiP 
(Figures 2.8 and 2.10). The rescue of these phenotypes is not the result of restoring the 
catalytic activity of Flag-Dronc
K78RC318A
 by the K78R mutation because in vitro cleavage 
assays demonstrated that the effector caspase drICE was not processed and in vivo IOC 
apoptosis was not rescued in dronc null mutants (Figure 2.8A, B; Figure 2.9), indicating 
that Flag-Dronc
K78RC318A
 has no catalytic and thus no apoptotic activity. Therefore, even 
though Flag-Dronc
K78R
 is released from inhibitory ubiquitylation, it still needs its 
catalytic activity to execute apoptosis. Flag-Dronc
K78RC318A
 is an intragenic suppressor of 
several, but not all, phenotypes associated with loss of the catalytic activity of Dronc. 
Therefore, the Flag-Dronc
K78RC318A
 transgene offers unique opportunities to identify and 
characterize apoptosis- (effector caspase-) independent functions of Dronc and to 
distinguish them from effector caspase-dependent ones. 
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These results allow making the following important conclusions about Dronc 
function. Firstly, the pupal lethality (which is actually a strong semi-lethality) associated 
with dronc null mutations is not only due to loss of the catalytic (enzymatic) activity. It 
appears that some non-catalytic functions of Dronc are also very important for survival of 
the animal. Loss of the catalytic activity may contribute to the pupal lethality, but it may 
not be the underlying cause. This conclusion may not apply to the embryonic lethality of 
dronc germline clones [61]. Secondly, because we demonstrated that K78 mono-
ubiquitylation controls the interaction of Dronc with Dark, it appears that Flag-
Dronc
K78RC318A
 executes its non-enzymatic functions also through increased interaction 
with Dark. Thus, increased interaction with Dark is sufficient for induction of several 
non-apoptotic functions of Dronc such as AiP. Thirdly, it is a hot debate in the caspase 
field how caspases are restrained from inducing apoptotic death during non-apoptotic 
processes [315-317]. However, our results imply that at least for the caspase Dronc, its 
catalytic activity is not strictly required for non-apoptotic processes, although it may 
contribute to it. Instead, it appears that K78 mono-ubiquitylation controls activation of 
Dronc for non-apoptotic processes without requiring the catalytic function of Dronc. 
Evolutionary considerations 
Dronc is considered to be the Drosophila Caspase-9 ortholog; however, it has 
more protein similarity to mammalian Caspase-2 [58]. Alignment of the CARD domains 
of Dronc and Caspase 2 showed that K78 is not a conserved residue. However, there are 
two conserved Lys residues at positions 20 and 65. It is possible that Caspase-2 may be 
ubiquitylated at one of these residues and this ubiquitylation may play a role in formation 
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of the PIDDosome, an apoptosome-like protein complex required for Caspase-2 
activation [318]. On the other hand, Caspase-9 does not have any Lys residue in its 
CARD domain. It is possible that the CARD domain of Caspase-9 has not evolved an 
ubiquitylation control mechanism because the interaction between Caspase-9 and Apaf-1 
is not rate limiting for Caspase-9 activation (Cytochrome c release is). Nevertheless, 
similar to Dronc, mature Caspase-9 ubiquitylation has been shown in vitro [240], 
suggesting that Caspase-9 activation may be controlled by ubiquitylation after activation 
in the Apaf-1 apoptosome.  
Our work highlights a mechanism where Dronc’s activity is negatively regulated 
through mono-ubiquitylation that interferes with its interaction partner Dark. This work 
may help understanding the similarities and differences of caspase activation in 
mammalian and Drosophila apoptosomes. 
Experimental Procedure 
Immunoprecipitations and immunoblotting 
Embryos, 3
rd
 instar wandering larvae, 1-2 days old pupae and heads of adult flies 
were lysed in 100 ul of SDS lysis buffer containing 2% SDS, 150 nM NaCl, 10 mM 
TrisHCl, 20 uM NEM and protease inhibitors (Promega), respectively. The samples were 
sonicated for 10 seconds twice after they were boiled at 100°C for 10 minutes. 900 ul of 
dilution buffer (10 mM TrisHCl, 150 mM NaCl, 2 mM EDTA and 1% Triton-X) was 
added to the samples and samples were rotated at 4°C for 1 hour before centrifugation for 
30 minutes. Protein concentrations of supernatants were measured by Bradford Assay. 30 
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ug and 425 ug of total protein were used for western blots and IPs, respectively. IP was 
performed with anti-Flag M2 magnetic beads (Sigma-Aldrich M8823) overnight at 4°C 
with rocking. 100 ul of 150 ng/ul Flag peptide in TBS was used for elution which took 
place at 4°C for 2 hours. 25 ul of eluted protein was used for western blotting. Dilutions 
of antibodies used are as follows: anti-Flag M2 antibody (1:1000), FK2 and FK1 (Enzo 
Life Sciences – 1:200), anti-Actin (Millipore Mab1501- 1:2000).  
For ubiquitin pull-down assays, 3
rd
 instar larvae were collected and lysed in urea 
lysis buffer containing 8 M Urea, 0.1 M NaH2PO4, 0.01 M TrisHCl, 0.05% Tween 20, pH 
8.0 and protease inhibitors. IP was performed with Nickel-NTA magnetic agarose beads 
(Qiagen 36111) at 4°C overnight with rocking. 60 ul of 250 mM of Imidazole in urea 
lysis buffer (pH 4.5) was used for elution. 30 ul of eluted protein was analyzed by 
western blot. Anti-His antibody (Thermo Scientific-Fisher MA1-21315) was used at 
1:1000 dilution. 
For co-IPs, 3
rd
 instar larvae were collected and lysed in NP40 buffer (20 mM 
TrisHCl pH 8.0, 137 mM NaCl, 1% NP40, 2 mM EDTA and protease inhibitors). IP was 
performed with GFP-Trap (ChromoTek) magnetic beads at 4°C overnight. GFP-Dark 
protein was eluted with 50 ul of 0.2M Glycine buffer pH 2.5.  25 ul of eluted protein was 
used for western blot. Anti-GFP antibody (Thermo Scientific-Fisher MA5-15256) was 
used at 1:200 for IP-western blots, 1:1000 for western blots. 
Immunoblot band intensities are quantified with GelQuantNET software provided 
by biochemlabsolution.com.  
110 
 
 
 
Deubiquitylation Assay 
Immunoprecipitated Flag-Dronc was incubated with 3 ul of USP2 enzyme (Boston 
Biochem E-504) in deubiquitylation assay solution (50 mm EDTA, 100 mm DTT, 50 mm 
Tris-HCl and 150 mm NaCl) for 90 min at 37°C. 
LC-MS/MS Analysis 
Flag-Dronc was immunoprecipitated from larval and pupal da>Flag-Dronc extracts as 
described above. 1 mg of protein was used for IPs. Elutions of eight IPs were pooled and 
concentrated with 0.5 ml centrifugal tubes (Millipore UFC500324). In vitro 
ubiquitylation assays were performed as described previously [88].  Concentrated IP 
samples and in vitro ubiquitylated Dronc were loaded to 4-20% gradient SDS-PAGE 
gels. The gels were stained with Coomassie Blue Solution (Thermo Scientific-Fisher- 
24590) and the 60 kDa band as well as higher molecular weight bands (for in vivo 
samples) were excised and submitted to MS Bioworks (Ann Arbor, MI). Samples were 
digested with Chymotrypsin and analyzed by LC-MS/MS. In the in vitro and in vivo 
samples, one peptide (K
78
ITQRGPTAY) carried the di-Glycine motif, characteristic for 
ubiquitylation.  
Fly Work and Generation of Transgenic Flies 
The following fly stocks were used: daughterless (da)-Gal4; GMR-Gal4; UAS-
Flag-Dronc [98]; UAS-Flag-Dronc
wt
; UAS-Flag-Dronc
K78R
, UAS-Flag-Dronc
C318A
 and 
UAS-Flag-Dronc
K78RC318A
 (this work); UAS-6xHis-ubiquitin (this work); UAS-GFP-Dark, 
UAS-GFP-Dark
V
 and UAS-GFP-Dark
CC
 [99]. dronc
I24
 and dronc
I29
 [61]; ey>p35 and 
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ey>hid,p35 [181]; diap1
5
 [36, 37]. Please note that two UAS-Flag-Dronc
wt
 transgenes 
were used. The first one (a kind gift of Dr. Sally Kornbluth) was used in the initial phases 
of this work and has a random insertion on chromosome 3 [98]. The second one was 
obtained by phiC31 site-specific integration in the VK37 landing site on chromosome 2 
(see below). This line was used in combination with UAS-Flag-Dronc
K78R
, UAS-Flag-
Dronc
C318A
 and UAS-Flag-Dronc
K78RC318A
. All crosses were carried out at room 
temperature. 3L MARCM clones were induced by heat shocking L1 larvae at 37°C for 45 
minutes as described [319]. Co-expression of UAS-GFP-Dark and UAS-Flag-Dronc 
transgenes was controlled by GAL80
ts
 [320]. Temperature shift was performed at 29°C 
for 24 h. 3
rd
 instar larvae were collected for lysis immediately after temperature shift. 
Wild-type and mutant UAS-Flag-Dronc transgenic flies were generated by the 
phiC31 site-specific integration system [304, 305]. Flag-Dronc-pTFW and Flag-
Dronc
C318A
-pAFW vectors were kind gifts from Dr. Sally Kornbluth. Flag-Dronc and 
Flag-Dronc
C318A
 were cloned into pENTR3C vector. Point mutations were generated by 
site-directed mutagenesis. AttB site for site-specific integration was cloned into pTFW 
vector (DGRC - 1115). Wild-type and mutant Flag-Dronc coding sequences were cloned 
into attB-pTFW vector by Gateway Cloning Technology (Gateway LR Clonase II 
Enzyme Mix). Plasmids were sent to Genetivision for injection. VK37 landing site was 
used for phiC31 integration [321].  
UAS-6xHis-Ubiquitin transgenic flies were generated by random integration 
(Bestgene) of a pUAST-6xHis-Ubiquitin construct created by inserting a KpnI-XbaI 
fragment of N-terminal 6xHis human Ubiquitin pcDNA3.1 into pUAST [302]. 
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Expression of 6xHis-Ubiquitin was validated by FK2 Western blotting of urea-based 
lysis/Ni
2+
-based purification lysates generated from 20 adult da-GAL4;UAS-6xHis-
Ubiquitin flies. 
Immunohistochemistry 
3
rd
 instar larval brain lobes with eye discs were dissected in PBS and fixed in 4% 
PFA. Samples were blocked with 2% NDS in PBST and stained with c-Dcp-1 (Cell 
Signaling 9578- 1:100) and anti-Flag (1:200) antibodies [322]. TUNEL was performed as 
described [323]. For pupal dissections, pupae were aged to 42 h-48 h APF. Pupal discs 
were dissected, fixed and stained for c-Dcp-1 and Dlg (DSHB 4F3 anti-disc large -1:100) 
[322]. Imaginal discs were mounted in Vectashield and imaged by confocal microscopy. 
Caspase Activity Assays 
Caspase activity assays were performed as described [323, 324]. Briefly, adult 
heads were lysed in caspase assay buffer (50 mM HEPES pH 7.5, 100 mM NaCl, 1 mM 
EDTA, 0.1% CHAPS, 10% sucrose, 5 mM DTT, 0.5% TritonX-100, 4% glycerol and 
protease inhibitors). Protein concentration was measured with Bradford Assay. 40 ug of 
protein was incubated with 100 uM of DEVD-AMC caspase substrate (MP Biomedicals 
195868) in a final volume of 100 ul of caspase assay buffer. Fluorescence was measured 
with spectrophotometer (excitation 385 nM emission 460 nM) at 15 min intervals for 3 
hours at 37°C. Each experiment was done at least three times. 
Caspase Cleavage Assay 
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For in vitro cleavage assays, wild type and mutant Dronc coding sequences were 
cloned into pET-28a plasmid to yield 6xHis fusion proteins. Generated plasmids were 
transformed to BL21(DE3)pLysS competent cells (Promega L1191). 50 ul of bacterial 
culture was grown at 37°C. Plasmid expression was induced by 0.2 mM IPTG for 3 h at 
30°C as described [325]. Bacterial pellets were lysed with 4 ml of CellLytic B Cell Lysis 
Reagent (Sigma-Aldrich B7435) after adding 0.2 mg/ml Lysozyme, 50 units/ml 
Benzonase and 1X protease inhibitor (Roche).  
drICE
C211A
-pET23b plasmid was a kind gift from Dr. Guy Salvesen [97]. 
drICE
C211A
 coding sequence was cloned into PT7CFE1-Nmyc plasmid (Thermo 
Scientific 88863). Myc-drICE
C211A
 protein was generated by using TNT Rabbit 
Reticulocyte Lysate System (Promega L4610). 4 ul of Myc-drICE
C211A
 protein was 
incubated with 100 ug of wild-type and mutant 6xHis-Dronc protein in caspase assay 
buffer (100 mM Hepes pH 7.5, 0.1 % CHAPs, 10% sucrose, 10 mM DTT, 50 mM Nacl, 
0.5 mM EDTA, protease inhibitor). The reaction was incubated at 30°C for 3 hours [96] 
and analyzed by western blotting. Anti-Myc antibody (Santa Cruz SC40) was used at 
1:200 concentration. 
Statistical Analyses 
Student’s t-test is used in all graphical analyses with parametric statistics. Crosses 
are repeated at least three times. Numbers of fly eyes used for area calculation and 
staining intensity are indicated in corresponding figures. The quantification of eye size 
was done using the Histogram function in Photoshop. 
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CHAPTER III 
 
Conclusions and Future Directions 
 
Part I. Conclusions 
The ubiquitin system generally correlated with cell death. In particular, 
ubiquitylation has been shown to control stability and activity of pro- and anti-apoptotic 
proteins. This control is crucial as even a slight deflection could have catastrophic results 
for cells. This thesis study provides a great example of how activity of an initiator 
caspase Dronc could be regulated by ubiquitylation without causing degradation and how 
this ubiquitylation is important for both apoptotic and non-apoptotic functions of this 
initiator caspase Dronc. 
As opposed to what previous in vitro studies suggested [78, 80, 81], our study 
demonstrated that Dronc is mono-ubiquitylated throughout development from embryonic 
stages to adulthood. Persistence of this ubiquitylation throughout development could hint 
its importance for Dronc’s regulation. Incubating IPed Flag-Dronc with USP2 
deubiquitinase removed this ubiquitylation almost completely. Interestingly, although we 
expected to observe a size difference between ubiquitylated and un-ubiquitylated Flag-
Dronc, we could not observe this after removing mono-ubiquitin on Dronc with USP2. 
Because our results suggested that Dronc is mono-ubiquitylated, which is a non-
degradative mark, we thought of a few ways how ubiquitylation controls Dronc. 
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Ubiquitylation of Dronc could affect the interaction with Dark, its dimerization or its 
catalytic activity. Further examination of this ubiquitylation through mass-spectrometry 
analysis identified K78 in the CARD of Dronc as the site of ubiquitylation and suggested 
a role for its interaction with Dark. Generating a K78R mutant Dronc (Flag-Dronc
K78R
) 
resulted a significant reduction of mono-ubiquitylation. Although K78 is the only residue 
shown to be ubiquitylated by mass-spec analyses of Flag-Dronc
wt
, we could still see 
residual ubiquitylation of Flag-Dronc
K78R
. Dronc has 32 lysine residues. It is possible that 
the ubiquitin machinery could act on another lysine when K78 is mutated. Nonetheless, 
K78 is the major ubiquitin acceptor site.  
Understanding the function of this ubiquitylation is crucial for Dronc’s activity 
because mono-ubiquitylation is not degradative and there are not many examples for 
caspases regulated by mono-ubiquitylation. In fact, the ubiquitylation status of most 
mammalian caspases is still unclear. Thus, understanding this regulatory ubiquitylation 
could help us to extend our knowledge to other caspases that could have similar 
regulations. A previous study suggested that separate expression of each apoptosome 
component in the Drosophila eye does not lead to any phenotype; however, simultaneous 
expression of both leads to small and deformed eyes [99]. In the light of this information, 
we analyzed expression of mutant Dronc and Dark in the Drosophila eye. Expression of 
Flag-Dronc
K78R
 with GFP-Dark showed smaller and more deformed eyes than expression 
of Flag-Dronc
wt
 and GFP-Dark due to increased apoptosis. A caspase activity assay 
further confirmed the observed results that Flag-Dronc
K78R
 has more activity when co-
expressed with GFP-Dark. In addition, in vitro cleavage assay with Myc-drICE
C211A
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showed that the enhanced activity of Flag-Dronc
K78R
 does not result from alterations in 
its catalytic activity. Co-IP experiments supported the genetic data that Flag-Dronc
K78R
 
could interact with GFP-Dark better than Flag-Dronc
wt
 because inhibitory ubiquitylation 
is removed in Flag-Dronc
K78R
. This enhanced interaction resulted in a better auto-
cleavage of Flag-Dronc
K78R
 than Flag-Dronc
wt
 and was the reason for increased apoptotic 
labeling in the larval eye discs. In support of these findings, a recent structural study 
showed that K78 forms an intramolecular H-bond with a critical residue (Q81) to 
enhance the interactions between the CARDs of Dronc and Dark in the apoptosome. All 
in all, we conclude that K78 mono-ubiquitylation of Dronc is indeed inhibitory of 
Dronc’s activation due to its impaired interaction with Dark (Figure 3.1).  
Previous studies conducted in vitro showed that DIAP1 ubiquitylates Dronc [78, 
80, 89]. We tested this possibility in vivo and observed that heterozygosity at diap1 
decreased mono-ubiquitylation of Dronc, suggesting that DIAP1 mono-ubiquitylates 
Dronc in vivo. Next, we sought to identify if DIAP1 ubiquitylates Dronc at K78. For this 
we used two different approaches. In our first approach, we performed in vitro 
ubiquitylation assays with Dronc, DIAP1 and Ubcd1 or its human homolog UBE2D2 and 
submitted it for mass-spectrometry analysis. These analyses indicated that DIAP1 can 
ubiquitylate Dronc at K78. Secondly, loss of one functional copy of diap1 enhanced the 
eye phenotype of GMR-driven GFP-Dark and Flag-Dronc
wt
 much more than expression 
of GFP-Dark and Flag-Dronc
K78R
. Our results conclude that DIAP1 mono-ubiquitylates 
Dronc at K78 in vivo (Figure 3.1). 
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When K78 inhibitory ubiquitylation is released by K78R mutation, we expected 
cell lethality of Flag-Dronc
K78R
 flies due to uncontrollable caspase activity and generated 
a cautionary construct, which was both non-ubiquitable and catalytically inactive (Flag-
Dronc
K78RC318A
). By examining Flag-Dronc
K78RC318A
, we made a surprising discovery. 
Very interestingly, ubiquitous expression of Flag-Dronc
K78RC318A
 could rescue the 
lethality caused by dronc null mutations, whereas Flag-Dronc
C318A
 alone could not rescue 
lethality. Investigation of Flag-Dronc
K78RC318A
 in a developmental apoptosis setting such 
as interommatidial cell (IOC) death in pupal eye discs showed that Flag-Dronc
K78RC318A
 
could not rescue extra IOC phenotype in dronc null mutants, suggesting that loss of K78 
ubiquitylation does not restore the catalytic activity of Flag-Dronc
K78RC318A
. These 
findings support two important conclusions: first, the catalytic activity of Dronc may not 
be essential for survival of the fly and second, removal of the inhibitory ubiquitylation of 
Dronc could bypass the requirement for its catalytic activity. Therefore, Dronc’s non-
apoptotic functions appear to be more important for the survival of the fly than its 
apoptotic function. 
We tested Flag-Dronc
K78RC318A
 in two different experimental settings where 
Dronc is known to have apoptosis-independent functions. In the first approach, we 
examined Flag-Dronc
K78RC318A
 in AiP. Interestingly, expression of Flag-Dronc
K78RC318A
 in 
ey>hid+p35 background resulted in significantly enhanced overgrowth, which could be 
suppressed by downregulation of Dark. Secondly, we analyzed male genitalia rotation 
defects observed in dronc null mutants. Surprisingly, Flag-Dronc
K78RC318A
 could rescue  
 
119 
 
 
 
 
Figure 3.1. Regulation of Dronc’s activity through mono-ubiquitylation. 
DIAP1 mono-ubiquitylates Dronc at K78 which resides in Dronc’s CARD domain. This 
ubiquitylation interferes Dronc’s interaction with Dark and thus apoptosome formation. 
As apoptosome formation is required for Dronc activation, K78 ubiquitylation has 
inhibitory implications for both apoptotic and non-apoptotic functions of Dronc. It is 
possible that K78 ubiquitylation may block interactions with other proteins that may have 
an effect in Dronc’s non-apoptotic functions. 
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male genitalia rotation defects by 62%, which could be reverted to 38% by expression of 
dark RNAi. We conclude that K78 ubiquitylation also plays an inhibitory role in AiP and 
male genitalia rotation, suggesting the importance of K78 ubiquitylation in Dronc’s non-
apoptotic functions. These findings also revealed that the non-apoptotic functions of 
Dronc
K78RC318A
 could be Dark-dependent (Figure 3.1). 
 
Part II. Discussion and Future Directions 
This thesis study uncovered a regulatory link between the ubiquitin system and 
apoptosis. Caspases require a tight control due to the nature of their protease activity. 
This control may involve proteasomal degradation or non-degradative means of 
inhibition through the ubiquitin system. Our studies showed that Dronc could be mono-
ubiquitylated, which is a non-degradative mark. Site of the mono-ubiquitylation resides 
in Dronc’s CARD domain at K78. K78 mono-ubiquitylation functions to block Dronc’s 
interaction with Dark, which is essential for formation of the apoptosome and activation 
of Dronc. Further examination of mono-ubiquitylation of Dronc unraveled its importance 
for two apoptosis-independent functions of Dronc, AiP and male genitalia rotation. 
However, it is unclear whether K78 ubiquitylation also plays a role in other non-apoptotic 
functions of Dronc. In addition, the underlying mechanisms for these apoptosis-
independent functions are unknown. The following section will discuss aspects of K78 
ubiquitylation in both apoptotic and non-apoptotic signaling and its possible relations to 
its mammalian counterparts. 
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A. Connecting Links Between K78 Ubiquitylation and Apoptosis 
There is a big debate in the Drosophila apoptosis field about how caspase activity 
could be controlled when activated by the apoptotic stimuli to avoid unnecessary cell 
death. Some studies suggest that the apoptosome in complex with DIAP1 is formed in 
tolerable amounts and when apoptotic stimuli arrive, its activity is amplified [99]. 
However, when the job is done, “feedback inhibition” and DIAP1 keep caspase activity 
in control to go back to normal. Specifically, “feedback inhibition” system suggested that 
Dark and most likely an active, proteolytically cleaved Dronc undergoes degradation 
potentially through DIAP1. On the other hand, there is evidence of increased 
transcriptional activity of caspases as a response to apoptosis induction [16]. 
Furthermore, in the case of effector caspases, unwanted caspase activity could be 
inhibited after they are activated [88].  
K78 ubiquitylation of Dronc is important for answering the question of how 
initiator caspases are kept inactive; however, it could be contradictory to the “feedback 
inhibition” theory. It is possible that both scenarios could work. For example, K78 
ubiquitylation could be an extra control step. At first step, Dronc activity is inhibited 
through K78 ubiquitylation but if surpassed, in the second step, apoptosome could be 
regulated through “feedback inhibition”. Then the next question would be how the first 
step could be surpassed? This could be regulated through the ubiquitin system such as a 
specific deubiquitinase that could determine release of K78 ubiquitylation on Dronc so 
that it could be recruited to the apoptosome. It is possible that after the first step is 
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surpassed, caspase activity is achieved and could be turned off once again through 
“feedback inhibition” to avoid further cell death at the end. 
Et deubiquitinase was discovered to carry out both anti- and pro-apoptotic 
functions through long and short isoforms [279]. Induction of apoptosis by the short 
isoform could be suppressed by upregulation of DIAP1 or downregulation of Dronc but 
not by P35 expression. This suggests that the function of Et may be exerted through 
Dronc, but not the effector caspases. Et was shown have homology to mammalian 
USP36, USP42 and USP17. As an example for the function of a mammalian homolog of 
Et, USP36 could remove c-Myc and SOD2 poly-ubiquitylation for their stabilization 
[326, 327]. Furthermore, two recent studies suggested that USP42 could remove poly-
ubiquitylation of P53 for its stabilization and mono-ubiquitylation of Histone H2B for 
activation of gene expression [328, 329]. In addition, USP17 was indicated to remove 
both K48- and K63-linked poly-ubiquitin chains from substrates [330, 331]. Although 
there is no evidence of functional specificity of Et, its mammalian homologs suggest that 
Et may hydrolyze both poly- and mono-ubiquitin. Thus, it is possible that K78 
ubiquitylation of Dronc could be removed by Et to mediate apoptosis induction and/or to 
surpass the first step of the control mechanism. 
As DIAP1 being a short-lived and its target Dronc being a long-lived protein, it is 
intriguing how DIAP1 keeps Dronc ubiquitylated at K78. Because mono-ubiquitylated 
Dronc is the major form we observed in vivo. DIAP1 was shown to undergo N-end rule 
degradation. When the first 20 aa of DIAP1 are removed, it is a more stable protein and 
can bind to UBR proteins to enhance ubiquitylation of effector caspases. It is possible 
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that binding to caspases blocks DIAP1’s interaction with RHG proteins. Thus, DIAP1 
could be a more stable and efficient E3 ligase toward effector caspases. It will be 
interesting to investigate whether K78 ubiquitylation also involves UBR proteins. 
Apoptosis induced by downregulation of UBR3 in the Drosophila eye could be 
suppressed by homozygosity at dronc, which may suggest that UBR3 may be involved in 
Dronc’s ubiquitylation at K78. There are 5 other UBR-box containing E3 ligases in the 
Drosophila genome. Testing each of them for K78 ubiquitylation through in vitro 
ubiquitylation and genetic interaction assays will be uncovering their involvement. 
Possible degradation of an active, processed Dronc in the apoptosome by DIAP1 
is what the “feedback inhibition” theory suggested [99]. It is possible that, as a second 
control mechanism, in case the first control mechanism is surpassed, Dronc and Dark 
could be poly-ubiquitylated for its degradation by DIAP1 while in the apoptosome. In 
fact, expression of both apoptosome components resulted in reduced Dark levels and 
Dark poly-ubiquitylation (preliminary observation). This is an interesting observation 
because it supports the “feedback inhibition” theory. It is compelling to find out the site 
of ubiquitylation and whether DIAP1 is responsible of this event. Because cleavage of 
Dark at residue 1292 may expose Lysine residues to be poly-ubiquitylated for 
degradation. Although, Dronc levels are also reduced, there was not any detectable Dronc 
poly-ubiquitylation in this context (preliminary observation). 
In addition to the idea of Dark ubiquitylation in the apoptosome, it will be 
interesting to investigate any possible ubiquitylation of free Dark for a tighter control of 
the apoptosome formation. Interestingly, alignment of the CARD domains of Dark and 
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Dronc shows that K78 is conserved in Dark (K93). This is a residue close to Y85 which 
forms a critical H bond with a critical residue (R82) in Dronc for apoptosome formation 
[95]. In addition, atomic resolution of the Dark-Dronc complex unraveled K86 of Dark’s 
CARD interacting with N92 of Dronc’s CARD through Hydrogen bond, which makes 
K86 another candidate for regulation of the apoptosome through ubiquitylation [95]. It is 
intriguing to study whether Dark is ubiquitylated at these residues or others to potentially 
regulate apoptosome formation. 
As seen in male genitalia rotation context, Flag-Dronc
K78RC318A
 could rescue 
rotation defect by 62% and this phenotype could be reverted by only 38% when Dark is 
downregulated. This suggests that Flag-Dronc
K78RC318A
 could exert this function partially 
independent from Dark. In the case of AiP, Dark downregulation suppressed 100% of 
Flag-Dronc
K78RC318A
-induced overgrowth. It is still a mystery how a catalytically inactive 
protein could induce such an effect. It is possible that removing the inhibitory mono-
ubiquitylation makes Dronc more susceptible for protein-protein interactions. This could 
result in recruitment of other initiator caspases or mediating its interaction with 
scaffolding proteins to recruit Dronc to caspase-rich areas in the cell. To answer these 
questions, it will be best to do an interactor mass-spectrometry analysis to find out 
interaction partners of Flag-Dronc
wt
, Flag-Dronc
K78R
, Flag-Dronc
K78RC318A
 and Flag-
Dronc
C318A
. This analysis may uncover scaffolding proteins such as Crinkled and/or 
caspases containing CARD domains. It could be also interesting to see novel or annotated 
UBD proteins that associate Dronc. Interestingly, a structural study of the Drosophila 
apoptosome showed that Dronc CARD (55-67) could interact with Dark WD1 (597-965) 
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[95]. This suggests that the CARD domain could interact with WD40 repeats. Thus, it is 
also possible to see WD40 repeat containing proteins in an interactor assay. Identified 
interactors could later be tested for their potential involvement in apoptosis or non-
apoptotic functions of Dronc. 
Post-translational modifications (PTM) are important for fine-tuning of protein 
activity. There are not many studies on regulation of Dronc through PTMs. In fact, there 
has been only one study which was about regulation of Dronc through inhibitory 
phosphorylation as a response to increased NADPH levels [98]. Caspase-9 and caspase-2 
were also shown to be phosphorylated at multiple sites. Our mass-spectrometry analyses 
on Dronc to find out ubiquitylated sites uncovered additional phosphorylation sites other 
than the reported one. These phosphorylation sites reside at the beginning of the caspase 
domain of Dronc. Dronc can be cleaved to release its caspase domain from its CARD 
domain  [95-97], which enhances its activity. These phosphorylation sites could 
potentially regulate cleavage of Dronc to release the caspase domain and to fine-tune its 
activity. Surprisingly, the same mass-spec analyses also indicated multiple methylation 
sites for Dronc. Although protein methylation was observed in the cell death field such as 
inhibitory mono-methylation of P53, there has not been any caspase reported to be 
methylated [332]. In a mammalian study, Numb was shown to be methylated at its 
PhosphoTyrosine Binding (PTB) domain, which blocks its interaction with P53 and thus 
apoptosis of breast cancer cells [333]. A recent study showed that Drosophila epithelial 
tissue regeneration is impaired when methionine metabolism is altered [334]. In addition, 
metabolic profiling of hemolymph of dark hypomorph showed reduced methylation 
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index due to a reduction of S-Adenosyl Methionine (SAM) level [335]. On the other 
hand, increased SAM level was associated with aging of flies [336]. There is clearly 
regulation of cellular pathways by methionine metabolism in Drosophila that are yet to 
be discovered. It will be very interesting to see if Dronc is involved in this process. 
Studying the methylation sites of Dronc observed in the mass-spec analysis and 
identifying their function will shed light on potential apoptotic or non-apoptotic functions 
of Dronc in methionine metabolism. 
In Drosophila testis, during spermatogenesis, spermatogonial cysts undergo cell 
death before entering meiosis, which is called Germ Cell Death (GCD) [337]. 
Interestingly, dronc null mutant showed a significant decrease in GCD, whereas dark 
mutant did not display any decrease in GCD, suggesting Dronc’s function is required 
independently of Dark in this process [337]. In addition, effector caspases were not 
essential for GCD [337]. It is intriguing to test whether Flag-Dronc
K78R
 and Flag-
Dronc
K78RC318A
 could function in GCD. Dronc’s activation mechanism has not been 
investigated in this context. Examining the role of K78 ubiquitylation of Dronc in this 
process could clarify if Dronc’s activity and/or presence is required for GCD.  
B. Potential Roles for K78 Ubiquitylation in Non-Apoptotic Systems 
The rescue of lethality of dronc
I24
/dronc
I29
 flies with expression of catalytically 
inactive and non-ubiquitable Flag-Dronc
K78RC318A
 was unexpected and fascinating. This 
observation strongly suggests that K78 ubiquitylation may exert its function 
independently of Dronc’s catalytic activity which seems to be dispensable for survival. 
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Further examination of this phenomena in AiP uncovered an inhibitory role for Flag-
Dronc
K78RC318A
. In addition to AiP, Dronc has other distinct non-apoptotic functions in 
different systems (discussed in detail in Part ID2). Flag-Dronc
K78RC318A
 construct carries a 
great importance for discovering mechanisms for its non-apoptotic functions that do not 
require its catalytic activity such as neuroblast differentiation and border cell migration. 
Flag-Dronc
K78R
 and Flag-Dronc
K78RC318A
 constructs could also help identifying 
mechanisms underlying non-apoptotic functions of Dronc that require its catalytic 
activity such as SOP development, neural pruning and spermatid individualization.  
A recent study identified Numb as an interactor of Dronc in Type II neuroblasts in 
the Drosophila Central Nervous System (CNS) [200]. Specifically, the PTB domain of 
Numb which includes conserved phosphorylation sites and the small subunit of Dronc are 
essential for this interaction [200]. Furthermore, phosphorylation of Numb impairs its 
interaction with Dronc. Numb localizes and inhibits Notch signaling in differentiating 
neurons [200]. Not localization but its function was impaired by phosphorylation of 
Numb, eliminating its tumor suppressor role [200]. Interestingly, expression of 
catalytically inactive Dronc could suppress the overproliferative neuroblast phenotype 
similar to wild-type Dronc by initiating neuronal differentiation [200]. This suggests that 
interaction of Numb and Dronc may not result in cleavage of Numb but may involve a 
signaling event downstream which is required for neural differentiation. Numb could 
inhibit Notch signaling through recruiting endocytic machinery for receptor-mediated 
endocytosis of Notch [338]. In another mechanism, Numb could bind to Sanpodo (a 
transmembrane protein that interacts with NICD for its activation) to prevent its 
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localization to the plasma membrane [339]. Although CARD of Dronc is not required for 
its interaction with Numb, it may still serve a function through binding adaptor proteins 
such as Crinkled for recruitment of Numb to the plasma membrane for its function. It will 
be interesting to investigate whether K78 ubiquitylation has a role in Numb/Dronc-
mediated function. Specifically, testing Flag-Dronc
K78R
 or Flag-Dronc
K78RC318A
 to see 
whether removal of K78 ubiquitylation could enhance inhibition of Notch signaling 
together with Numb will be interesting. Similarly, testing involvement of Dark in this 
process will be intriguing.  
In addition to CNS, Numb has also been implicated to function in asymmetric cell 
division and differentiation of neurons by inhibiting Notch signaling in SOP development 
[340]. It is unclear whether Dronc could interact with Numb in this context as well. 
Interestingly enough, Numb carries a Dronc cleavage site (TQTD) outside of its PTB 
domain. It is possible that Dronc may exert its function in SOP development or other 
contexts through cleaving Numb. 
During Drosophila oogenesis, a group of epithelial cells migrate from the anterior 
end of the egg chamber to the anterior end of oocyte (egg chamber stage early 9-10), 
which is called border cell migration [201]. There are many regulators of this process. 
For example, Rac GTPase could control actin rearrangement during migration [201]. A 
dominant negative form of Rac (RacN17) was shown to inhibit border cell migration, 
which could be rescued by overexpression of DIAP1 [203]. This phenotype could be 
further rescued by dominant negative form of Dronc or hypomorphic dark mutants, but 
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not by P35 expression [203]. This suggest that border cell migration is negatively 
regulated by the apoptosome, but not effector caspases. In this context, Dronc may cleave 
proteins that are downstream of Rac activity such as actin cytoskeleton components to 
impair border cell migration. Testing Dronc’s involvement in this context by examining 
its expression levels with Dark in the egg chambers, its possible interactions with and its 
activity toward other players of border cell migration will be intriguing. In addition, 
investigating whether Flag-Dronc
K78RC318A
 could rescue Rac17-induced phenotype better 
or worse than Flag-Dronc
C318A
 will be interesting. Moreover, testing defects after 
expression of UAS-Dronc constructs including Flag-Dronc
K78RC318A
 in the migrating cells 
could indicate surprising results. Slow border cells (Slbo) is a transcription factor that is 
required to turn on activation of motility effectors such as E-cadherin in border cells 
between Stages 8-9 [201]. Expression of Slbo is controlled by the JAK/STAT pathway. 
Overexpression of Slbo did not rescue RacN17-induced impairment of cell migration, 
suggesting Slbo could be upstream of or in parallel to Rac activity [201]. Interestingly, 
Slbo has a Dronc cleavage site (TQTD). Potential cleavage of Slbo by Dronc may 
interfere with its activation in a parallel pathway to Rac-DIAP1-Dronc-Dark pathway. 
Drosophila bristles originate from a single cell called Sensory Organ Precursor 
cell through asymmetric divisions and differentiation [341]. This process occurs between 
late larval to early pupal stages and involves various players and signaling events [341]. 
One of these players is Shaggy46 which regulates Wg signaling negatively [189]. 
Interestingly, Shaggy46 was shown to interact with Dronc, which facilitates its cleavage 
by effector caspases [189]. Further investigation showed that Crinkled acts as a 
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scaffolding protein to recruit Shaggy46 to caspases and mediate its cleavage by effector 
caspases [188]. Shaggy46 cleavage is essential for its kinase activation and inhibition of 
Wg signaling [189]. Because Dark and activation of Dronc are required for this process, 
it will be interesting whether the Flag-Dronc
K78R
 mutant could provide a better cleavage 
hence increased activation of Shaggy46 due to its enhanced interaction with Dark. This 
may even lead to missing bristles on the notum. Another consideration would be testing 
Flag-Dronc
K78RC318A
 in this context to see whether Shaggy46 could still be activated as 
K78R mutation was found to be intrinsic suppressor of catalytic inactivity in other 
contexts.  
Another context where both initiator and effector caspases are required for tissue 
remodeling is dendrite pruning. During metamorphosis, dendrites of C4da neurons are 
eliminated without damaging the neuron itself between 7-12 h after puparium formation 
[192, 193]. Localized caspase activity in dendrites provides this specialized event. 
Because dronc mutants provided a better protection against dendrite pruning than P35 
expression, effector caspases are possibly not the only targets of Dronc in this context 
[195]. Previous studies mostly focused on upstream regulation of Dronc such as DIAP1. 
It is compelling to find out the downstream effectors of Dronc for dendrite pruning. 
Dendrite pruning resembles apoptosis. For example, severing of dendrites occurs before 
caspase activation and debris is cleared by phagocytosis [342]. There may be common 
substrates of Dronc in dendrite pruning and canonical apoptosis. Because expression of a 
dominant negative form of Dronc impairs dendrite pruning, it will be intriguing to 
examine Flag-Dronc
K78RC318A
 in C4da neurons to see whether the process will be 
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impaired or not. Moreover, it could be investigated whether Flag-Dronc
K78R
 is more 
active than Flag-Dronc
wt
 in rescuing defects in neural pruning. In addition, Dark’s role 
has never been examined in dendrite pruning. It will be interesting to see whether dark 
mutants also exhibit impairment in this process.  
Spermatid individualization is a process occurring in late spermatogenesis. Both 
initiator and effector caspase activity could be observed in elongated cysts, cystic bulges 
and waste bags [103, 205]. Individualization Complexes (IC) form close to nuclear ends 
of elongated cysts and consist of cytoskeletal membrane complexes. IC of each spermatid 
goes along in great synchronization along the cyst. Expression of a dominant negative 
form of dronc or dronc null mutants interferes with IC and thus spermatid 
individualization [103, 205]. My preliminary observation suggests that Flag-
Dronc
K78RC318A
 could surprisingly suppress spermatid individualization defects in dronc 
null mutants. It is a mystery how Flag-Dronc
K78RC318A
 could have such an effect. As 
suggested for other functions, Flag-Dronc
K78RC318A
 could be interacting with other 
proteins/caspases to exert its function. It is important to note that sterility due to catalytic 
inactivity could not be suppressed by removing inhibitory ubiquitylation. The cyt c-d 
isoform was previously shown to be required for spermatid individualization and caspase 
activation [103, 105]. It will be interesting to test whether cyt c-d associates with the 
Drosophila apoptosome during spermatid individualization. dBruce, an E2 conjugase 
with BIR domain, is also involved in this process. dBruce levels are higher where caspase 
activity is lower [207]. dBruce null mutants showed condensed and rounded nuclei in the 
cysts, suggesting excessive caspase activity [103]. dBruce is known to target Reaper and 
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Grim; however, its function in this context is not clarified. dBruce could potentially target 
RHG proteins for degradation to inhibit caspases or target caspases directly during 
spermatid individualization. Examining these scenarios in testes could be interesting, 
especially in terms of ubiquitylation of Dronc. As a side note, the mammalian dBruce 
homolog, Apollon was shown to ubiquitylate caspase-9 in mammalian cells [254]. On the 
other hand, a deubiquitinase, DUBA is required for proper spermatid individualization 
[280]. It is unknown whether K78 ubiquitylation also occurs in spermatid 
individualization for controlling caspase activity; however, DUBA may be 
deubiquitylating Dronc at K78 to remove inhibition during spermatid individualization. 
Examining the phenotypes of Flag-Dronc
K78RC318A
 in above-mentioned systems 
could take advantage of a more practical system. An effector caspase biosensor such as 
CaspaseTracker could be useful and efficient for identifying both ongoing and past 
caspase activity in specific tissue types [343]. For Dronc-only-dependent functions, a 
Dronc-specific biosensor could be developed. CaspaseTracker sensor relies on 
endogenous caspase activity [343]. Using UAS-Flag-Dronc constructs may not answer 
our questions correctly. It will be a good idea to mutate endogenous Dronc at K78 and/or 
C318A and generate endogenous Flag-Dronc
K78R
 and Flag-Dronc
K78RC318A
 fly lines 
through Crispr/Cas9 technology [344]. These fly lines will more accurately show caspase 
activity and localization associated with K78R and K78RC318A mutations in these non-
apoptotic systems. 
C. Connecting Links Between K78 Ubiquitylation and Diseases 
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Downregulation of apoptosis is commonly seen in cancer cells. Circumventing 
inhibitory ubiquitylation of caspases could help activating apoptosis machinery in tumor 
cells. K78 residue is unfortunately not conserved in caspase-9. In fact, caspase-9 does not 
have any Lysine residues at its CARD domain. However, caspase-2 which has 46% 
similarity to Dronc have multiple Lysine residues at its CARD domain. Investigation of 
caspase-2 ubiquitylation status at its CARD domain could reveal a controlling 
mechanism for its activation, similar to Dronc. Lack of caspase-2 was shown to 
accelerate oncogene-driven tumorigenesis in various models, suggesting a tumor 
suppressor function for caspase-2 [173]. Finding an inhibitory ubiquitylation of caspase-2 
could help developing therapeutic tools for its tumor suppressor function. 
On the other hand, caspase-2 has been implicated in neurodegenerative diseases 
such as Alzheimer’s Disease. A recent study showed that caspase-2 cleavage of Tau 
contributes to impairment of memory function in Alzheimer’s Disease [169]. 
Interestingly, Dronc-dependent Tau cleavage was also shown in a study that links 
circadian clock and Alzheimer’s Disease [345]. It will be compelling to investigate if 
K78 ubiquitylation of Dronc has an inhibitory function toward cleavage of Tau. Tau 
expression could induce a rough eye phenotype due to degeneration of photoreceptor 
neurons of Drosophila [346]. Furthermore, shaggy expression can enhance tau-induced 
rough eye phenotype through phosphorylating Tau which contributes to its toxicity [347]. 
An isoform of Shaggy, Shaggy46 was shown to be activated by caspase cleavage in SOP 
development [189]. It is not clear whether Shaggy46 could also phosphorylate Tau. 
However, it is intriguing to investigate whether Tau phosphorylation could also be 
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regulated through cleavage of Shaggy or Shaggy46 by caspases and contribute to toxicity 
of Tau in Drosophila. In this direction, examining whether Flag-Dronc
K78R
 could enhance 
Shaggy-induced Tau toxicity in Drosophila could be interesting. If Dronc contributes to 
Tau toxicity through cleavage of Tau or Shaggy, generation of a ubiquitin-mimetic Dronc 
to rescue Tau-dependent neurodegeneration will be intriguing to study. 
A study questioning effects of apoptosis on aging discovered that caspase-2-
deficient mice had decreased life span and increased aging-related traits [348]. Further 
studies identified that caspase-2 plays a role in responding oxidative stress, regulation of 
mitochondrial function and metabolic pathways, which can be possible mechanisms of 
how caspase-2 regulates aging [349]. If caspase-2 activity is negatively regulated by an 
inhibitory ubiquitylation similar to Dronc, it would be interesting to examine a non-
ubiquitable caspase-2 in terms of aging. Similar to caspase-2, dronc null mutant flies also 
die in a few days after eclosion [61]. Moreover, another study showed that aging flies 
have increased levels of activated Dronc [345]. Interestingly, paraquat (a superoxide 
radical generator) injection into mice caused activation of caspase-2 and caspase-2
 
deficient mice displayed upregulation of JNK signaling [349]. A recent study from our 
lab also linked oxidative stress, JNK signaling and Dronc in AiP model [182]. It will be 
interesting to investigate whether a more active Dronc such as Flag-Dronc
K78R
 could have 
any impact on fly life span through influencing oxidative stress response, mitochondrial 
functions, metabolic pathways or other mechanisms yet to be discovered.  
Caspase-1 is an important regulator of immune responses in mammals. Upon 
infectious stimuli, caspase-1 is activated after forming a protein complex called 
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inflammasome with NOD-like receptor proteins (such as NLRP3) through interactions 
between their CARD domains [173, 174]. Inflammasome is required for cleavage and 
maturation of cytokines IL-1β and IL-18 for immune responses [173, 174]. 
Inflammasome assembly is similar to the apoptosome assembly because in both cases, 
caspases and scaffolding proteins interact through their CARD domains with induced-
proximity [173, 174]. Therefore, it is possible that the inflammasome formation may be 
regulated by ubiquitylation in CARD of caspase-1. In fact, caspase-1 CARD domain 
carries 8 lysine residues. Previous studies showed conflicting results on caspase-1 
activation through ubiquitylation [350, 351]. One study suggested cIAP-1 and cIAP-2 
conjugate K63 poly-ubiquitin chains on caspase-1, which promotes caspase-1 activation; 
whereas another study suggested combined depletion of XIAP, cIAP-1 and cIAP-2 leads 
to caspase-1 activation [350, 351]. None of these studies examined site of ubiquitylation 
and its mechanism in detail. It will be interesting to see if CARD domain of caspase-1 
can be ubiquitylated and whether this potential ubiquitylation or reported K63 poly-
ubiquitylation has any effect on inflammasome assembly.  
As exampled above, K78 mono-ubiquitylation could open doors to new research 
revenues in the apoptosis field. Testing function of this ubiquitylation in the context of 
Dronc’s activation and its mammalian counterpart by extension could allow us to make 
discoveries which will benefit our understanding of the apoptotic machinery and caspase 
activation. Studying this ubiquitylation and its relationship to Dronc’s catalytic activity in 
the context of its non-apoptotic functions may also result in identifying new regulatory 
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mechanisms that could help us understand roles of caspases in apoptosis-independent 
cellular pathways. 
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Abstract 
A major function of ubiquitylation is to deliver target proteins to the proteasome 
for degradation. In the apoptotic pathway in Drosophila, the inhibitor of apoptosis protein 
1 (Diap1) regulates the activity of the initiator caspase Dronc (Caspase-9 ortholog) by 
ubiquitylation, supposedly targeting Dronc for degradation by the proteasome. Using a 
genetic approach to analyze proteasome function in epithelial cells in vivo, we show that 
Dronc is not subject of proteasome-mediated degradation, contrary to the expectation. 
Likewise, an alternative catabolic pathway, autophagy, does not mediate degradation of 
Dronc either. However, combined impairment of the proteasome and autophagy triggers 
accumulation of Dronc protein levels suggesting that autophagy compensates for the loss 
of the proteasome with respect to Dronc turnover. Consistently, we show that loss of the 
proteasome enhances endogenous autophagy in epithelial cells. We propose that 
enhanced autophagy degrades Dronc if proteasome function is impaired.  
Introduction 
There are two major catabolic pathways in eukaryotic cells that degrade the bulk 
of cellular proteins, the ubiquitin-proteasome system (UPS) and macro-autophagy, 
usually referred to as autophagy [295, 352-354]. In the UPS, poly-ubiquitylated proteins 
are delivered to the 26S proteasome for degradation. The 26S proteasome consists of a 
20S catalytic core, flanked by two 19S regulatory complexes [355, 356]. The 20S 
catalytic core is composed of a total of 28 α- and β-type subunits which are organized in a 
barrel with four stacked rings. The outer two rings are formed by seven α-type subunits 
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each, the two inner rings by seven β-type subunits each [355]. All α- and β-type subunits 
are needed for structural integrity of the proteasome [357]. Three β-type subunits, β1, β2 
and β5, have proteolytic activity [356]. The 19S regulatory particle is composed of at 
least nineteen subunits involved in recognition of ubiquitin-conjugated substrates, ATP 
hydrolysis, de-ubiquitination, protein unfolding and feeding of the substrates into the 20S 
catalytic core for degradation [355]. Genetic studies in yeast and Drosophila have 
revealed that mutations in many subunits of the 20S core and the 19S regulatory domains 
impair proteasome function [358, 359]. Genetic analysis of proteasome function is also of 
clinical importance as proteasome inhibition may be used as potential anti-tumor strategy, 
especially for treatment of multiple myeloma [360-363]. 
Autophagy is characterized by the formation of double-membrane vesicles termed 
autophagosomes [364, 365]. During autophagosome maturation, cytosolic proteins and 
entire organelles are trapped and delivered to the lysosome for degradation. Two 
ubiquitin-like conjugation pathways (Atg8/LC3 and Atg12) are active during maturation 
of autophagosomes [364, 365]. Atg7 is an E1-activating enzyme involved in both 
conjugation pathways [364] and essential for autophagy [366]. The incorporation of Atg8 
fusion proteins (for example with GFP or mCherry) into autophagosomes is often used as 
a marker for autophagosomes [367] and autophagic flux [368].  
While it was initially assumed that the UPS system and autophagy are 
independent of each other, recent evidence has suggested that there is crosstalk and 
feedback between the two [352, 369-377] (reviewed by [353, 378, 379]). This is mostly 
due to the observation that autophagy can also degrade ubiquitylated proteins [380-384]. 
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Mechanistically, p62, an adaptor protein with an ubiquitin-binding domain and a LC3 
interacting region (LIR), links poly-ubiquitylated proteins to LC3/Atg8 at the 
autophagosome [380]. Loss of autophagy can lead to the formation of protein aggregates 
composed of poly-ubiquitylated proteins and p62. These protein aggregates are 
frequently associated with neurodegenerative diseases in humans [385-387]. 
Apoptosis is the major form of cell death and evolutionarily well conserved from 
flies to humans [283, 388]. Caspases are highly specific Cys-proteases and are the main 
effectors of apoptosis. They are produced as inactive precursor zymogens that are 
activated either through incorporation into large protein complexes such as the 
apoptosome (initiator caspases) or by proteolytic processing (effector caspases) [173, 
286]. After activation in the apoptosome, initiator caspases such as Caspase-9 and its 
Drosophila ortholog Dronc cleave and activate effector caspases such as Caspase-3 and 
its Drosophila ortholog DrICE [4, 283].  
The activity of caspases is controlled at multiple levels. In addition to zymogen 
production, apoptosome-mediated activation of Caspase-9/Dronc and proteolytic 
processing of Caspase-3/DrICE, caspases are also inhibited by inhibitor of apoptosis 
proteins (IAPs), most notably XIAP in mammals and Diap1 in Drosophila [4]. IAPs 
carry a RING domain which has E3 ubiquitin ligase activity [291]. In Drosophila, 
because the RING domain of Diap1 ubiquitylates Dronc [78-80, 389], it is commonly 
assumed that this ubiquitylation targets the caspase for proteasome-mediated degradation 
[79, 80].  However, in vivo this has not been observed. On the contrary, we have shown 
that loss or gain of Diap1 does not affect the protein levels of Dronc in surviving cells 
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[89]. A similar observation has been reported for DrICE [389].  Furthermore, a mouse 
mutant deleting the RING domain of XIAP does not significantly affect caspase protein 
levels [146]. Therefore, it is currently unclear how the protein levels of Dronc are 
controlled in living cells to avoid deleterious accumulation and potentially auto-
processing of these dangerous proteins. 
Traditionally, in Drosophila the function of autophagy has been studied mainly in 
large non-epithelial cells such as the fat body, midgut and salivary glands, because these 
tissues require autophagy for turnover during metamorphosis [364]. A role of autophagy 
in epithelial cells such as larval imaginal discs has been less explored. Here, we report 
that in epithelial cells the protein levels of Dronc are unaffected by proteasome 
impairment. Similarly, loss of autophagy by itself does not affect Dronc protein levels. 
However, simultaneous impairment of the proteasome and autophagy causes 
accumulation of Dronc suggesting that autophagy can compensate for the loss of the 
proteasome with respect to Dronc turnover. Consistently, autophagy is enhanced in 
proteasome mutants in epithelial cells. In summary, these data identify Dronc as a 
common substrate for both the proteasome and autophagy.   
Results 
Accumulation of polyubiquitylated proteins is a convenient marker for proteasome 
dysfunction 
Ubiquitylation of Dronc by Diap1 has previously been observed in vitro [78, 80]. 
To directly test if ubiquitylated Dronc is degraded by the proteasome, we analyzed Dronc 
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protein levels in two mutants affecting the proteasome. The first mutant, prosβ2, also 
known as DTS7 in Drosophila [390], affects the β2 subunit of the 20S catalytic core of 
the proteasome. The Prosβ2 subunit provides both structural integrity to the proteasome 
and proteolytic activity [357]. The second mutant affects the Mov34 gene (also known as 
p39B) which encodes a subunit in the 19S regulatory complex, corresponding to Rpn8 in 
yeast and S12 in the human regulatory complex [391]. Both mutants, prosβ2EP3067 and 
Mov34
k08003
, are caused by P-element insertions in the first exon which likely disrupt the 
transcripts. Both proteasome mutants behave identically in our assays (see below). 
Because these proteasome mutants are homozygous lethal, we induced mutant clones 
using the ey-Flp/FRT system [392, 393].  Not unexpectedly, mutant clones affecting the 
proteasome are very small and are difficult to identify using negative selection with GFP 
(Figure A1A-C). However, we were able to positively mark and identify mutant clones 
using antibodies that recognize ubiquitin or ubiquitin-conjugated proteins. Antibodies 
raised against ubiquitin display increased immunoreactivity in prosβ2 mutant clones 
(Figure A1A’). There is a perfect match between the GFP-negative areas which mark the 
prosβ2 mutant clones, and increased abundance of ubiquitin labeling (Figure A1A’’). 
Because poly-ubiquitin-conjugated proteins are usually subject to proteasome-mediated 
degradation, we tested whether ubiquitin-conjugated proteins account for the 
accumulation of ubiquitin in prosβ2 mutants. The FK1 and FK2 antibodies specifically 
recognize ubiquitin-conjugated proteins, but not unconjugated ubiquitin (FK1 labels 
poly-ubiquitylated conjugates, FK2 labels mono- and poly-ubiquitylated proteins)  
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Figure A1. prosβ2 mutant cells accumulate ubiquitin-conjugated proteins. 
Shown are high magnification images (100X) of the posterior compartment of prosβ2 
mosaic eye imaginal discs labeled for ubiquitin (A), FK2 (B) and FK1(C). The FK2 and 
FK1 antibodies detect ubiquitin-conjugated proteins, but not free unconjugated ubiquitin. 
The left panels indicate the positions of the proteasome mutant clones by absence of 
GFP, the middle panels show the experiment (in magenta), and the right panels are the 
merged images of left and middle panels. White arrows mark a few clones as examples. 
In this and all other figures, anterior is to the left. Similar data were obtained for Mov34 
mosaic discs (Figure A2). Wild-type mosaic control discs do not show accumulation of 
ubiquitin (Figure A2). Genotype: ey-FLP; prosβ2EP3067 FRT80 / ubi-GFP FRT80.  
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Figure A2. Mov34 mutants accumulate ubiquitin-conjugated proteins.  
Shown are high magnification images (100X) of the posterior compartment of Mov34 
mosaic eye imaginal discs labeled for FK2 (A’, A’’) and FK1(B’, B’’). The FK2 and FK1 
antibodies detect ubiquitin-conjugated proteins, but not free unconjugated ubiquitin. The 
left panels indicate the positions of the proteasome mutant clones by absence of GFP (A, 
B), the middle panels show the experiment (in magenta), and the right panels are the 
merged images of left and middle panels. White arrows mark a few clones as examples. 
Genotype: ey-FLP; FRT42D Mov34
k08003
 / FRT42D P[ubi-GFP]. 
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Figure A3. Wild-type control mosaic discs do not accumulate ubiquitin and 
ubiquitin-conjugated proteins. 
Shown are wild-type (wt) mosaic eye imaginal control discs (wt clones in wt 
background) labeled for ubiquitin (A, A’), FK1 (B, B’) and FK2 (C, C’). Control clones 
are marked by the absence of GFP. Ubiquitin and ubiquitin-conjugates do not accumulate 
in control clones. Genotype: ey-FLP; FRT42D P[ubi-GFP] / FRT42D. 
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[303, 394]. As shown in Figure A1B, C, the immunoreactivity of FK1 and FK2 
antibodies increases in prosβ2 mutant clones. We also find increased FK1 and FK2 
labeling in Mov34 mutant clones (Figure A2). In wild-type (wt) control mosaics (wt 
clones in wt background), an accumulation of ubiquitin and conjugated ubiquitin (FK1/2) 
is not observed (Figure A3) suggesting that ubiquitin-conjugated proteins specifically 
accumulate in proteasome-deficient cells in vivo, consistent with the expectation. 
Mutations in proteasome subunits cause cell death 
Based on the results presented above, we used FK2 labeling to positively mark 
and identify proteasome mutant clones. First, we examined the consequence of 
proteasome dysfunction for the survival of the affected cells. The rationale of this 
experiment was that in clinical applications, proteasome inhibitors are used to induce 
apoptosis in cancer patients including multiple myeloma [361, 363]. Consistently, 
pharmacological inhibition of the proteasome by Bortezomib in whole flies resulted in 
DrICE cleavage after 4 days of treatment [377]. This treatment correlated with a strong 
reduction of longevity of the affected animals. In contrast, tissue-specific inhibition of the 
proteasome in fat body cells by RNAi did not confirm such an apoptotic response [395]. 
Because RNAi is known to cause partial loss-of-function phenotypes, we tested the 
strong prosβ2 mutant allele in mosaic eye-antennal imaginal discs for apoptosis 
induction. Indeed, using cleaved caspase-3 antibody labelings, we observed activated 
caspases in proteasome-deficient clones (Figure A3). However, not all mutant clones 
contain active caspases. Nevertheless, whether apoptotic or not, all clones are very small 
indicating that the mutant cells do not grow very well. 
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Figure A4. Mutations in proteasome subunits result in cell death. 
Shown are high magnification images (100X) of the posterior compartment of prosβ2 
mosaic eye imaginal discs labeled for cleaved caspase-3 (Csp3) and FK2 to identify 
prosβ2 mutant clones. Csp3 labeling is increased in some, but not all prosβ2 mutant 
clones (red in A’ and A”). Genotype: ey-FLP; prosβ2EP3067 FRT80 / ubi-GFP FRT80.    
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Mutant clones of proteasome subunits accumulate Diap1, but do not affect Dronc 
protein levels 
Because Diap1 can ubiquitylate Dronc in vitro, [78, 80] it was predicted that 
Dronc is subject to proteasome-mediated degradation in surviving cells [79, 80]. It 
follows that in surviving cells the protein levels of Dronc would accumulate in 
proteasome mutants. We tested this prediction by analyzing prosβ2 and Mov34 mutant 
clones located in the posterior eye imaginal disc of third instar larvae. We chose the 
posterior eye imaginal disc in this analysis because under normal conditions, there is no 
developmental apoptosis in this tissue, thus avoiding complications with physiological 
apoptosis. Surprisingly, Dronc protein levels are not detectably altered in prosβ2 and 
Mov34 mutant clones (Figure A5A, B). We also found the same result using a different 
prosβ2 mutant allele, the commonly used DTS7 allele (Figure A6), although this allele 
did not cause accumulation of poly-ubiquitylated proteins (FK1 antibody labeling) 
suggesting that it is a weaker allele as the one used in Figure A5A. The specificity of the 
anti-Dronc antibody was previously established in dronc mosaic eye and wing imaginal 
discs, and the antibody can also detect accumulated Dronc protein [89].   
However, to further confirm the lack of Dronc accumulation in proteasome 
mutants, we analyzed the protein levels of a heterologously expressed Flag-tagged Dronc 
[98] in proteasome mosaic eye discs. Using the Flag antibody as a tool to monitor Dronc 
levels, we also did not detect an accumulation of Flag-Dronc in Mov34 mutant cells 
(Figure A7). 
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Figure A5. Diap1, but not Dronc, accumulate in proteasome mutant clones. 
Shown are high magnification images (100X) of the posterior compartment of prosβ2 
(A,C) and Mov34 (B,D) mosaic eye imaginal discs labeled for Dronc (A,B) and Diap1 
(C,D). FK2 labeling was used to identify mutant clones. The left panels indicate the 
positions of the proteasome mutant clones by absence of GFP. In the middle panels, the 
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proteasome mutant clones are positively marked by FK2 labeling (in magenta). The right 
panels show the Dronc (A’’, B’’) and Diap1 labelings (C’’, D’’) in red. White arrows 
mark a few clones as examples.  
Genotype in (A) and (C): ey-FLP; prosβ2EP3067 FRT80 / P[ubi-GFP] FRT80. Genotype in 
(B) and (D): ey-FLP; FRT42D Mov34
k08003
 / FRT42D P[ubi-GFP]. 
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Figure A6. Mutant clones of the DTS7 allele of prosβ2 do not accumulate Dronc. 
Mosaic prosβ2DTS7 eye imaginal discs labeled for Dronc (A’, A’’) and FK1 (A’’’, A’’’’). 
Mutant clones are marked by the absence of GFP (A). Dronc does not accumulate in 
mutant clones. However, FK1 labeling is also not enhanced suggesting that DTS7 in 
homozygous clones is a weak allele. The cross was performed at 25°C. Genotype: ey-
FLP; prosβ2DTS7 FRT80 / P[ubi-GFP] FRT80. 
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Figure A7. Flag-Dronc protein does not accumulate in Mov34 mutant clones. 
Shown is the posterior compartment of a Mov34 mosaic eye imaginal disc expressing 
Flag-dronc by the da-Gal4 driver. Mov34 clones are marked by the absence of GFP (A, 
A’). Heterologous Flag-Dronc protein levels are detected using an anti-Flag antibody (A, 
A’’). White arrows highlight a few select Mov34 clones as examples. Flag-Dronc does 
not accumulate in Mov34 clones. Genotype: ey-FLP; FRT42D Mov34
k08003
 / FRT42D 
P[ubi-GFP]; da-Gal4 UAS-Flag-dronc. 
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As a positive control, we analyzed Diap1 protein levels in proteasome mutants. 
Diap1 degradation in dying cells has been demonstrated in vivo [82, 84, 85, 273].  
Consistently, we observe accumulation of Diap1 in prosβ2 and Mov34 mutant clones 
(Figure A5C, D). Thus, our assay can detect accumulating proteins in vivo.  
Because there is no or only very little apoptosis occurring at the investigated stage 
of the mosaic discs (obtained from late third instar larvae), these data suggest that the 
protein levels of Diap1 in living cells are regulated by the UPS system. In contrast, 
protein levels of Dronc in living cells are either not regulated by the UPS system, or there 
are compensatory mechanisms operating that turn over Dronc upon proteasome 
dysfunction. 
Loss of the autophagy gene Atg7 does not affect Dronc protein levels 
In addition to the UPS, autophagy is a cellular catabolic process known to degrade 
proteins [352, 354, 365]. We considered the possibility that autophagy may regulate the 
protein levels of Dronc. As described in the Introduction, the autophagy gene Atg7 
encodes the E1-activating enzyme for the two ubiquitin-like conjugation systems and is 
an essential gene for autophagy [364, 366]. Therefore, because proteasomal dysfunction 
does not affect the protein levels of Dronc in living epithelial cells, we tested the 
possibility that autophagy may control it. For that purpose, we down-regulated Atg7 
function by RNAi or inactivated Atg7 in mutant clones. However, similar to proteasomal 
dysfunction, impaired autophagy does not affect Dronc protein levels in mosaic eye-
antennal imaginal discs (Figure A8A, B).  
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Figure A8. Loss of Atg7 alone does not affect Dronc protein levels. 
Dronc labeling of Atg7 mosaic eye imaginal discs. Atg7 was either down-regulated by 
RNAi (A) or genetically inactivated in mutant clones (B). Atg7-deficient clones are 
marked by absence of GFP. White arrows highlight one clone in each panel as example. 
Dronc protein levels are unaltered in Atg7-deficient clones.  
Genotypes: (A) yw hsFLP; tub>GFP>Gal4 / UAS-Atg7
12-3
 (> denotes FRT). (B) yw 
eyFLP; FRT42D Atg7
d14
 / FRT42D P[ubi-GFP]. 
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Simultaneous inactivation of both the proteasome and autophagy triggers 
accumulation of Dronc protein 
We examined the possibility that the protein levels of Dronc are coordinately 
regulated by both catabolic pathways. To address this question, we inactivated autophagy 
by ATG7 RNAi in prosβ2 mutant clones using the MARCM method [319].  Indeed, 
simultaneous impairment of both the proteasome and autophagy causes strong 
accumulation of Dronc protein in eye-antennal imaginal discs (Figure A9A). Similar 
observations were also made in wing imaginal discs, another epithelial tissue (Figure 
A9B). The accumulation of Dronc in proteasome/autophagy double-deficient clones is 
not due to a transcriptional upregulation of dronc transcripts (Figure A10). Together, 
these data suggest that Dronc protein levels are coordinately regulated by both the 
proteasome and autophagy. 
Loss of proteasome function enhances autophagy in epithelial cells 
To explain the synergistic control of Dronc protein levels by the UPS system and 
autophagy, we considered two scenarios. First, it is possible that both catabolic processes 
degrade Dronc independently of each other and if one process is lost, the other one can 
still maintain Dronc at normal protein levels. In the second scenario, we considered that, 
because the UPS system and autophagy are mechanistically linked, impairment of the 
UPS can enhance autophagy which is often referred to as compensatory autophagy [352, 
369-377] (reviewed by [353, 378, 379]). For example, in Drosophila, compensatory 
autophagy after proteasome impairment has been reported in neurons, in fat body cells  
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Figure A9. Dronc accumulates in clones simultaneously mutant for the proteasome 
and autophagy. 
Mosaic eye (A) and wing (B) imaginal discs doubly deficient for the proteasome and 
autophagy labeled for Dronc (red). Atg7 knockdown was induced by RNAi in prosβ2 
mutant clones using the MARCM method. Clones are marked by GFP. Dronc 
accumulates in double deficient clones. The cross was performed at 25°C. Genotype: hs-
FLP UAS-GFP tub-Gal4; UAS-Atg7
12-3
/+ ; prosβ2DTS7 FRT80B / tub-Gal80 FRT80B. 
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Figure A10. dronc transcripts do not accumulate in proteasome and autophagy-
deficient animals.  
Late L3 larvae of control (w1118) and experimental genotype (w; UAS-Atg7RNAi; da-
Gal4 / DTS7) were shifted to 29°C until eclosion of adult flies. mRNA was extracted 
from 1-3 days old flies. Extracted RNA was subjected to qPCR for dronc and tubulin (as 
control). dronc transcripts are not significantly increased in proteasome and autophagy-
deficient animals. This experiment was performed twice. The student t-test was used. 
Error bars are SD. ns – not significant. 
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and in adult flies [372, 377, 395]. To examine this scenario in epithelial cells, we 
monitored autophagy using a tandem fusion protein GFP-mCherry-Atg8 as reporter for 
autophagic flux [368]. This reporter is incorporated into autophagosomes which mature 
into autolysosomes. In autolysosomes, fluorescence of the GFP moiety of the reporter is 
quenched, while mCherry signals persist. Therefore, this reporter is suited to monitor 
autophagic flux from autophagosomes into autolysosomes. Indeed, mCherry signals, but 
not GFP, strongly accumulate in Mov34 mutant clones (Figure 6) suggesting that 
autophagic flux is induced in response to proteasome impairment.   
Discussion 
In this paper, we examined the consequences of impaired proteasome function on 
apoptosis and components of the apoptotic pathway in epithelial cells. We observed that 
proteasome dysfunction triggers apoptosis in some, but not all, mutant clones (Figure 
A4). We also found that protein levels of Diap1, but not Dronc, accumulate in 
proteasome-deficient cells (Figure A5). Dronc also does not accumulate in autophagy-
deficient cells in which the E1 encoding gene Atg7 was mutant or down-regulated by 
RNAi (Figure A8). However, simultaneous inactivation of the proteasome and Atg7 
resulted in strong accumulation of Dronc (Figure A9). In addition, autophagy is strongly 
enhanced in proteasome mutants (Figure A11).  
Our data indicate that Dronc is a shared substrate for degradation by both the UPS 
and autophagy. There are not many substrates known which are common to both the UPS 
and autophagy. α-synuclein is one substrate and mutant forms of this protein appear to  
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Figure A11. Impaired proteasome function induces autophagic flux.  
Mov34 mosaic eye imaginal discs expressing GFP-mCherry-Atg8a as marker for 
autophagic flux. Mov34 mutant cells were identified by FK2 labeling (blue in a; gray in 
a’). White arrows mark representative Mov34 mutant cells as examples. Although there is 
little to no GFP labeling in Mov34 mutant cell clones (a’’), all clones contain increased 
mCherry labeling (a’’’) suggesting that autophagic flux is enhanced in proteasome-
deficient cells. Genotype: ey-FLP; 
FRT42D Mov34k08003 /FRT42D; patg8a4GFP-mCherry-Atg8a 
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poison both the UPS and autophagy causing Parkinson’s disease [396-398]. Another 
shared substrate is IĸBα, the inhibitor of the transcription factor NF-kB.[399]  IĸBα 
appears to be degraded by the UPS and autophagy in different cellular compartments 
with different rates [399]. In addition to these specific shared substrates, misfolded 
proteins are common substrates for both the UPS and autophagy [379, 400]. Whether this 
relates to Dronc, is currently unknown.  
It is unclear what distinguishes Dronc from Diap1 with respect to proteasome-
mediated degradation and enhanced autophagy. The alternative question would be why 
Diap1 is not degraded by enhanced autophagy in proteasome-deficient cells. There may 
be specific ubiquitylation marks or other post-translational modifications that distinguish 
between these possibilities. Additional work is necessary to answer these questions in the 
future. 
Given the accumulation of the anti-apoptotic protein Diap1 in proteasome-
deficient cells, it is somewhat surprising that some of them undergo apoptosis. However, 
many other proteins likely also accumulate in proteasome-deficient cells which combined 
will tilt the fate of the affected cells to either survival or death depending on relative 
ratios. This consideration may explain why some cells are apoptotic and others are not. 
Another possibility is that the non-apoptotic cells in mutant clones will die later or are 
already dead. Consistent with the latter notion, we have previously shown that dead cells 
lack protein and DNA [401], hence the cleaved caspase-3 antibody would not label these 
cells. Importantly also, even though not all proteasome-deficient cells may be apoptotic at 
the time of investigation, they do not grow very well and remain small. These 
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considerations are important for the potential clinical use of proteasome inhibitors for 
treatment of cancer.  
Genetic analysis of proteasome function 
This is the first report in which a clonal analysis of proteasome mutants was 
performed. Usually, dominant temperature sensitive (DTS) alleles of proteasome subunits 
(DTS5, DTS7, etc.), RNAi or pharmacological inhibition have been used to study 
proteasome function [358, 372, 377, 390, 395, 402].  In other approaches, whole embryos 
mutant for proteasome subunits were characterized for defects in dendrite pruning in 
sensory neurons in Drosophila [193, 403, 404]. However, a specific analysis 
characterizing recessive alleles for defects in proteasome activity has not been reported. 
The reasons for this omission are obvious. Mutant animals are homozygous lethal and 
mutant clones in otherwise heterozygous animals are very small and difficult to identify. 
We found that cells mutant for proteasome function accumulate ubiquitin-conjugated 
proteins (Figure A1), consistent with the expectation. We used markers detecting 
ubiquitin-conjugated proteins to positively identify mutant clones. That enabled us to 
identify Diap1 as substrate of the proteasome, whereas control of Dronc protein levels 
appears to be independent of the proteasome (Figure A5). The proteasome alleles used in 
this study and our approach to identify mutant clones will be of general use for future 
analysis of proteasome function. 
Methods 
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Fly stocks: prosβ2EP3067 is a P element transposon insertion in the first exon at base pair 
63 [405].  Mov34
k08003 
is a P element transposon insertion in the first exon at base pair 
263 [403, 404]. Both insertions disrupt the transcripts. prosβ2DTS7 encodes a dominant 
temperature sensitive allele of prosβ2; however, in this work, we used it in genetic 
mosaics using FRT80B DTS7, not applying a temperature-shift. Atg7
d14
 is a mutant allele 
as described [366]. UAS-ATG7
12-3
 and UAS-ATG7
IR
 (VDRC TID45561) are RNAi lines 
that target ATG7. UAS-Flag-dronc encodes a Dronc protein with an N-terminal Flag-tag 
[98]. It was expressed using daughterless-Gal4 (da-Gal4) in Mov34 mosaic background 
(Figure A7). A transgene encoding the tandem protein GFP-mCherry-ATG8a was 
generated and used to determine autophagic flux [368].  
Generation of mutant clones: Mutant clones of prosβ2, Mov34 and Atg7 were induced 
in eye-antennal imaginal discs using the FLP/FRT-induced mitotic recombination system 
using ey-FLP [392, 393]. For this purpose, mutant alleles of prosβ2 and Mov34 were 
recombined on FRT80B and FRT42D bearing chromosomes, respectively. FRT42D 
Atg7
d14
 was used as described [366]. To generate wild-type control mosaics (Figure A3), 
ey-Flp; FRT42D P[ubi-GFP] was used. Clones are marked by loss of GFP. To induce 
Atg7 RNAi in prosβ2 mutant clones, the MARCM method was used [319]. 
Immunohistochemistry: Eye-antennal imaginal discs from third instar larvae were 
dissected using standard protocols [322] and labeled with antibodies raised against the 
following antigens: Ubiquitin (Sigma); FK1 and FK2 (Biomol); cleaved Caspase-3 (Cell 
Signaling Technology); Dronc (kind gift of Pascal Meier), Diap1 (a kind gift of Hermann 
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Steller and Hyung Don Ryoo) and Flag (Sigma Aldrich). Cy3- and Cy-5 fluorescently-
conjugated secondary antibodies are obtained from Jackson ImmunoResearch and were 
used at dilutions of 1:400. In each experiment, multiple clones in 10-20 eye imaginal 
discs were analyzed, unless otherwise noted. Images were captured using Olympus 
Optical FV500 or Zeiss LSM700 confocal microscopes. 
Generation of the GFP-mCherry-Atg8a tandem reporter: A transgene encoding the 
tandem protein GFP-mCherry-Atg8a was generated and used to determine autophagic 
flux.18 A region 2-kb upstream of Atg8a (CG32672) was inserted upstream of GFP-
mCherry-Atg8a in the pCaSpeR4 Drosophila transformation vector, as was previously 
described for similar GFP-Atg8a and mCherry-Atg8a reporter lines [406, 407]. The 
resulting plasmid pCaSpeR4-promoter GFPmCherry-Atg8a was used to generate 
transgenic Drosophila lines using standard procedures. 
qPCR of dronc transcripts: Late 3rd larval stage (L3) larvae of control (w
1118
) and 
experimental genotype (w; UAS-Atg7
RNAi
; da-Gal4/DTS7) were shifted to 29 °C until 
eclosion of adult flies. mRNA was extracted from 1 to 3 days old flies using RNAeasy 
(Qiagen, Hilden, Germany) and quantitative polymerase chain reaction (qPCR) was 
performed with the following dronc-specific primers: Nedd2-like caspase forward primer 
(NcF) 5'-CTCGCTAAACGAACGGAGAAC-3' and Nedd2-like caspase reverse primer 
(NcR) 5'-CAACGACACCCACATAAGGG-3', as described [408]. Tubulin was used for 
normalization. 
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